10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

FORM 10-Q

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2019

or

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 1-9819

DYNEX CAPITAL, INC.

(Exact name of registrant as specified in its charter)

Virginia	52-1549373
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
4991 Lake Brook Drive, Suite 100, Glen Allen, Virginia	23060-9245
(Address of principal executive offices)	(Zip Code)
(804) 217-5800 (Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes           x           No           o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes           x           No           o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	x
Non-accelerated filer	o	Smaller reporting company	o
		Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes           o           No           x

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value	DX	New York Stock Exchange
8.50% Series A Cumulative Redeemable Preferred Stock, par value $0.01 per share	DXPRA	New York Stock Exchange
7.625% Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share	DXPRB	New York Stock Exchange

On April 30, 2019, the registrant had 73,763,826 shares outstanding of common stock, $0.01 par value, which is the registrant’s only class of common stock.

DYNEX CAPITAL, INC.

FORM 10-Q

INDEX

			Page
PART I.	FINANCIAL INFORMATION
	Item 1.	Financial Statements
		Consolidated Balance Sheets as of March 31, 2019 (unaudited) and December 31, 2018	1
		Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2019 (unaudited) and March 31, 2018 (unaudited)	2
		Consolidated Statements of Shareholders' Equity for the three months ended March 31, 2019 and March 31, 2018 (unaudited)	3
		Consolidated Statements of Cash Flows for the three months ended March 31, 2019 (unaudited) and March 31, 2018 (unaudited)	4
		Notes to the Unaudited Consolidated Financial Statements	5
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	45
	Item 4.	Controls and Procedures	49
PART II.	OTHER INFORMATION
	Item 1.	Legal Proceedings	50
	Item 1A.	Risk Factors	51
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	51
	Item 3.	Defaults Upon Senior Securities	51
	Item 4.	Mine Safety Disclosures	51
	Item 5.	Other Information	51
	Item 6.	Exhibits	52
SIGNATURES			53

i

PART I.        FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

CONSOLIDATED BALANCE SHEETS

(amounts in thousands except share data)

	March 31, 2019			December 31, 2018
ASSETS	(unaudited)
Mortgage-backed securities (including pledged of $4,547,769 and $3,511,604 respectively)	$	4,842,447		$	3,749,464
Mortgage loans held for investment, net	10,862			11,527
Cash and cash equivalents	55,902			34,598
Restricted cash	86,761			54,106
Derivative assets	6,030			6,563
Accrued interest receivable	26,075			21,019
Other assets, net	7,056			8,812
Total assets	$	5,035,133		$	3,886,089
LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities:
Repurchase agreements	$	4,252,893		$	3,267,984
Payable for unsettled securities	151,075			58,915
Non-recourse collateralized financing	3,219			3,458
Derivative liabilities	—			1,218
Accrued interest payable	12,939			10,308
Accrued dividends payable	6,927			13,810
Other liabilities	3,406			3,243
Total liabilities	4,430,459			3,358,936
Shareholders’ equity:
Preferred stock, par value $.01 per share; 50,000,000 shares authorized; 6,168,062 and 5,954,594 shares issued and outstanding, respectively ($154,202 and $148,865 aggregate liquidation preference, respectively)	$	147,898		$	142,883
Common stock, par value $.01 per share, 200,000,000 shares authorized; 72,248,146 and 62,817,218 shares issued and outstanding, respectively	722			628
Additional paid-in capital	872,010			818,442
Accumulated other comprehensive income (loss)	50,688			(35,779		)
Accumulated deficit	(466,644		)	(399,021		)
Total shareholders’ equity	604,674			527,153
Total liabilities and shareholders’ equity	$	5,035,133		$	3,886,089

See notes to the unaudited consolidated financial statements.

1

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(unaudited)

(amounts in thousands except per share data)

	Three Months Ended
	March 31,
	2019			2018
Interest income	$	39,957		$	25,190
Interest expense	26,276			11,595
Net interest income	13,681			13,595
(Loss) gain on derivative instruments, net	(61,697		)	38,354
Loss on sale of investments, net	—			(3,775		)
Fair value adjustments, net	(13		)	29
Other operating expense, net	(231		)	(253		)
General and administrative expenses:
Compensation and benefits	(1,898		)	(1,962		)
Other general and administrative	(2,056		)	(1,681		)
Net (loss) income	(52,214		)	44,307
Preferred stock dividends	(3,059		)	(2,940		)
Net (loss) income to common shareholders	$	(55,273	)	$	41,367
Other comprehensive income:
Unrealized gain (loss) on available-for-sale investments, net	$	86,632		$	(49,189	)
Reclassification adjustment for loss on sale of investments, net	—			3,775
Reclassification adjustment for de-designated cash flow hedges	(165		)	(48		)
Total other comprehensive income (loss)	86,467			(45,462		)
Comprehensive income (loss) to common shareholders	$	31,194		$	(4,095	)
Net (loss) income per common share-basic and diluted	$	(0.81	)	$	0.74
Weighted average common shares-basic and diluted	68,435			55,871

See notes to the unaudited consolidated financial statements.

2

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(unaudited)

($ in thousands)

	Preferred Stock			Common Stock					Additional Paid-in Capital			Accumulated Other Comprehensive Loss			Accumulated Deficit			Total Shareholders’ Equity
	Shares	Amount		Shares		Amount
Balance as of December 31, 2017	5,888,680	$	141,294	55,831,549		$	558		$	775,873		$	(8,697	)	$	(351,970	)	$	557,058
Stock issuance	20,319	494		45,401		1			293			—			—			788
Restricted stock granted, net of amortization	—	—		176,233		2			333			—			—			335
Adjustments for tax withholding on share-based compensation	—	—		(57,135	)	(1		)	(363		)	—			—			(364		)
Stock issuance costs	—	—		—		—			(19		)	—			—			(19		)
Net income	—	—		—		—			—			—			44,307			44,307
Dividends on preferred stock	—	—		—		—			—			—			(2,940		)	(2,940		)
Dividends on common stock	—	—		—		—			—			—			(10,079		)	(10,079		)
Other comprehensive loss	—	—		—		—			—			(45,462		)	—			(45,462		)
Balance as of March 31, 2018	5,908,999	$	141,788	55,996,048		$	560		$	776,117		$	(54,159	)	$	(320,682	)	$	543,624
Balance as of December 31, 2018	5,954,594	$	142,883	62,817,218		$	628		$	818,442		$	(35,779	)	$	(399,021	)	$	527,153
Stock issuance	213,468	5,015		9,327,139		93			53,779			—			—			58,887
Restricted stock granted, net of amortization	—	—		152,462		2			296			—			—			298
Adjustments for tax withholding on share-based compensation	—	—		(48,693	)	(1		)	(295		)	—			—			(296		)
Stock issuance costs	—	—		—		—			(212		)	—			—			(212		)
Net loss	—	—		—		—			—			—			(52,214		)	(52,214		)
Dividends on preferred stock	—	—		—		—			—			—			(3,059		)	(3,059		)
Dividends on common stock	—	—		—		—			—			—			(12,350		)	(12,350		)
Other comprehensive income	—	—		—		—			—			86,467			—			86,467
Balance as of March 31, 2019	6,168,062	$	147,898	72,248,126		$	722		$	872,010		$	50,688		$	(466,644	)	$	604,674

See notes to the unaudited consolidated financial statements.

3

DYNEX CAPITAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

($ in thousands)

	Three Months Ended
	March 31,
	2019			2018
Operating activities:
Net (loss) income	$	(52,214	)	$	44,307
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Increase in accrued interest receivable	(5,056		)	(3,094		)
Increase in accrued interest payable	2,631			1,389
Loss (gain) on derivative instruments, net	61,697			(38,354		)
Loss on sale of investments, net	—			3,775
Fair value adjustments, net	13			(29		)
Amortization of investment premiums, net	31,083			35,769
Other amortization and depreciation, net	222			312
Stock-based compensation expense	298			335
Change in other assets and liabilities, net	1,625			(2,514		)
Net cash and cash equivalents provided by operating activities	40,299			41,896
Investing activities:
Purchase of investments	(1,019,100		)	(321,348		)
Principal payments received on investments	73,817			51,972
Proceeds from sales of investments	—			154,613
Principal payments received on mortgage loans held for investment, net	646			649
Net (payments) receipts on derivatives, including terminations	(62,382		)	36,271
Other investing activities	(102		)	(67		)
Net cash and cash equivalents used in investing activities	(1,007,121		)	(77,910		)
Financing activities:
Borrowings under repurchase agreements	32,608,826			27,508,732
Repayments of repurchase agreement borrowings	(31,623,917		)	(27,460,742		)
Principal payments on non-recourse collateralized financing	(242		)	(234		)
Proceeds from issuance of preferred stock	5,015			494
Proceeds from issuance of common stock	53,872			294
Cash paid for stock issuance costs	(185		)	—
Payments related to tax withholding for stock-based compensation	(296		)	(364		)
Dividends paid	(22,292		)	(12,982		)
Net cash and cash equivalents provided by financing activities	1,020,781			35,198
Net increase (decrease) in cash, cash equivalents, and restricted cash	53,959			(816		)
Cash, cash equivalents, and restricted cash at beginning of period	88,704			87,200
Cash, cash equivalents, and restricted cash at end of period	$	142,663		$	86,384
Supplemental Disclosure of Cash Activity:
Cash paid for interest	$	23,807		$	10,251

See notes to the unaudited consolidated financial statements.

4

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

Dynex Capital, Inc. (“Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in debt securities, the majority of which are specified pools of Agency and non-Agency mortgage-backed securities (“MBS”) consisting of residential MBS (“RMBS”), commercial MBS (“CMBS”) and CMBS interest-only (“IO”) securities that are issued or guaranteed by U.S. Government sponsored agencies (“Agency MBS”) and MBS issued by others (“non-Agency MBS”). The Company also invests in other types of mortgage-related securities, such as to-be-announced securities (“TBAs” or “TBA securities”).

Basis of Presentation

The accompanying unaudited consolidated financial statements of Dynex Capital, Inc. and its subsidiaries (together, “Dynex” or, as appropriate, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all significant adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the consolidated financial statements have been included. Operating results for the three months endedMarch 31, 2019 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2019. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Form 10-K”) filed with the SEC.

Consolidation and Variable Interest Entities

The consolidated financial statements include the accounts of the Company and the accounts of its majority owned subsidiaries and variable interest entities (“VIE”) for which it is the primary beneficiary. All intercompany accounts and transactions have been eliminated in consolidation.

The Company consolidates a VIE if the Company is determined to be the VIE’s primary beneficiary, which is defined as the party that has both: (i) the power to control the activities that most significantly impact the VIE’s financial performance and (ii) the right to receive benefits or absorb losses that could potentially be significant to the VIE. The Company reconsiders its evaluation of whether to consolidate a VIE on an ongoing basis, based on changes in the facts and circumstances pertaining to the VIE.

The Company consolidates a securitization trust, which has residential mortgage loans included in “mortgage loans held for investment, net” on its consolidated balance sheet, of which a portion is pledged as collateral for one remaining bond recorded as “non-recourse collateralized financing” on its consolidated balance sheet. The Company owns the subordinate class in the trust and has been deemed the primary beneficiary.

Though the Company invests in Agency and non-Agency MBS which are generally considered to be interests in VIEs, the Company does not consolidate these entities because it does not meet the criteria necessary to be deemed a primary beneficiary. Please refer to Note 2 for financial information regarding the Company’s investments in these debt securities.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to,

5

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

amortization of premiums and discounts, fair value measurements of its investments, and other-than-temporary impairments. These items are discussed further below within this note to the consolidated financial statements.

Income Taxes

The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986 and the corresponding provisions of state law. To qualify as a REIT, the Company must meet certain tests including investing in primarily real estate-related assets and the required distribution of at least 90% of its annual REIT taxable income to stockholders after consideration of its net operating loss (“NOL”) carryforward and not including taxable income retained in its taxable subsidiaries. As a REIT, the Company generally will not be subject to federal income tax on the amount of its income or capital gains that is distributed as dividends to shareholders.

The Company assesses its tax positions for all open tax years and determines whether the Company has any material unrecognized liabilities in accordance with Accounting Standards Codification (“ASC”) Topic 740. The Company records these liabilities, if any, to the extent they are deemed more likely than not to have been incurred.

Net Income (Loss) Per Common Share

The Company calculates basic net income per common share by dividing net income to common shareholders for the period by weighted-average shares of common stock outstanding for that period. The Company did not have any potentially dilutive securities outstanding during the three months ended March 31, 2019 or March 31, 2018.

Holders of unvested shares of the Company’s issued and outstanding restricted common stock are eligible to receive non-forfeitable dividends. As such, these unvested shares are considered participating securities as per ASC Topic 260-10 and therefore are included in the computation of basic net income per common share using the two-class method. Upon vesting, restrictions on transfer expire on each share of restricted stock, and each such share of restricted stock represents one unrestricted share of common stock.

Because the Company’s 8.50% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) and 7.625% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”) are redeemable at the Company’s option for cash only and may convert into shares of common stock only upon a change of control of the Company, the effect of those shares and their related dividends is excluded from the calculation of diluted net income per common share.

Cash and Cash Equivalents

Cash and cash equivalents include cash on hand and highly liquid investments with original maturities of three months or less.

Restricted Cash

Restricted cash consists of cash the Company has pledged to cover initial and variation margin with its financing and derivative counterparties.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported on the Company's consolidated balance sheet as of March 31, 2019 that sum to the total of the same such amounts shown on the Company’s consolidated statement of cash flows for the three months endedMarch 31, 2019:

	March 31, 2019
Cash and cash equivalents	$	55,902
Restricted cash	86,761
Total cash, cash equivalents, and restricted cash shown on consolidated statement of cash flows	$	142,663

6

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

Investments in Debt Securities

The Company’s investments in debt securities are designated as available-for-sale (“AFS”) and are recorded at fair value on the Company’s consolidated balance sheet. Changes in unrealized gain (loss) on the Company’s debt securities are reported in other comprehensive income (“OCI”) until the investment is sold, matures, or is determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income (“AOCI”) into net income as a realized “gain (loss) on sale of investments, net” using the specific identification method.

The fair value of the Company’s debt securities pledged as collateral against repurchase agreements and derivative instruments is disclosed parenthetically on the Company’s consolidated balance sheets.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on debt securities is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or “IO”, securities) and their contractual terms. Premiums or discounts associated with the purchase of Agency MBS as well as any non-Agency MBS rated ‘AA’ and higher are amortized or accreted into interest income over the expected life of such securities using the effective yield method, and adjustments to premium amortization and discount accretion are made for actual cash payments. The Company may also adjust premium amortization and discount accretion for changes in projected future cash payments. The Company’s projections of future cash payments are based on input and analysis received from external sources and internal models and include assumptions about the amount and timing of loan prepayment rates, fluctuations in interest rates, credit losses, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets. The Company does not estimate future prepayments on its fixed-rate Agency RMBS.

The Company holds certain non-Agency MBS that had credit ratings of less than ‘AA’ at the time of purchase or were not rated by any of the nationally recognized credit rating agencies. A portion of these non-Agency MBS were purchased at discounts to their par value, which management does not believe to be substantial. The discount is accreted into income over the security’s expected life based on management’s estimate of the security’s projected cash flows. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

Determination of MBS Fair Value.The Company estimates the fair value of the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company’s MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security’s coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. Refer to Note 5 for further discussion of MBS fair value measurements.

Other-than-Temporary Impairment. An MBS is considered impaired when its fair value is less than its amortized cost. The Company evaluates all of its impaired MBS for other-than-temporary impairments (“OTTI”) on at least a quarterly basis. An impairment is considered other-than-temporary if: (1) the Company intends to sell the MBS; (2) it is more likely than not that the Company will be required to sell the MBS before its fair value recovers; or (3) the Company does not expect to recover the full amortized cost basis of the MBS. If either of the first two conditions is met, the entire amount of the impairment is recognized in earnings. If the impairment is solely due to the inability to fully recover the amortized cost basis, the security is further analyzed to quantify any credit loss, which is the difference between the present value of cash flows expected to be collected on the MBS and its amortized cost. The credit loss, if any, is then recognized in earnings, while the balance of impairment related to other factors is recognized in other comprehensive income.

Following the recognition of an OTTI through earnings, a new cost basis is established for the security. Any subsequent recoveries in fair value may be accreted back into the amortized cost basis of the MBS on a prospective basis through interest income. Please see Note 2 for additional information related to the Company’s evaluation for OTTI.

Repurchase Agreements

7

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

The Company’s repurchase agreements, which are used to finance its purchases of debt securities, are accounted for as secured borrowings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

Derivative Instruments

The Company’s derivative instruments generally include interest rate swaps, futures, and forward contracts for the purchase or sale of non-specified Agency RMBS, commonly referred to as “TBA securities” or “TBA contracts”. Derivative instruments are accounted for at the fair value of their unit of account. Derivative instruments in a gain position are reported as derivative assets and derivative instruments in a loss position are reported as derivative liabilities on the Company’s consolidated balance sheet. All periodic interest benefits/costs and changes in fair value of derivative instruments, including gains and losses realized upon termination, maturity, or settlement are recorded in “gain (loss) on derivative instruments, net” on the Company’s consolidated statement of comprehensive income. Cash receipts and payments related to derivative instruments are classified in the investing activities section of the consolidated statements of cash flows in accordance with the underlying nature or purpose of the derivative transactions.

The Company’s interest rate swap agreements are privately negotiated in the over-the-counter (“OTC”) market and the majority of these agreements are centrally cleared through the Chicago Mercantile Exchange (“CME”) with the rest being subject to bilateral agreements between the Company and the swap counterparty. The Company’s CME cleared swaps require that the Company post initial margin as determined by the CME, and in addition, variation margin is exchanged, typically in cash, for changes in the fair value of the CME cleared swaps. The exchange of variation margin for CME cleared swaps is legally considered to be the settlement of the derivative itself as opposed to a pledge of collateral. Accordingly, the Company accounts for the daily exchange of variation margin associated with its CME cleared interest rate swaps as a direct increase or decrease to the carrying value of the related derivative asset or liability. The carrying value of derivative instruments on the Company’s consolidated balance sheets is the unsettled fair value of the instruments subject to bilateral agreements and not centrally cleared through the CME.

A TBA security is a forward contract (“TBA contract”) for the purchase (“long position”) or sale (“short position”) of a non-specified Agency MBS at a predetermined price with certain principal and interest terms and certain types of collateral, but the particular Agency securities to be delivered are not identified until shortly before the settlement date. The Company accounts for long and short positions in TBAs as derivative instruments because the Company cannot assert that it is probable at inception and throughout the term of an individual TBA transaction that its settlement will result in physical delivery of the underlying Agency RMBS, or the individual TBA transaction will not settle in the shortest time period possible.

Please refer to Note 4 for additional information regarding the Company’s derivative instruments as well as Note 5 for information on how the fair value of these instruments are calculated.

8

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

Share-Based Compensation

Pursuant to the Company’s 2018 Stock and Incentive Plan (“2018 Plan”), the Company may grant share-based compensation to eligible employees, non-employee directors or consultants or advisors to the Company, including restricted stock awards, stock options, stock appreciation rights, performance units, restricted stock units, and performance cash awards. The Company’s restricted stock currently issued and outstanding may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date and recognized as compensation cost over the requisite service period with a corresponding credit to shareholders’ equity. The requisite service period is the period during which a participant is required to provide service in exchange for an award, which is equivalent to the vesting period specified in the terms of the time-based restricted stock award. None of the Company’s restricted stock awards have performance-based conditions. The Company does not currently have any share-based compensation issued or outstanding other than restricted stock issued to its employees, officers, and directors.

Contingencies

In the normal course of business, there may be various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, the Company evaluates whether to establish provisions for estimated losses from those matters. The Company recognizes a liability for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, Financial Instruments - Credit Losses, which replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For assets measured at amortized cost, the amendments in this ASU eliminate the probable initial recognition threshold in current GAAP and broaden the information that an entity must consider in developing its expected credit loss estimate to include the use of forecasted information. For assets classified as available-for-sale with changes in fair value recorded in other comprehensive income, measurement of credit losses will be similar to current GAAP. However, the amendments in this ASU require that credit losses be presented as an allowance rather than as a write-down, which is referred to in current GAAP as an other-than-temporary impairment. An entity will be able to record reversals of credit losses, if credit loss estimates decline, in net income for the current period. The amendments in this ASU will not permit an entity to use the length of time a debt security has been in an unrealized loss position to avoid recording a credit loss and removes the requirements to consider historical and implied volatility of the fair value of a security as well as recoveries or declines in fair value after the balance sheet date. The amendments in this ASU will affect an entity by varying degrees depending on a number of factors, including but not limited to, the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. These amendments will become effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. An entity will apply the amendments in this ASU through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Though the Company has not fully completed evaluating the impact this ASU will have on its financial condition and results of operations, the Company does not expect it will have a material impact given that the majority of its investments are Agency MBS.

NOTE 2 – INVESTMENTS IN DEBT SECURITIES

The majority of the Company’s debt securities are pledged as collateral for the Company’s repurchase agreements. The following tables present the Company’s debt securities by investment type (including securities pending settlement) as of the dates indicated:

9

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

	March 31, 2019
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC (1)
RMBS:
Agency	$	2,683,276	$	77,584		$	2,760,860	$	31,813	$	(11,403	)	$	2,781,270	4.04	%
Non-Agency	803		—			803		27		(21		)	809		6.75	%
	2,684,079		77,584			2,761,663		31,840		(11,424		)	2,782,079
CMBS:
Agency	1,507,835		10,775			1,518,610		30,766		(9,864		)	1,539,512		3.23	%
Non-Agency	2,910		(1,927		)	983		677		—			1,660		6.27	%
	1,510,745		8,848			1,519,593		31,443		(9,864		)	1,541,172
CMBS IO (2):
Agency	—		282,636			282,636		5,982		(154		)	288,464		0.53	%
Non-Agency	—		227,868			227,868		3,249		(385		)	230,732		0.56	%
	—		510,504			510,504		9,231		(539		)	519,196
Total AFS securities:	$	4,194,824	$	596,936		$	4,791,760	$	72,514	$	(21,827	)	$	4,842,447

(1) The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).

(2) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $13,146,249 and $10,158,055 respectively, as of March 31, 2019.

	December 31, 2018
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC (1)
RMBS:
Agency	$	2,118,639	$	56,744		$	2,175,383	$	8,902	$	(26,264	)	$	2,158,021	3.95	%
Non-Agency	856		—			856		24		(22		)	858		6.75	%
	2,119,495		56,744			2,176,239		8,926		(26,286		)	2,158,879
CMBS:
Agency	1,071,906		8,518			1,080,424		6,141		(29,550		)	1,057,015		3.22	%
Non-Agency	3,040		(2,037		)	1,003		413		—			1,416		6.47	%
	1,074,946		6,481			1,081,427		6,554		(29,550		)	1,058,431
CMBS IO (2):
Agency	—		287,062			287,062		4,281		(239		)	291,104		0.55	%
Non-Agency	—		240,681			240,681		1,675		(1,306		)	241,050		0.57	%
	—		527,743			527,743		5,956		(1,545		)	532,154
Total AFS securities:	$	3,194,441	$	590,968		$	3,785,409	$	21,436	$	(57,381	)	$	3,749,464

(1) The WAC is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).

(2) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $13,048,666 and $10,275,494, respectively, as of December 31, 2018.

10

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

Actual maturities of MBS are affected by the contractual lives of the underlying mortgage collateral, periodic payments of principal, prepayments of principal, and the payment priority structure of the security; therefore, actual maturities are generally shorter than the securities' stated contractual maturities. The following table categorizes the Company’s debt securities according to their stated maturity as of the dates indicated:

	March 31, 2019				December 31, 2018
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Less than 1 year	$	119,121	$	121,882	$	39,868	$	39,808
>1 and <5 years	151,888		154,615		151,041		152,917
>5 and <10 years	911,278		910,315		828,543		806,015
> 10 years	3,609,473		3,655,635		2,765,957		2,750,724
	$	4,791,760	$	4,842,447	$	3,785,409	$	3,749,464

The following table presents information regarding the sales that generated the “loss on sale of investments, net” on the Company’s consolidated statements of comprehensive income (loss) for the periods indicated:

	Three Months Ended
	March 31,
	2019				2018
	Proceeds Received		Realized Gain (Loss)		Proceeds Received		Realized Gain (Loss)
Agency CMBS	—		—		$	108,758	$	(2,052	)
U.S. Treasuries	—		—		46,498		(1,723		)
	$	—	$	—	$	155,256	$	(3,775	)

The following table presents certain information for the AFS securities in an unrealized loss position as of the dates indicated:

	March 31, 2019						December 31, 2018
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	46,127	$	(174	)	9	$	581,440	$	(1,793	)	28
Non-Agency MBS	25,130		(177		)	7	70,876		(581		)	22
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	1,293,417	$	(21,248	)	61	$	1,543,892	$	(54,260	)	88
Non-Agency MBS	21,512		(228		)	13	46,154		(747		)	19

Because the principal related to Agency MBS is guaranteed by the government-sponsored entities Fannie Mae and Freddie Mac which have AAA ratings due to the Treasury’s commitment of capital under the Senior Preferred Stock Purchase Agreement, the Company does not consider any of the unrealized losses on its Agency MBS to be credit related. Although the unrealized losses are not credit related, the Company assesses its ability and intent to hold any Agency MBS with an unrealized loss until the recovery in its value in accordance with GAAP. This assessment is based on the amount of the unrealized loss and significance of the related investment as well as the Company’s leverage and liquidity position. Based on this analysis, the

11

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

Company has determined that the unrealized losses on its Agency MBS as of March 31, 2019 and December 31, 2018 were temporary.

The Company reviews any non-Agency MBS in an unrealized loss position to evaluate whether any decline in fair value represents an OTTI. The evaluation includes a review of the credit ratings of the non-Agency MBS, the credit characteristics of the mortgage loans collateralizing these securities, and the estimated future cash flows including projected collateral losses. The Company also assesses its ability and intent to hold any non-Agency MBS with an unrealized loss until the recovery in its value in accordance with GAAP. The Company performed this evaluation for its non-Agency MBS in an unrealized loss position and has determined that there have not been any adverse changes in the timing or amount of estimated future cash flows that necessitate a recognition of OTTI amounts as of March 31, 2019 or December 31, 2018.

NOTE 3 – REPURCHASE AGREEMENTS

The Company’s repurchase agreements outstanding as of March 31, 2019 and December 31, 2018 are summarized in the following tables:

	March 31, 2019						December 31, 2018
Collateral Type	Balance		Weighted Average Rate		Fair Value of Collateral Pledged		Balance		Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,582,697	2.75	%	$	2,719,705	$	1,887,878	2.66	%	$	1,998,922
Agency CMBS	1,220,326		2.68	%	1,304,731		919,833		2.51	%	986,861
Agency CMBS IO	253,168		3.05	%	282,927		253,258		2.96	%	285,247
Non-Agency CMBS IO	196,702		3.39	%	230,244		207,015		3.38	%	240,574
Total repurchase agreements	$	4,252,893	2.78	%	$	4,537,607	$	3,267,984	2.69	%	$	3,511,604

The Company also had $151,075 and $58,915 payable to counterparties as of March 31, 2019 and December 31, 2018, respectively, which consisted of securities pending settlement as of those respective dates.

The following table provides information on the remaining term to maturity and original term to maturity for the Company’s repurchase agreements as of the dates indicated:

	March 31, 2019			December 31, 2018
Remaining Term to Maturity	Balance		WAVG Original Term to Maturity	Balance		WAVG Original Term to Maturity
Less than 30 days	$	3,459,566	52	$	2,319,911	56
30 to 90 days	793,327		82	948,073		89
Total	$	4,252,893	58	$	3,267,984	66

The following table lists the counterparties with whom the Company had approximately 10% or more of its shareholders’ equity at risk (defined as the excess of collateral pledged over the borrowings outstanding) as of the date indicated:

	March 31, 2019
Counterparty Name	Balance		Weighted Average Rate		Equity at Risk
Wells Fargo Bank, N. A. and affiliates	$	357,111	3.56	%	$	43,381

Of the amount outstanding with Wells Fargo Bank, N.A. and affiliates, $212,631 is under a committed repurchase facility which has an aggregate maximum borrowing capacity of $400,000 and is scheduled to mature on May 12, 2019, subject

12

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

to early termination provisions contained in the master repurchase agreement. The facility is collateralized by CMBS IO, and its weighted average borrowing rate as of March 31, 2019 was 3.32%.

As of March 31, 2019, the Company had repurchase agreement amounts outstanding with 19 of its 36 available repurchase agreement counterparties. The Company’s counterparties, as set forth in the master repurchase agreement with the counterparty, require the Company to comply with various customary operating and financial covenants, including, but not limited to, minimum net worth and earnings, maximum declines in net worth in a given period, and maximum leverage requirements as well as maintaining the Company’s REIT status. In addition, some of the agreements contain cross default features, whereby default under an agreement with one lender simultaneously causes default under agreements with other lenders. To the extent that the Company fails to comply with the covenants contained in these financing agreements or is otherwise found to be in default under the terms of such agreements, the counterparty has the right to accelerate amounts due under the master repurchase agreement. The Company was in full compliance with all covenants as of March 31, 2019.

The Company's repurchase agreements are subject to underlying agreements with master netting or similar arrangements, which provide for the right of offset in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its repurchase agreements to these arrangements on a gross basis. The following tables present information regarding the Company's repurchase agreements as if the Company had presented them on a net basis as of March 31, 2019 and December 31, 2018:

	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet (1)					Net Amount
							Financial Instruments Posted as Collateral			Cash Posted as Collateral
March 31, 2019
Repurchase agreements	$	4,252,893	$	—	$	4,252,893	$	(4,252,893	)	$	—	$	—
December 31, 2018
Repurchase agreements	$	3,267,984	$	—	$	3,267,984	$	(3,267,984	)	$	—	$	—

(1) Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of debt securities up to and not exceeding the net amount of the repurchase agreement liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented.

Please see Note 4 for information related to the Company’s derivatives which are also subject to underlying agreements with master netting or similar arrangements.

NOTE 4 – DERIVATIVES

     The Company is a party to certain types of financial instruments that are accounted for as derivative instruments. Please refer to Note 1 for information related to the Company’s accounting policy for its derivative instruments.

Types and Uses of Derivatives Instruments

Interest Rate Derivatives. Changing interest rates impact the fair value of the Company’s investments as well as the interest rates on the Company’s repurchase agreement borrowings used to finance its investments. The Company primarily uses interest rate swaps as economic hedges to mitigate declines in book value and to protect some portion of the Company's earnings from rising interest rates. The Company may also periodically utilize other types of interest rate derivatives, such as Eurodollar and U.S. Treasury futures as economic hedges.

TBA Transactions. The Company also holds long positions in TBA securities by executing a series of transactions which effectively delay the settlement of a forward purchase of a non-specified Agency RMBS by entering into an offsetting TBA short position, net settling the paired-off positions in cash, and simultaneously entering into an identical TBA long position with a later settlement date. These long positions in TBA securities (“dollar roll positions”) are viewed by management as economically

13

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

equivalent to investing in and financing non-specified fixed-rate Agency RMBS. TBA securities purchased for a forward settlement month are generally priced at a discount relative to TBA securities sold for settlement in the current month. This discount, often referred to as “drop income” represents the economic equivalent of net interest income (interest income less implied financing cost) on the underlying Agency security from trade date to settlement date.

Periodically, the Company may also hold short positions in TBA securities for the purpose of economically hedging a portion of the impact of changing interest rates on the fair value of the Company’s fixed-rate Agency RMBS. The Company did not hold any short positions in TBA securities as of March 31, 2019.

The table below summarizes information about the fair value by type of derivative instrument on the Company’s consolidated balance sheets as of the dates indicated:  

Type of Derivative Instrument	Balance Sheet Location	Purpose	March 31, 2019		December 31, 2018
Interest rate swaps	Derivative assets	Economic hedging	$	112	$	324
TBA securities	Derivative assets	Trading	5,918		6,239
			$	6,030	$	6,563
U.S. Treasury futures	Derivative liabilities	Economic hedging	$	—	$	(1,218	)

The table below provides detail of the Company’s “(loss) gain on derivative instruments, net” by type of derivative for the periods indicated:

	Three Months Ended
	March 31,
Type of Derivative Instrument	2019			2018
Receive-fixed interest rate swaps	$	—		$	(1,129	)
Pay-fixed interest rate swaps	(71,764		)	49,372
Eurodollar futures	—			1,905
TBA dollar roll positions	10,176			(12,087		)
TBA economic hedges	—			293
U.S. Treasury futures	(109		)	—
(Loss) gain on derivative instruments, net	$	(61,697	)	$	38,354

14

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

Interest Rate Swaps

The following tables present information about the Company’s interest rate swaps as of the dates indicated:

	March 31, 2019
			Weighted-Average:
Years to Maturity:	Notional Amount (1)		Pay Rate (2)		Life Remaining (in Years)	Fair Value (3)
< 3 years	$	1,435,000	2.01	%	1.3	$	112
>3 and < 6 years	1,930,000		2.27	%	5.7	—
>6 and < 10 years	1,530,000		2.85	%	9.0	—
>10 years	120,000		2.84	%	28.4	—
Total	$	5,015,000	2.38	%	6.0	$	112
	December 31, 2018
			Weighted-Average:
Years to Maturity:	Notional Amount (1)		Pay Rate (2)		Life Remaining (in Years)	Fair Value (3)
< 3 years	$	1,560,000	1.96	%	1.4	$	324
>3 and < 6 years	1,230,000		2.23	%	4.4	—
>6 and < 10 years	1,505,000		2.80	%	8.3	—
>10 years	220,000		2.81	%	21.9	—
Total	$	4,515,000	2.35	%	5.5	$	324

(1) The notional amounts include $0 and $775,000 of forward starting pay-fixed interest rate swaps as of March 31, 2019 and December 31, 2018, respectively.

(2) Excluding forward starting pay-fixed interest rate swaps, the weighted average pay rate was 2.38% and 2.29% as of March 31, 2019 and December 31, 2018, respectively.

(3) The majority of the Company’s interest rate swap agreements are centrally cleared through the CME. Please refer to Note 1 for information regarding the exchange of variation margin being legally considered as settlement of the derivative as opposed to a pledge of collateral.

A portion of the Company’s interest rate swaps were entered into under bilateral agreements which contain cross-default provisions with other agreements between the parties. In addition, these bilateral agreements contain financial and operational covenants similar to those contained in the repurchase agreements as described in Note 3. The Company was in compliance with all covenants with respect to bilateral agreements under which interest rate swaps were entered into as of March 31, 2019.

TBA Securities

The following table summarizes information about the Company's TBA securities as of the dates indicated:

	March 31, 2019		December 31, 2018
Implied market value (1)	$	733,130	$	888,469
Implied cost basis (2)	727,212		882,230
Net carrying value (3)	$	5,918	$	6,239

(1) Implied market value represents the estimated fair value of the underlying Agency MBS as if settled as of the date indicated.

(2) Implied cost basis represents the forward price to be paid for the underlying Agency MBS as if settled as of the date indicated.

15

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

(3) Net carrying value is the amount included on the consolidated balance sheets within “derivative assets (liabilities)” and represents the difference between the implied market value and the implied cost basis of the TBA security as of the date indicated.

Volume of Activity

The tables below summarize changes in the Company’s derivative instruments for the periods indicated:

Type of Derivative Instrument	Notional Amount as of December 31, 2018		Additions		Settlements, Terminations, or Pair-Offs			Notional Amount as of March 31, 2019
Interest rate swaps	$	4,515,000	$	1,500,000	$	(1,000,000	)	$	5,015,000
TBA dollar roll positions	860,000		2,720,000		(2,865,000		)	715,000
U.S. Treasury futures	50,000		—		(50,000		)	—

Offsetting

The Company's derivatives are subject to underlying agreements with master netting or similar arrangements, which provide for the right of offset in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its derivative assets and liabilities subject to these arrangements on a gross basis. The following tables present information regarding those derivative assets and liabilities subject to such arrangements as if the Company had presented them on a net basis as of March 31, 2019 and December 31, 2018:

	Offsetting of Assets
	Gross Amount of Recognized Assets		Gross Amount Offset in the Balance Sheet		Net Amount of Assets Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet (1)					Net Amount
							Financial Instruments Received as Collateral		Cash Received as Collateral
March 31, 2019
Interest rate swaps	$	112	$	—	$	112	$	—	$	—		$	112
TBA securities	5,918		—		5,918		—		(1,699		)	4,219
Derivative assets	$	6,030	$	—	$	6,030	$	—	$	(1,699	)	$	4,331
December 31, 2018
Interest rate swaps	$	324	$	—	$	324	$	—	$	—		$	324
TBA securities	6,239		—		6,239		—		(1,719		)	4,520
Derivative assets	$	6,563	$	—	$	6,563	$	—	$	(1,719	)	$	4,844

16

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

	Offsetting of Liabilities
	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet (1)					Net Amount
							Financial Instruments Posted as Collateral		Cash Posted as Collateral
March 31, 2019
U.S. Treasury futures	—		—		—		—		—			—
Derivative liabilities	$	—	$	—	$	—	$	—	$	—		$	—
December 31, 2018
U.S. Treasury futures	1,218		—		1,218		—		(1,218		)	—
Derivative liabilities	$	1,218	$	—	$	1,218	$	—	$	(1,218	)	$	—

(1) Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the derivative asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented. Please refer to the consolidated balance sheets for the total cash posted as collateral, which is recorded as "restricted cash", and the total fair value of financial instruments pledged as collateral for derivatives and repurchase agreements, which is shown parenthetically.

Please see Note 3 for information related to the Company’s repurchase agreements which are also subject to underlying agreements with master netting or similar arrangements.

NOTE 5 – FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 clarifies that fair value should be based on the assumptions market participants would use when pricing an asset or liability and also requires an entity to consider all aspects of nonperformance risk, including the entity’s own credit standing, when measuring fair value of a liability. ASC Topic 820 established a valuation hierarchy of three levels as follows:

• Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

• Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.  

• Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.  

The following table presents the Company’s financial instruments that are measured at fair value on a recurring basis by their valuation hierarchy levels as of the dates indicated:

17

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

	March 31, 2019								December 31, 2018
	Fair Value		Level 1		Level 2		Level 3		Fair Value		Level 1		Level 2		Level 3
Assets carried at fair value:
MBS	$	4,842,447	$	—	$	4,839,977	$	2,470	$	3,749,464	$	—	$	3,747,190	$	2,274
Derivative assets:
Interest rate swaps	112		—		112		—		324		—		324		—
TBA securities	5,918		—		5,918		—		6,239		—		6,239		—
Total assets carried at fair value	$	4,848,477	$	—	$	4,846,007	$	2,470	$	3,756,027	$	—	$	3,753,753	$	2,274
Liabilities carried at fair value:
U.S. Treasury futures	$	—	$	—	$	—	$	—	$	1,218	$	1,218	$	—	$	—
Total liabilities carried at fair value	$	—	$	—	$	—	$	—	$	1,218	$	1,218	$	—	$	—

The fair value of interest rate swaps is measured using the income approach with the primary input being the forward interest rate swap curve, which is considered an observable input, and thus their fair values are considered Level 2 measurements. U.S. Treasury futures are valued based on closing exchange prices on these contracts and are classified accordingly as Level 1 measurements. The fair value of TBA securities is estimated using methods similar those used to fair value the Company’s Level 2 MBS.

The fair value measurements for a majority of the Company's MBS are considered Level 2 because these securities are substantially similar to securities that either are actively traded or have been recently traded in their respective markets. The Company determines the fair value of its Level 2 securities based on prices received from the Company's primary pricing service as well as other pricing services and brokers. The Company evaluates the third-party prices it receives to assess their reasonableness. Although the Company does not adjust third-party prices, they may be excluded from use in the determination of a security's fair value if they are significantly different from other observable market data. In valuing a security, the primary pricing service uses either a market approach, which uses observable prices and other relevant information that is generated by market transactions of identical or similar securities, or an income approach, which uses valuation techniques to convert future amounts to a single, discounted present value amount. The Company also reviews the assumptions and inputs utilized in the valuation techniques of its primary pricing service. Examples of these observable inputs and assumptions include market interest rates, credit spreads, and projected prepayment speeds, among other things.

The Company owns certain non-Agency MBS for which there are not sufficiently recent trades of substantially similar securities, and their fair value measurements are thus considered Level 3. The Company determines the fair value of its Level 3 securities by discounting the estimated future cash flows derived from cash flow models using significant inputs which are determined by the Company when market observable inputs are not available. Information utilized in those pricing models include the security’s credit rating, coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected credit losses, and credit enhancement as well as certain other relevant information. Significant changes in any of these inputs in isolation may result in a significantly different fair value measurement. Level 3 assets are generally most sensitive to the default rate and severity assumptions.

The activity of the Company’s non-Agency MBS measured at fair value on a recurring basis using Level 3 inputs is presented in the following table for the periods indicated:

18

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

	Three Months Ended
	March 31,
	2019			2018
Balance as of beginning of period	$	2,274		$	7,243
Unrealized gain included in OCI	268			(310		)
Principal payments	(183		)	(361		)
Accretion	111			311
Balance as of end of period	$	2,470		$	6,883

The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future if a change in type of inputs occurs.

The following table presents a summary of the carrying value and estimated fair values of the Company’s financial instruments as of the dates indicated:

	March 31, 2019				December 31, 2018
	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets:
Mortgage-backed securities	$	4,842,447	$	4,842,447	$	3,749,464	$	3,749,464
Mortgage loans held for investment, net (1)	10,862		7,458		11,527		8,566
Derivative assets	6,030		6,030		6,563		6,563
Liabilities:
Repurchase agreements (2)	$	4,252,893	$	4,252,893	$	3,267,984	$	3,267,984
Non-recourse collateralized financing (1)	3,219		3,073		3,458		3,475
Derivative liabilities	—		—		1,218		1,218

(1) The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.

(2) The carrying value of repurchase agreements generally approximates fair value due to their short-term maturities.

NOTE 6 – SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION

Preferred Stock. The Company's articles of incorporation authorize the issuance of up to 50,000,000 shares of preferred stock, par value $0.01 per share, of which the Company’s Board of Directors has designated 8,000,000 shares of 8.50% Series A Preferred Stock and 7,000,000 shares of 7.625% Series B Preferred Stock, (the Series A Preferred Stock and the Series B Preferred Stock collectively, the “Preferred Stock”). The Company had 2,300,000 shares of its Series A Preferred Stock and 3,868,062 shares of its Series B Preferred Stock issued and outstanding as of March 31, 2019 compared to 2,300,000 shares of Series A Preferred Stock and 3,654,594 shares of Series B Preferred Stock as of December 31, 2018.

The Preferred Stock has no maturity and will remain outstanding indefinitely unless redeemed or otherwise repurchased or converted into common stock pursuant to the terms of the Preferred Stock. The Company's Preferred Stock may be redeemed in whole, or in part, at any time and from time to time at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. Because the Preferred Stock is redeemable only at the option of the issuer, it is classified as equity on the Company’s consolidated balance sheet. The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year. The Company paid its regular quarterly dividends of $0.053125 and $0.4765625on its Series A and Series B Preferred Stock, respectively, for the first quarter on April 15, 2019 to shareholders of record as of April 1, 2019.

19

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

DYNEX CAPITAL, INC.

(amounts in thousands except share data)

Common Stock. The following table summarizes information regarding monthly dividend declarations on the Company’s common stock for the first quarter of 2019:

	Three Months Ended
	March 31, 2018
Declaration Date	Amount Declared		Record Date	Payment Date
January 7, 2019	$	0.06	January 18, 2019	January 31, 2019
January 28, 2019	0.06		February 14, 2019	February 28, 2019
March 12, 2019	0.06		March 22, 2019	April 1, 2019

Stock and Incentive Plans. The Company’s 2018 Stock and Incentive Plan, which replaced the Company’s 2009 Stock and Incentive Plan (the “2009 Plan”), reserves for issuance up to 3,000,000 shares of common stock for eligible employees, non-employee directors, consultants, and advisors to the Company to be granted in the form of stock options, restricted stock awards, restricted stock units, stock appreciation rights, performance units, and performance cash awards. Total stock-based compensation expense recognized by the Company for the three months endedMarch 31, 2019 was $298 compared to $335 for the three months endedMarch 31, 2018, respectively. The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended
	March 31,
	2019				2018
	Shares		Weighted Average Grant Date Fair Value Per Share		Shares		Weighted Average Grant Date Fair Value Per Share
Restricted stock outstanding as of beginning of period (1)	341,713		$	6.37	353,103		$	7.01
Restricted stock granted	152,462		6.10		176,233		6.28
Restricted stock vested (1)	(151,139	)	6.37		(194,827	)	7.37
Restricted stock outstanding as of end of period (1)	343,036		$	6.25	334,509		$	6.42

(1) Amounts include awards previously granted under the 2009 Plan which will remain outstanding in accordance with their terms. The Company is no longer granting new equity awards under the 2009 Plan.

As of March 31, 2019, the grant date fair value of the Company’s remaining nonvested restricted stock is $1,865 which will be amortized into compensation expense over a weighted average period of 2.3 years.

NOTE 7 – SUBSEQUENT EVENTS

Management has evaluated events and circumstances occurring as of and through the date this Quarterly Report on Form 10-Q was filed with the SEC and has determined that there have been no significant events or circumstances that qualify as a "recognized" or "nonrecognized" subsequent event as defined by ASC Topic 855.

20

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our unaudited financial statements and the accompanying notes included in Part 1, Item 1. “Financial Statements” in this Quarterly Report on Form 10-Q and our audited financial statements and the accompanying notes included in Part II, Item 8 in our Annual Report on Form 10-K for the year ended December 31, 2018. References herein to “Dynex,” the “Company,” “we,” “us,” and “our” include Dynex Capital, Inc. and its consolidated subsidiaries, unless the context otherwise requires. In addition to current and historical information, the following discussion and analysis contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to our future business, financial condition or results of operations. For a description of certain factors that may have a significant impact on our future business, financial condition or results of operations, see “Forward-Looking Statements” at the end of this discussion and analysis.

For more information about our business including our operating policies, investment philosophy and strategy, financing and hedging strategies, and other important information, please refer to Part I, Item 1 of our Annual Report on Form 10-K for the year ended December 31, 2018.

EXECUTIVE OVERVIEW

Company Overview

We are an internally managed mortgage real estate investment trust, or mortgage REIT, which primarily invests in residential and commercial mortgage-backed securities (“MBS”) on a leveraged basis. We finance our investments principally with borrowings under repurchase agreements. Our objective is to provide attractive risk-adjusted returns to our shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. We seek to provide returns to our shareholders primarily through the payment of regular dividends and also potentially through capital appreciation of our investments.

Our common stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “DX”. We have two series of preferred stock outstanding, our 8.50% Series A Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") which is traded on the NYSE under the symbol "DXPRA", and our 7.625% Series B Cumulative Redeemable Preferred Stock (the "Series B Preferred Stock") which is traded on the NYSE under the symbol "DXPRB".

Our investments consist principally of Agency and non-Agency MBS including residential MBS (“RMBS”), commercial MBS (“CMBS”) and CMBS interest-only (“IO”) securities. Agency MBS have a guaranty of principal payment by an agency of the U.S. government or a U.S. government-sponsored entity (“GSE”) such as Fannie Mae and Freddie Mac. Non-Agency MBS are issued by non-governmental enterprises and do not have a guaranty of principal payment. CMBS IO securities in which we invest may be issued by a GSE or a non-governmental enterprise.

RMBS. Substantially all of our investments in RMBS as of March 31, 2019 were Agency issued securities collateralized primarily by fixed-rate single-family mortgage loans. The remainder of our RMBS portfolio is collateralized by adjustable-rate mortgage loans (“ARMs”), which have interest rates that generally adjust at least annually to an increment over a specified interest rate index, and hybrid ARMs, which are loans that have a fixed rate of interest for a specified period (typically three to ten years) and then adjust their interest rate at least annually to an increment over a specified interest rate index (primarily one-year LIBOR).

We also purchase to-be-announced securities (“TBAs” or “TBA securities”) as a means of investing in non-specified fixed-rate Agency RMBS. A TBA security is a forward contract (“TBA contract”) for the purchase (“long position”) or sale (“short position”) of a fixed-rate Agency MBS at a predetermined price with certain principal and interest terms and certain types of collateral, but the particular Agency securities to be delivered are not identified until shortly before the settlement date. Our TBA purchases are financed by executing a series of transactions which effectively delay the settlement of a forward purchase of a non-specified Agency RMBS by entering into an offsetting TBA short position, net settling the paired-off positions

21

in cash, and simultaneously entering into an identical TBA long position with a later settlement date. These net long TBA positions are referred to as “dollar roll positions”, and we view them as economically equivalent to investing in and financing Agency RMBS using short-term repurchase agreements. TBAs purchased for a forward settlement month are generally priced at a discount relative to TBAs sold for settlement in the current month. This discount, often referred to as “drop income”, represents the economic equivalent of net interest income (interest income less implied financing cost) on the underlying Agency security from trade date to settlement date. We account for TBAs as derivative instruments because we cannot assert that it is probable at inception and throughout the term of an individual TBA transaction that its settlement will result in physical delivery of the underlying Agency RMBS, or the individual TBA transaction will not settle in the shortest period possible.

CMBS. Substantially all of our CMBS investments as of March 31, 2019 were fixed-rate Agency-issued securities backed by multifamily housing loans. Loans underlying CMBS are generally fixed-rate, mature in eight to eighteen years, have amortization terms of up to 30 years, and are geographically dispersed. These loans typically have some form of prepayment protection provisions (such as prepayment lock-out) or prepayment compensation provisions (such as yield maintenance or prepayment penalty). Yield maintenance and prepayment penalty requirements are intended to create an economic disincentive for the loans to prepay. From time to time we have invested in non-Agency CMBS backed by loans on multifamily housing, office buildings, retail, hospitality, and health care properties.

CMBS IO. CMBS IO are interest-only securities issued as part of a CMBS securitization and represent the right to receive a portion of the monthly interest payments (but not principal cash flows) on the unpaid principal balance of the underlying pool of commercial mortgage loans. We invest in both Agency-issued and non-Agency issued CMBS IO. The loans collateralizing CMBS IO pools are very similar in composition to the pools of loans that collateralize CMBS as discussed above. Since CMBS IO securities have no principal associated with them, the interest payments received are based on the unpaid principal balance of the underlying pool of mortgage loans, which is often referred to as the notional amount. Most loans in these securities have some form of prepayment protection from early repayment including absolute loan prepayment lock-outs, loan prepayment penalties, or yield maintenance requirements similar to those typical for CMBS described above. There are no prepayment protections, however, if the loan defaults and is partially or wholly repaid earlier because of loss mitigation actions taken by the underlying loan servicer, and therefore yields on CMBS IO investments are dependent upon the underlying loan performance. Because Agency-issued MBS generally contain higher credit quality loans, Agency CMBS IO are expected to have a lower risk of default than non-Agency CMBS IO. Our CMBS IO investments are investment grade-rated with the majority rated ‘AAA’ by at least one of the nationally recognized statistical rating organizations.

Financing. We use leverage to enhance the returns on our invested capital by pledging our investments as collateral for borrowings primarily through the use of uncommitted repurchase agreements with major financial institutions and broker-dealers. Repurchase agreements generally have original terms to maturity of overnight to six months, though in some instances we may enter into longer-dated maturities depending on market conditions. We pay interest on our repurchase agreement borrowings at a rate usually based on a spread to a short-term interest rate such as LIBOR and fixed for the term of the borrowing. Borrowings under these repurchase agreements are renewable at the discretion of our lenders and do not contain guaranteed roll-over terms.

Hedging. We use derivative instruments, primarily interest rate swaps, to economically hedge our exposure to adverse changes in interest rates resulting from our ownership of primarily fixed-rate investments financed with short-term repurchase agreements. Changes in interest rates can impact net interest income, the market value of our investments, and book value per common share. We frequently adjust our hedging portfolio based on our expectation of future interest rates, including the absolute level of rates and the slope of the yield curve versus market expectations.

Factors that Affect Our Results of Operations and Financial Condition

Our financial performance is largely driven by the performance of our investment portfolio and related financing and hedging activity. In assessing our financial performance, management primarily focuses on net interest income, net interest spread, net income, comprehensive income, book value per common share, and core net operating income to common shareholders (a non-GAAP measure) and total economic return (measured as dividends declared plus changes in book value). Our financial performance is also impacted by a number of factors including, but not limited to, the absolute level of interest rates, the relative slope of interest rate curves, changes in interest rates and market expectations of future interest rates, actual and estimated future prepayment rates on our investments, supply of and competition for investments, the influence of economic conditions on the

22

credit performance of our investments, and market required yields as reflected by market spreads. These factors are influenced by market forces beyond our control such as macroeconomic and geopolitical conditions, market volatility, U.S. Federal Reserve policy, U.S. fiscal and regulatory policy, and foreign central bank and government policy.

Our business model may also be impacted by the availability and cost of financing and the state of the overall credit markets. Reductions or limitations in the availability of financing for our investments could significantly impact our business or force us to sell assets, potentially at losses. Repurchase agreement lending markets have been stable for the last several years, but lending by larger U.S. domiciled banks has declined in recent years due to increased regulation and changes to regulatory capital requirements. Their repurchase market participation has been replaced by smaller independent broker dealers that are generally less regulated and by U.S. domiciled broker dealer subsidiaries of foreign financial institutions. It is uncertain how these relatively new participants will react during periods of market stress. Other factors that could also impact our business include changes in regulatory requirements, including requirements to qualify for registration under the 1940 Act, and REIT requirements.

We believe that regulatory impacts on financial institutions, many of which are our trading and financing counterparties, pose a potential threat to the overall liquidity in the capital markets. In 2017, the Federal Reserve began curtailing its reinvestment of principal payments received on its Agency RMBS portfolio. Prices in Agency RMBS generally have not been significantly impacted by the reduction, however prices may be more significantly impacted as the amount of curtailment increases each successive quarter. Market liquidity of our investments and the financing markets could be negatively impacted if the Federal Reserve's Federal Open Market Committee (or "FOMC") suddenly changes market expectations of the target Federal Funds Rate or takes other actions which have the effect of tightening monetary policy that are not anticipated by the market. And finally, there remains uncertainty as to the ultimate impact or outcome of certain regulations under the Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act"), and restrictions on market-making activities of large U.S. financial institutions could result in reduced liquidity in times of market stress.

Fannie Mae and Freddie Mac have announced that the Single Security Initiative will become effective for all newly issued securities June 3, 2019. All securities issued by the GSE’s after that date will be pursuant to the Uniform Mortgage-Backed Securities (“UMBS”) platform established by the GSE’s. Fannie Mae securities previously issued will automatically be considered UMBS. Beginning in May 2019, Freddie Mac securities can be exchanged for new UMBS securities with the same material characteristics of the RMBS exchanged except with a different payment delay. The Company is evaluating the strategy of exchanging all or a portion of our existing Freddie Mac RMBS for UMBS securities, including the impact on our borrowing capabilities, operations, and liquidity. Thus far, the Company has not received any indication from its repurchase agreement counterparties that our borrowing capability or liquidity on existing Freddie RMBS will be impaired. The payment delay feature for UMBS securities follows that of existing Fannie Mae securities which is slightly longer than Freddie Mac.

From time to time, we also consider expanding our capital base as well as merger, acquisition or divestiture opportunities. We analyze and evaluate potential business opportunities that we identify or are presented to us, including possible merger, acquisition, or divestiture transactions, that might be a strategic fit for our investment strategy or asset allocation or otherwise maximize value for our shareholders. Pursuing such an opportunity or transaction could require us to issue additional equity or debt securities.

Investing in mortgage-related securities (including on a leveraged basis) subjects us to many risks including interest rate risk, prepayment and reinvestment risk, credit risk, spread risk, and liquidity risk. Please refer to Part I, Item 1A, "Risk Factors" of our 2018 Form 10-K as well as Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Item 3, "Quantitative and Qualitative Disclosures about Market Risk" of this Quarterly Report on Form 10-Q for a detailed discussion of these factors and others that have the potential to impact our results of operations and financial condition.

Market Conditions and Recent Activity

During the first quarter of 2019, we recovered approximately 30% of the book value per common share that we lost in the fourth quarter of 2018 as interest rates generally rallied across the curve and Agency MBS mortgage credit spreads tightened, partially reversing their widening in the fourth quarter of 2018. Markets appeared to price in slower economic activity and lower inflation domestically and globally. The FOMC elected to not increase the U.S. Federal Funds Target Rate (“Federal Funds

23

rate”) at its first quarter 2019 meetings, holding the targeted Federal Funds rate range at 2.25%-2.50%. Though the Federal Funds rate has been increased eight times since late 2016, in March 2019 the FOMC guided the markets to a lower terminal target rate. Globally, interest rates generally declined during the first quarter of 2019, particularly in safe haven markets such as the Eurozone and Japan. We believe that markets are reflecting uncertainty regarding inflation and the overall economic environment and, in our opinion, such uncertainty is likely to continue for the remainder of 2019. As such, we expect yields to remain relatively range-bound for the remainder of the year.

The charts below show the highest and lowest U.S. Treasury and swap rates during the three months ended March 31, 2019 as well as the rates as of March 31, 2019 and December 31, 2018:    

Highlights of First Quarter 2019 Results

24

Comprehensive income to common shareholders for the first quarter of 2019 was $31.2 million versus a comprehensive loss to common shareholders for the fourth quarter of 2018 of $(31.4) million. Lower interest rates experienced during the first quarter of 2019 and the recovery of credit spread widening from the fourth quarter of 2018 principally drove this increase in our comprehensive income as our MBS increased in fair value by $86.6 million.

Net loss to common shareholders for the first quarter of 2019 of $(55.3) million primarily consisted of a net loss on derivative instruments of $(61.7) million compared to a net loss to common shareholders of $(81.5) million in the fourth quarter of 2018. Like the prior quarter, net loss on derivative instruments for the first quarter of 2019 was primarily the result of a net loss in fair value of our interest rate swaps due to the interest rates on the 2-10 year portion of the swap curve declining for the second consecutive quarter. Also included in net loss to common shareholders was net interest income which increased $0.7 million compared to the prior quarter due to a larger and higher yielding portfolio of interest earning assets, which offset our increased interest expense resulting from a higher average balance of repurchase agreement borrowings and higher borrowing costs due to the markets pricing in the 0.25% increase in the targeted Federal Funds rate announced in December 2018.

Though net interest income increased modestly for the first quarter of 2019 compared to the fourth quarter of 2018, net interest spread declined 9 basis points as the increase in our interest income as a percentage of average interest earning assets was not enough to offset the increase in our interest expense as a percentage of our repurchase agreement borrowings. As shown in the table below, the downward trend in net interest spread for the majority of our investments continues as a result of higher funding costs and a flattening yield curve:

	Agency MBS (1)						CMBS IO (2)
Quarter Ended	Yield		Cost (3)		Net Interest Spread		Yield		Cost (3)		Net Interest Spread
March 31, 2019	3.42	%	2.62	%	0.80	%	4.04	%	3.20	%	0.84	%
December 31, 2018	3.28	%	2.41	%	0.87	%	3.89	%	2.99	%	0.90	%
September 30, 2018	3.12	%	2.13	%	0.99	%	3.98	%	2.76	%	1.22	%
June 30, 2018	2.94	%	1.93	%	1.01	%	3.78	%	2.59	%	1.19	%
March 31, 2018	2.85	%	1.60	%	1.25	%	3.84	%	2.33	%	1.51	%

(1) Includes Agency RMBS and CMBS.

(2) Includes Agency and non-Agency issued securities.

(3) Excludes net periodic interest benefit/cost of interest rate swaps used to economically hedge the interest rate risk of using repurchase agreement borrowings to finance our investments.

(4) Amounts represent net periodic interest benefit/cost of interest rate swaps expressed as a percentage of average repurchase agreement borrowings outstanding for the period indicated. Please refer to “Non-GAAP Financial Measures” below for information on why management includes this benefit/cost in its assessment of investment portfolio performance.

Core net operating income to common shareholders, a non-GAAP measure, increased to $12.1 million for the first quarter of 2019 versus $10.9 million for the fourth quarter of 2018 due substantially to an increase in adjusted net interest income of $1.5 million. Adjusted net interest income, a non-GAAP measure, increased due to the larger and higher yielding investment portfolio mentioned above as well as higher net periodic interest benefit from our interest rate swaps, which offset higher interest expense on repurchase agreement borrowings and lower TBA drop income. We reduced our TBA dollar roll transactions during the first quarter of 2019 as higher anticipated prepayment speeds negatively impacted the pricing of TBA contracts. While adjusted net interest income increased for the first quarter of 2019 compared to the prior quarter, adjusted net interest spread declined 5 basis points as the 14 basis point increase in net periodic interest benefit was not enough to offset the 9 basis point decline in net interest spread and the 9 basis point decline in TBA drop income. Please refer to "Use of Non-GAAP Financial Measures" below for additional important information about non-GAAP measures.

Book value per common share increased to $6.24 as of March 31, 2019 from $6.02 as of December 31, 2018. This increase of $0.22 per common share and the first quarter dividend of $0.18 per common share resulted in a quarterly total economic return on book value per common share of 6.6%, This increase in book value was driven primarily by the increase in

25

fair value of MBS, net of the decline in fair value of interest rate hedges. We issued over 9.3 million shares of common stock during the first quarter of 2019 through an underwritten secondary offering and our at-the-market (“ATM”) program, which impacted book value per common share by $(0.05).

Management Outlook

As we noted in the fourth quarter of 2018, we seek to assess the probability of events and to identify the most dominant factors that may ultimately influence the future path of economic activity, interest rates, and global asset prices. We continue to believe that we are in a lower return environment characterized by interest rates that will spend more time in a narrower range than in recent history. Fundamentally, we believe that increasing global debt, demographic trends, the impact of technological advances on productivity and employment, and human conflict could keep the 10-year U.S. Treasury below 3.5% and within a broader range of 2% to 4% substantially into the future. The aggregate amount of global debt yielding negative interest rates is trending higher again after trending lower since a peak in 2016. Additionally, there are multiple global factors that could rapidly force interest rates to, or below, the 2% lower bound of this narrower interest rate range.

Negative side effects of monetary policy tightening are already developing in the global economy and impacting global capital markets, which has limited the most recent rise in interest rates in the U.S. During the first quarter of 2019, markets repriced future short-term interest rates to reflect expectations that there will not be additional increases in the Federal Funds rate through the remainder of 2019 as well as a potential decrease in 2020. Additionally, interest rates inverted between 1-month and 3-month maturities. This inversion and having interest rates near the lower end of our expected range of 2% to 4% has created modest headwinds for our earnings profile for the balance of 2019. The lower rate environment has led to an increase in anticipated prepayment speeds on our Agency RMBS and less benefit from our interest rate swaps due to the decline in the 3-month LIBOR rate upon which the receive leg on our interest rate swaps is based. While we believe we will navigate these challenges, we may not fully earn our dividend in the near term. As we expect to continue increasing our investments in Agency MBS, we expect leverage to continue increasing over the balance of the year. Historically, we have observed that flat or inverted yield curves resolve themselves to a steeper yield curve within a 6-9 month period. As such, we believe the current environment will evolve over the intermediate term in a manner that ultimately supports higher net interest spreads.

Non-GAAP Financial Measures

In addition to the Company's operating results presented in accordance with GAAP, the information presented within Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations" of this Quarterly Report on Form 10-Q contains the following non-GAAP financial measures: core net operating income to common shareholders (including per common share), adjusted interest expense, adjusted net interest income, and the related metrics adjusted cost of funds and adjusted net interest spread. Because these measures are used in the Company's internal analysis of financial and operating performance, management believes that they provide greater transparency to our investors of management's view of our economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with the Company's GAAP operating results, allows investors to more effectively evaluate and compare the performance of the Company to that of its peers, although the Company's presentation of its non-GAAP measures may not be comparable to other similarly-titled measures of other companies. Reconciliations of core net operating income to common shareholders, adjusted interest expense, and adjusted net interest income to the related GAAP financial measures are provided below and within “Results of Operations”.

Management views core net operating income to common shareholders as an estimate of the Company’s financial performance excluding changes in fair value of its investments and derivatives. In addition to the non-GAAP reconciliation set forth below, which derives core net operating income to common shareholders from GAAP net income to common shareholders as the nearest GAAP equivalent measure, core net operating income to common shareholders can also be determined by adjusting net interest income to include interest rate swap periodic interest benefit/cost, drop income on TBA dollar roll positions, general and administrative expenses, and preferred dividends. Management includes drop income, which is included in "gain (loss) on derivatives instruments, net" on the Company's consolidated statements of comprehensive income, in core net operating income and in adjusted net interest income because TBA dollar roll positions are viewed by management as economically equivalent to holding and financing Agency RMBS using short-term repurchase agreements. Management also includes periodic interest benefit/cost from its interest rate swaps, which are also included in "gain (loss) on derivatives instruments, net", in adjusted net interest expense, and in adjusted net interest income because interest rate swaps are used by the Company to economically hedge

26

the impact of changing interest rates on its borrowing costs from repurchase agreements, and including periodic interest benefit/cost from interest rate swaps is a helpful indicator of the Company’s total cost of financing in addition to GAAP interest expense. However, these non-GAAP measures do not provide a full perspective on our results of operations, and therefore, their usefulness is limited. For example, these non-GAAP measures do not include gains or losses from available-for-sale investments, changes in fair value of and costs of terminating interest rate swaps, as well as realized and unrealized gains or losses from any instrument used by management to economically hedge the impact of changing interest rates on its portfolio and book value per common share. As a result, these non-GAAP measures should be considered as a supplement to, and not as a substitute for, the Company's GAAP results as reported on its consolidated statements of comprehensive income.

	Three Months Ended
($ in thousands, except per share amounts)	March 31, 2019			December 31, 2018
GAAP net loss to common shareholders	$	(55,273	)	$	(81,485	)
Less:
Change in fair value of derivative instruments, net (1)	67,557			86,993
Loss on sale of investments, net	—			5,428
De-designated cash flow hedge accretion (2)	(165		)	(75		)
Fair value adjustments, net	13			16
Core net operating income to common shareholders	$	12,132		$	10,877
Weighted average common shares outstanding	68,434,709			60,870,479
Core net operating income per common share	$	0.18		$	0.18

(1) Amount represents net realized and unrealized gains and losses on derivatives and excludes net periodic interest benefits related to these instruments.

(2) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.

	Three Months Ended
	March 31, 2019					December 31, 2018
($ in thousands)	Amount			Rate		Amount			Rate
Net interest income	$	13,681		0.84	%	$	12,961		0.93	%
Add: TBA drop income (1)	1,963			(0.03	)%	3,072			0.06	%
Add: net periodic interest benefit (2)	3,897			0.40	%	1,940			0.26	%
Less: de-designated cash flow hedge accretion (3)	(165		)	(0.02	)%	(75		)	(0.01	)%
Adjusted net interest income	$	19,376		1.19	%	$	17,898		1.24	%

(1) TBA drop income is calculated by multiplying the notional amount of the TBA dollar roll positions by the difference in price between two TBA securities with the same terms but different settlement dates. The impact of TBA drop income on adjusted net interest spread includes the implied average funding cost of TBA dollar roll transactions during the periods indicated.

(2) Amount represents net periodic interest benefit of effective interest rate swaps outstanding during the period and excludes realized and unrealized gains and losses from changes in fair value of derivatives.

(3) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.

CRITICAL ACCOUNTING POLICIES

The discussion and analysis of our financial condition and results of operations are based in large part upon our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of our consolidated

27

financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities. We base these estimates and judgments on historical experience and assumptions believed to be reasonable under current facts and circumstances. Actual results, however, may differ from the estimated amounts we have recorded.

Critical accounting policies are defined as those that require management's most difficult, subjective or complex judgments, and which may result in materially different results under different assumptions and conditions. Our critical accounting policies are discussed in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2018 Form 10-K under “Critical Accounting Policies”. There have been no significant changes in our critical accounting policies during the three months endedMarch 31, 2019.

FINANCIAL CONDITION

Investment Portfolio

Our investment portfolio is comprised mostly of Agency fixed-rate investments which have more a more favorable risk-return profile and higher liquidity in the current macroeconomic environment versus other types of MBS. Approximately 62% of our investments were 30-year Agency RMBS including TBA dollar roll positions as of March 31, 2019 compared to approximately 65% as of December 31, 2018. Approximately 28% of our investments were Agency CMBS as of March 31, 2019 compared to approximately 23% as of December 31, 2018. These CMBS are mainly in the multifamily sector and have more predictable prepayment profiles relative to RMBS and are therefore less costly to hedge.

The following table provides a summary of the amortized cost and fair value of our investment portfolio (including TBA dollar roll positions and securities pending settlement) used for investment purposes as of the dates indicated:

	March 31, 2019				December 31, 2018
($ in thousands)	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Agency RMBS, fixed-rate	$	2,730,610	$	2,750,526	$	2,142,717	$	2,124,810
TBAs, fixed-rate (1)	727,212		733,130		882,230		888,469
Agency RMBS, adjustable rate	30,250		30,744		32,666		33,211
Agency CMBS, fixed-rate	1,518,610		1,539,512		1,080,424		1,057,015
CMBS IO (2)	510,504		519,196		527,743		532,154
Non-Agency other (3)	1,786		2,469		1,859		2,274
Mortgage loans held for investment, net (4)	10,862		7,458		11,527		8,566
Total investment portfolio including TBA dollar roll positions	$	5,529,834	$	5,583,035	$	4,679,166	$	4,646,499

(1) Consists of long positions in TBAs used for investment purposes at their implied cost basis and implied market value, respectively, as if settled which are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.

(2) Includes Agency and non-Agency issued securities.

(3) Includes non-Agency CMBS and RMBS.

(4) Recorded on consolidated balance sheet at amortized cost.

28

The following table details the activity related to our MBS portfolio including TBA dollar roll positions during the three months endedMarch 31, 2019:

	Agency Fixed-Rate						CMBS IO (3)			Agency Adjustable Rate RMBS			Non-Agency Other (4)			Total
($ in thousands)	30-Year RMBS (1) (2)			CMBS
Balance as of December 31, 2018	$	3,013,279		$	1,057,015		$	532,154		$	33,211		$	2,274		$	4,637,933
Purchases	484,478			460,412			11,353			—			—			956,243
Principal payments	(49,587		)	(21,758		)	—			(2,298		)	(184		)	(73,827		)
Sales	—			—			—			—			—			—
(Amortization) accretion	(2,016		)	(468		)	(28,592		)	(117		)	111			(31,082		)
Change in fair value	37,502			44,311			4,281			(52		)	268			86,310
Balance as of March 31, 2019	$	3,483,656		$	1,539,512		$	519,196		$	30,744		$	2,469		$	5,575,577

(1) Includes securities pending settlement as of dates indicated.

(2) Includes long positions in TBAs used for investment purposes at their implied market value as if settled which are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.

(3) Includes Agency and non-Agency issued securities.

(4) Includes non-Agency CMBS and RMBS.

RMBS.The following table provides information on our Agency RMBS investments including securities pending settlement and TBA dollar roll positions as of the dates indicated:

29

	March 31, 2019
	Par		Amortized Cost/ Implied Cost Basis (1)(3)		Fair Value (2)(3)		Weighted Average
Coupon							Original Loan Balance (4)		Loan Age (in months) (4)	3 Month CPR (4)(5)		Duration (6)
	($ in thousands)
30-year fixed-rate:
3.0%	$	219,147	$	220,678	$	218,499	$	234,206	29	5.7	%	5.04
4.0%	1,820,059		1,871,185		1,886,576		260,667		13	5.2	%	2.91
4.5%	614,587		638,747		645,451		245,010		5	6.8	%	1.62
TBA 3.5%	250,000		250,703		253,359		n/a		n/a	n/a		3.22
TBA 4.0%	325,000		331,786		334,012		n/a		n/a	n/a		2.18
TBA 4.5%	140,000		144,723		145,759		n/a		n/a	n/a		1.46
Total 30-year fixed-rate	$	3,368,793	$	3,457,822	$	3,483,656	$	254,856	12	5.6	%	2.70
Adjustable-rate (7):	$	29,483	$	30,250	$	30,744	$	211,878	135	17.3	%	0.58
Total Agency RMBS (including TBA dollar roll positions)	$	3,398,276	$	3,488,072	$	3,514,400	$	254,384	14	5.7	%	2.68
	December 31, 2018
	Par		Amortized Cost/ Implied Cost Basis (1)(3)		Fair Value (2)(3)		Weighted Average
Coupon							Original Loan Balance (4)		Loan Age (in months) (4)	3 Month CPR (4)(5)		Duration (6)
	($ in thousands)
30-year fixed-rate:
3.0%	$	223,573	$	225,148	$	218,286	$	233,855	26	5.7	%	5.66
4.0%	1,651,854		1,699,012		1,687,390		272,159		10	5.2	%	4.06
4.5%	211,429		218,557		219,134		291,874		5	5.3	%	2.48
TBA 4.0%	110,000		111,175		112,101		n/a		n/a	n/a		3.54
TBA 4.5%	750,000		771,055		776,368		n/a		n/a	n/a		2.61
Total 30-year fixed-rate	$	2,946,856	$	3,024,947	$	3,013,279	$	270,053	10	5.3	%	3.67
Adjustable-rate (7):	$	31,782	$	32,666	$	33,211	$	210,597	132	25.6	%	0.52
Total Agency RMBS (including TBA dollar roll positions)	$	2,978,638	$	3,057,613	$	3,046,490	$	269,161	13	5.6	%	3.63

(1) Implied cost basis of TBA dollar roll positions represents the forward price to be paid for the underlying Agency MBS as if settled.

(2) Fair value of TBA dollar roll positions is the implied market value of the underlying Agency security as of the end of the period if settled.

(3) The net carrying value of TBA dollar roll positions, which is the difference between their implied market value and implied cost basis, was $5.9 million as of March 31, 2019 and $6.2 million as of December 31, 2018 and is included on the consolidated balance sheet within “derivative assets”.

(4) TBA dollar roll positions are excluded from this calculation as they do not have a defined weighted-average loan balance or age until mortgages have been assigned to the pool.

(5) Constant prepayment rate (“CPR”) represents the 3-month CPR of Agency RMBS held as of date indicated. Securities with no prepayment history are excluded from this calculation.

30

(6) Duration measures the sensitivity of a security's price to the change in interest rates and represents the percent change in price of a security for a 100-basis point increase in interest rates. We calculate duration using third-party financial models and empirical data. Different models and methodologies can produce different estimates of duration for the same securities.

(7) Weighted average coupon based on amortized cost was 4.6% as of March 31, 2019 and 4.3% as of December 31, 2018.

CMBS. The majority of our CMBS are Agency CMBS for which our credit exposure is limited to the unamortized premium remaining on those securities as the return of principal is guaranteed by the GSEs. The following table presents information about our CMBS investments by year of origination as of the dates indicated:

	March 31, 2019						December 31, 2018
($ in thousands)	Par Value		Amortized Cost		Months to Estimated Maturity (1)	WAC (2)	Par Value		Amortized Cost		Months to Estimated Maturity (1)	WAC (2)
Year of Origination:
Prior to 2009	$	19,532	$	18,166	31	5.67	$	20,302	$	18,868	33	5.72
2009 to 2012	55,086		56,519		26	4.83	74,935		76,567		23	4.98
2013 to 2014	13,451		13,713		70	3.61	13,516		13,790		73	3.61
2015	210,252		212,274		94	2.85	210,679		212,755		97	2.85
2016	238,390		239,809		95	2.43	238,559		240,033		98	2.43
2017	337,483		339,189		107	3.07	280,530		283,567		106	3.06
2018	330,769		330,622		137	3.68	236,425		235,847		142	3.76
2019 (3)	156,342		158,501		127	3.53	—		—		—	—
	$	1,361,305	$	1,368,793	108	3.24	$	1,074,946	$	1,081,427	102	3.22

(1) Months to estimated maturity is an average weighted by the amortized cost of the investment.

(2) The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance.

(3) Excludes securities pending settlement with a par value of $149.4 million and amortized cost of $150.8 million as of March 31, 2019.

CMBS IO. Income earned from CMBS IO is based on interest payments received on the underlying commercial mortgage loan pools. Our return on these investments may be negatively impacted by any change in scheduled cash flows such as modifications of the mortgage loans or involuntary prepayments including defaults, foreclosures, and liquidations on or of the underlying mortgage loans prior to its contractual maturity date. In order to manage our exposure to credit performance, we generally invest in senior tranches of these securities and where we have evaluated the credit profile of the underlying loan pool and can monitor credit performance. In addition, to address changes in market fundamentals and the composition of mortgage loans collateralizing an investment, we consider the year of origination of the loans underlying CMBS IO in our selection of investments.

31

As of March 31, 2019, our CMBS IO investments comprised approximately 9% of our total portfolio, of which approximately 55% are Agency-issued, relatively unchanged since December 31, 2018. The following table presents our CMBS IO investments as of March 31, 2019 by year of origination:

	March 31, 2019					December 31, 2018
($ in thousands)	Amortized Cost		Fair Value		Remaining WAL (1)	Amortized Cost		Fair Value		Remaining WAL (1)
Year of Origination:
2010-2012	$	53,792	$	54,960	23	$	59,593	$	60,763	17
2013	67,689		68,849		21	72,649		73,073		22
2014	126,889		128,131		28	134,114		134,808		30
2015	136,472		139,576		34	143,163		144,673		35
2016	65,260		66,319		40	67,625		68,015		41
2017	46,754		47,591		47	46,125		46,336		48
2018	4,405		4,470		71	4,474		4,486		73
2019	9,243		9,300		73	—		—		—
	$	510,504	$	519,196	32	$	527,743	$	532,154	32

(1) Remaining weighted average life (“WAL”) represents an estimate of the number of months of interest earnings remaining for the investments by year of origination.

Repurchase Agreements

The majority of our repurchase agreement borrowings are collateralized with Agency MBS which have historically had lower liquidity risk than non-Agency MBS. As of March 31, 2019 and December 31, 2018, all non-Agency MBS pledged as collateral for repurchase agreements were CMBS IO, of which approximately 82% are rated AAA. Please refer to Note 3 of the Notes to the Consolidated Financial Statements contained within this Quarterly Report on Form 10-Q as well as “Results of Operations” and “Liquidity and Capital Resources” contained within this Item 2 for additional information relating to our repurchase agreement borrowings.

Derivative Assets and Liabilities

We regularly monitor and adjust our hedging portfolio in response to many factors including, but not limited to, changes in our investment portfolio, shifts in the yield curve, and our expectations with respect to the future path of interest rates and interest rate volatility. Please refer to “Quantitative and Qualitative Disclosures about Market Risk” in Part I, Item 3 of this Quarterly Report on Form 10-Q for more information.

As of March 31, 2019 and December 31, 2018, we primarily used interest rate swaps to hedge a portion of our earnings and book value exposure to fluctuations in interest rates. The following graphs present the effective notional balance outstanding and weighted average pay-fixed rate for our interest rate derivatives outstanding through 2025 ⁽¹⁾ as of the periods indicated:

32

(1) Additional interest rate swaps outstanding from 2026-2047 had an average balance of $282.3 million at a weighted average pay-fixed rate of 2.85% as of March 31, 2019 and an average balance of $238.0 million at a weighted average pay-fixed rate of 2.86% as of December 31, 2018.

During the three months ended March 31, 2019 we added interest rate swaps with a combined notional balance of $1.5 billion at a weighted average net pay-fixed rate of 2.54%. We had interest rate swaps with a notional balance of $0.1 billion and a weighted average pay-fixed rate of 2.39% mature during the three months ended March 31, 2018. During that same period, we realized a loss of $6.8 million from terminated interest rate swaps with a notional balance of $0.9 billion and realized a loss of $1.3 million for terminated U.S. Treasury futures with a notional balance of $50.0 million.

33

Shareholders’ Equity

The increase in our shareholders’ equity during the three months ended March 31, 2019 was driven primarily by our issuance of 9.3 million shares of common stock through an underwritten public offering and our ATM program for net cash proceeds of $53.9 million. We used the cash proceeds in combination with repurchase agreement borrowings to purchase additional interest earning assets for our investment portfolio. In addition, shareholders’ equity increased as a result of an increase in the fair value of our MBS due to tightening credit spreads and declining longer-term interest rates during the first quarter. This increase in fair value was recorded within accumulated other comprehensive income, which increased $86.5 million during the three months endedMarch 31, 2019.

RESULTS OF OPERATIONS

The discussions below provide information on certain items on our consolidated statements of comprehensive income. These discussions include both GAAP and non-GAAP financial measures which management utilizes in its internal analysis of financial and operating performance. Please read the section “Non-GAAP Financial Measures” at the end of “Executive Overview” in Item 2 of this Quarterly Report on Form 10-Q for additional important information about these measures.

Net Interest Income for the Three Months EndedMarch 31, 2019 Compared to the Three Months EndedMarch 31, 2018

Net interest income for the three months endedMarch 31, 2019 remained relatively stable compared to the three months endedMarch 31, 2018 as the increase in interest income earned from a larger and higher yielding portfolio was mostly offset by an increase in interest expense resulting from a large average balance of borrowings and higher financing costs. Interest expense as a percentage of average balance of borrowings outpaced interest income as a percentage of interest earning assets, resulting in a decline of 50 basis points in net interest spread for the three months endedMarch 31, 2019 compared to the same period in 2018. The following table presents certain information about our interest-earning assets and interest-bearing liabilities and their performance for the three months endedMarch 31, 2019 and March 31, 2018:

	Three Months Ended
	March 31,
	2019							2018
($ in thousands)	Interest Income/Expense			Average Balance (1)(2)		Effective Yield/ Cost of Funds (3)(4)		Interest Income/Expense			Average Balance (1)(2)		Effective Yield/ Cost of Funds (3)(4)
Interest-earning assets:
Agency RMBS-fixed rate	$	23,411		$	2,605,294	3.59	%	$	7,102		$	903,134	3.15	%
Agency CMBS-fixed rate	9,132			1,200,521		3.04	%	7,628			1,082,206		2.80	%
Agency RMBS-adjustable rate	223			31,497		3.38	%	1,590			282,771		2.15	%
CMBS IO (5)	6,395			517,868		4.04	%	6,941			669,426		3.84	%
Non-Agency other (6)	177			1,822		33.22	%	622			18,638		11.37	%
U.S. Treasuries	—			—		—	%	967			168,508		2.33	%
Other investments (7)	619			11,238		4.87	%	340			15,442		4.05	%
Total:	$	39,957		$	4,368,240	3.51	%	$	25,190		$	3,140,125	3.09	%
Interest-bearing liabilities:
Repurchase agreements	$	26,414		$	3,931,335	2.69	%	$	11,614		$	2,645,714	1.76	%
Non-recourse collateralized financing	27			3,397		3.31	%	29			5,387		2.16	%
De-designated cash flow hedge accretion (8)	(165		)	n/a		0.02	%	(48		)	n/a		(0.01	)%
Total:	$	26,276		$	3,934,732	2.67	%	$	11,595		$	2,651,101	1.75	%
Net interest income/net interest spread	$	13,681				0.84	%	$	13,595				1.34	%

34

(1) Average balance for assets is calculated as a simple average of the daily amortized cost and excludes unrealized gains and losses as well as securities pending settlement if applicable.

(2) Average balance for liabilities is calculated as a simple average of the daily borrowings outstanding during the period.

(3) Effective yield is calculated by dividing the sum of gross interest income and scheduled premium amortization/discount accretion (both of which are annualized for any reporting period less than 12 months) and prepayment compensation and premium amortization/discount accretion adjustments (collectively, "prepayment adjustments"), which are not annualized, by the average balance of asset type outstanding during the reporting period.

(4) Cost of funds is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.

(5) Includes Agency and non-Agency issued securities.

(6) Includes privately-issued RMBS and CMBS.

(7) Interest income for other investments consists of $143 thousand from mortgage loans held for investment, net and $476 thousand from cash and cash equivalents for the three months endedMarch 31, 2019 compared to $162 thousand and $178 thousand for the three months endedMarch 31, 2018, respectively. Average balances and yields shown for other investments includes amortized cost of mortgage loans held for investment and excludes cash.

(8) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.

Rate/Volume Analysis. The following table presents the estimated impact on our net interest income due to changes in rate (effective yield/cost of funds) and changes in volume (average balance) of our interest-earning assets and interest-bearing liabilities for the periods indicated:

	Three Months Ended
	March 31, 2019 Compared to March 31, 2018
	Increase (Decrease) Due to Change In									Total Change in Interest Income/Expense
($ in thousands)	Rate			Volume			Prepayment Adjustments (1)
Interest-earning assets:
Agency RMBS-fixed rate	$	2,924		$	13,385		$	—		$	16,309
Agency CMBS-fixed rate	731			825			(52		)	1,504
Agency RMBS-adjustable rate	114			(1,326		)	(155		)	(1,367		)
CMBS IO (2)	870			(1		)	(1,415		)	(546		)
Non-Agency other (3)	102			(458		)	(89		)	(445		)
Treasuries	—			(967		)	—			(967		)
Other investments (4)	23			256			—			279
Total increase (decrease) in interest income	$	4,764		$	11,714		$	(1,711	)	$	14,767
Interest-bearing liabilities:
Repurchase agreements	$	9,156		$	5,644		$	—		$	14,800
Non-recourse collateralized financing, net of other (5)	(108		)	(11		)	—			(119		)
Total increase in interest expense	9,048			5,633			—			14,681
Total net change in net interest income	$	(4,284	)	$	6,081		$	(1,711	)	$	86

(1) Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for adjustable-rate RMBS and prepayment compensation, net of amortization adjustments for CMBS and CMBS IO and are not annualized in the calculation of effective yield.

(2) Includes Agency and non-Agency issued securities.

(3) Includes privately-issued RMBS and CMBS.

(4) Increase of $298 thousand in other interest income from cash and cash equivalents is included as a change in volume.

(5) Increase of $117 thousand in de-designated cash flow hedge accretion is included as a change in rate.

As shown in the table above, interest income increased for the first quarter of 2019 compared to the same period in 2018 primarily from the addition of higher yielding fixed-rate Agency RMBS. This increase in interest income was almost entirely offset

35

by the increase in interest expense due to a larger average outstanding balance of repurchase agreements borrowed at higher financing rates.

Adjusted Net Interest Income for the Three Months EndedMarch 31, 2019 Compared to the Three Months EndedMarch 31, 2018

Management includes drop income from TBA dollar roll transactions and net periodic interest benefit (cost) of interest rate swaps in a non-GAAP financial measure “adjusted net interest income” when evaluating the economic performance of its investments and financings. The following table reconciles adjusted net interest income to GAAP net interest income for the periods indicated:

	Three Months Ended
	March 31,
	2019					2018
($ in thousands)	Amount			Rate		Amount			Rate
Net interest income	$	13,681		0.84	%	$	13,595		1.34	%
Add: TBA drop income (1)	1,963			(0.03	)%	3,733			0.10	%
Add: net periodic interest benefit (cost) (2)	3,897			0.40	%	(220		)	(0.03	)%
De-designated cash flow hedge accretion (3)	(165		)	(0.02	)%	(48		)	(0.01	)%
Adjusted net interest income	$	19,376		1.19	%	$	17,060		1.40	%

(1) TBA drop income is calculated by multiplying the notional amount of the TBA dollar roll positions by the difference in price between two TBA securities with the same terms but different settlement dates. The impact of TBA drop income on adjusted net interest spread includes the implied average funding cost of TBA dollar roll transactions during the periods indicated.

(2) Amount represents net periodic interest benefit (cost) of effective interest rate swaps outstanding during the period and excludes realized and unrealized gains and losses from changes in fair value of derivatives.

(3) Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.

Adjusted net interest income increased $2.3 million for the three months endedMarch 31, 2019 compared to the same period in 2018 primarily because we received a net periodic interest benefit from interest rate swaps of $3.9 million for the three months endedMarch 31, 2019 compared to a net cost of $(0.2) million for the three months endedMarch 31, 2018 as discussed below in “(Loss) Gain on Derivative Instruments, Net”. This benefit was partially offset by a decline of $(1.8) million in TBA drop income because we reduced our volume of TBA dollar roll transactions during the first quarter of 2018 as higher expected prepayment speeds impacted the pricing of TBA contracts. Adjusted net interest spread declined 21 basis points for the three months ended March 31, 2019 compared to the same quarter in 2018 as the increase of 43 basis points in net periodic interest benefit from interest rate swaps as a percentage of repurchase agreement borrowings helped to offset the 92 basis point increase in cost of financing and lower TBA net interest spread.

The following table summarizes information related to our drop income from TBA dollar roll transactions for the periods indicated:

	Three Months Ended								Three Months Ended March 31, 2019 Compared to Three Months Ended March 31, 2018
	March 31,
	2019				2018				Total Change			Due to Change In
($ in thousands)	Amount		Average Yield/Cost		Amount		Average Yield/Cost					Rate			Volume
TBA implied interest income (1)	$	6,790	3.74	%	$	7,056	3.26	%	$	(266	)	$	873		$	(1,140	)
TBA implied interest expense (2)	4,827		2.66	%	3,323		1.53	%	1,504			2,040			(537		)
TBA drop income/net yield (3)	$	1,963	1.08	%	$	3,733	1.73	%	$	(1,770	)	$	(1,167	)	$	(603	)
Average dollar roll position	$	726,826			$	866,821

(1) Average yield for TBA dollar roll positions is extrapolated by adding average cost (see footnote 2) to the net yield (see footnote 3). Implied interest income is calculated by multiplying the average yield by the average TBA dollar roll position outstanding during the period.

36

(2) Average funding cost for TBA dollar roll positions is determined using the “price drop” between the near settling TBA contract and the price for the same contract with a later settlement date and market-based assumptions regarding the “cheapest-to-deliver” collateral that can satisfy the TBA contract, such as the security’s coupon, maturity, and projected prepayment rate anticipated for the collateral. TBA implied interest expense is calculated by multiplying the average funding cost by the average TBA dollar roll position outstanding during the period.

(3) TBA net yield is calculated by dividing drop income by the average TBA dollar roll position outstanding during the period.

(Loss) Gain on Derivative Instruments, Net

Changes in the fair value of derivative instruments and net periodic interest costs are impacted by changing market interest rates and adjustments that we may make to our hedging positions in any given period. Because of the changes made to our derivatives portfolio from one reporting period to the next, results of any given reporting period are generally not comparable to results of another.

The following table provides information on our financial instruments accounted for as derivative instruments for the periods indicated:

	Three Months Ended
	March 31,
($ in thousands)	2019			2018
Interest rate derivatives:
Interest rate swaps:
Net periodic interest benefit (cost)	$	3,897		$	(220	)
Change in fair value (1)	(75,661		)	48,463
Total interest rate swap (losses) gains, net	(71,764		)	48,243
U.S. Treasury and Eurodollar futures:
Change in fair value (1)	(109		)	1,905
TBA short positions (economic hedges):
Change in fair value (2)	—			293
Total interest rate derivative (losses) gains, net	(71,873		)	50,441
TBA dollar roll positions:
Change in fair value (2)	8,213			(15,820		)
TBA drop income (3)	1,963			3,733
Total TBA dollar roll gains (losses), net	10,176			(12,087		)
Total (loss) gain on derivative instruments, net	$	(61,697	)	$	38,354

(1) Changes in fair value for interest rate swaps and Eurodollar futures include unrealized gains (losses) from current and forward starting derivative instruments and realized gains (losses) from terminated derivative instruments.

(2) Changes in fair value for TBA positions include unrealized gains (losses) from open TBA contracts and realized gains (losses) on paired off or terminated positions.

(3) TBA drop income represents a portion of the change in fair value and is calculated as the difference in price between a TBA security sold for settlement in the current month and the price of a TBA security purchased for settlement in a future month times its notional amount.

For the three months ended March 31, 2019, the changes in fair value for the Company’s interest rate derivatives included net realized losses of $(6.8) million on terminated interest rate swaps and net realized losses of $(1.3) million on terminated U.S. Treasury futures. The increase in fair value of TBA dollar roll positions of $10.2 million was driven primarily by the decrease in longer-term interest rates during the first quarter of 2019 and is comprised of a net realized gain of $10.5 million and a net unrealized loss of $(0.3) million.

For the three months ended March 31, 2018, the changes in fair value for the Company’s interest rate derivatives included $(0.5) million of realized losses on terminated interest rate swaps and $0.9 million of realized gains resulting from Eurodollar futures that matured during that quarter. The decline in fair value of TBA dollar roll positions of $(15.8) million was

37

driven primarily by the increase in longer-term interest rates during the first quarter of 2018 and was comprised of a net realized loss of $(12.6) million and a net unrealized gain of $0.5 million.

Our interest rate swap hedge position for the first quarter of 2019 and 2018 was approximately 90% of our average borrowings and net TBAs outstanding as shown in the table below. The floating rate we receive on the majority of our pay-fixed interest rate swaps is based on 3-month LIBOR which increased to an average of 2.69% during the three months ended March 31, 2019 compared to 1.93% for the three months ended March 31, 2018. As a result, we earned a net periodic interest benefit of $3.9 million from our interest rate swaps during the first quarter of 2019 and incurred a net periodic interest cost of $(0.2) million during the first quarter of 2018.The following table provides details on the effective interest rate swaps outstanding during the periods indicated:

	Three Months Ended
	March 31,
($ in thousands)	2019			2018
Average repurchase agreement borrowings outstanding	$	3,931,335		$	2,645,714
Average net TBAs outstanding - at cost (1)	726,826			863,615
Average borrowings and net TBAs outstanding	4,658,161			3,509,329
Average notional amount of interest rate swaps outstanding (excluding forward starting swaps)	4,154,778			3,290,556
Ratio of average interest rate swaps to average borrowings and net TBAs outstanding (1)	0.9			0.9
Average interest rate swap net pay-fixed rate (excluding forward starting swaps) (2)	2.37		%	1.66		%
Average interest rate swap net receive-floating rate (2)	2.75		%	1.64		%
Average interest rate swap net pay/(receive) rate	(0.38		)%	0.02		%

(1) Because the Company executes TBA dollar roll transactions, which economically represent the purchase and financing of fixed-rate Agency RMBS, the average TBAs outstanding are included in the ratio calculation.

(2) Net rates include receive-fixed (pay-floating) interest rate swaps for the three months ended March 31, 2018.

General and Administrative Expenses

General and administrative expenses increased $0.3 million for the three months endedMarch 31, 2019 compared to the three months endedMarch 31, 2018 due primarily to higher legal, audit, and consulting expenses.

Other Comprehensive Income (Loss)

The majority of other comprehensive income of $86.5 million for the first quarter of 2019 was mostly comprised of net unrealized gains in Agency RMBS and CMBS due to tightening credit spreads and declining longer-term interest rates. Other comprehensive loss for the first quarter of 2018 of $(45.5) million was mostly comprised of net unrealized losses in Agency RMBS and CMBS due to increasing interest rates. The following table provides detail on the changes in fair value by type of available-for-sale investment which are recorded as unrealized gains (losses) in other comprehensive income on our consolidated statements of operations for the periods indicated:

38

	Three Months Ended
	March 31,
($ in thousands)	2019			2018
Fixed-rate Agency RMBS	$	37,824		$	(17,776	)
Adjustable-rate Agency RMBS	(52		)	(2,118		)
Agency CMBS	44,311			(21,363		)
CMBS IO (1)	4,281			(2,983		)
Non-Agency other (2)	268			(363		)
U.S. Treasuries	—			(811		)
Unrealized gain (loss) on available-for-sale investments	86,632			(45,414		)
Reclassification adjustment for de-designated cash flow hedges	(165		)	(48		)
Total other comprehensive income (loss)	$	86,467		$	(45,462	)

(1) Includes Agency and non-Agency issued securities.

(2) Includes non-Agency CMBS and RMBS.

LIQUIDITY AND CAPITAL RESOURCES

 Our primary sources of liquidity include borrowings under repurchase arrangements and monthly principal and interest payments we receive on our investments. Additional sources may also include proceeds from the sale of investments, equity offerings, and payments received from counterparties from interest rate swap agreements and other derivative instruments. We use our liquidity to purchase investments and to pay our operating expenses and dividends on our common and preferred stock. We also use our liquidity to post initial and variation margins on our repurchase agreements and derivative transactions, including TBA contracts, when required under the terms of the related agreements. We may also use liquidity to repurchase shares of our common stock periodically.

Our liquidity fluctuates based on our investment activities, our financing and capital raising activities, and changes in the fair value of our investments and derivative instruments. We seek to maintain sufficient liquidity to support our operations and to meet our anticipated liquidity demands, including potential margin calls from lenders (as discussed further below). Our most liquid assets include unrestricted cash and cash equivalents and unencumbered Agency RMBS, CMBS, and CMBS IO. As of March 31, 2019, our most liquid assets were $202.8 million compared to $210.8 million as of December 31, 2018.

We perform sensitivity analysis on our liquidity based on changes in the fair value of our investments due to, among other things, changes in the absolute level of interest rates and the shape of the yield curve, credit spreads, lender haircuts, and prepayment speeds as well as changes in the fair value of our derivative instruments due to changes in the absolute level of interest rates and the shape of the yield curve. In performing this analysis, we will also consider the current state of the fixed income markets and the repurchase agreement markets in order to determine if market forces such as supply-demand imbalances or structural changes to these markets could change the liquidity of MBS or the availability of financing. The objective of our analysis is to assess the adequacy of our liquidity to withstand potential adverse events. We may change our leverage targets based on market conditions and our perceptions of the liquidity of our investments.

We closely monitor our debt-to-invested equity ratio (which is the ratio of debt financing to invested equity for any investment) as part of our liquidity management process as well as our overall enterprise level debt-to-equity ratio. We also monitor the ratio of our available liquidity to outstanding repurchase agreement borrowings, which fluctuates due to changes in the fair value of collateral we have pledged to our lenders. We also include our TBA dollar roll positions (at cost if settled) in evaluating the Company’s leverage because it is possible under certain market conditions that it may be uneconomical for us to roll our TBA dollar roll positions into future months, which may result in us having to take physical delivery of the underlying securities and use cash or other financing sources to fund our total purchase commitment. Including our TBA dollar roll positions at cost (if settled), which was $727.2 million as of March 31, 2019, our leverage was 8.5 times shareholders’ equity compared to 8.0 times shareholders’ equity as of December 31, 2018.

39

The following table presents information regarding the balances of our repurchase agreement borrowings and our TBA dollar roll positions for the periods indicated:

	Repurchase Agreements						TBA Dollar Roll Positions (1)
($ in thousands)	Balance Outstanding As of Quarter End		Average Balance Outstanding For the Quarter Ended		Maximum Balance Outstanding During the Quarter Ended		Balance Outstanding As of Quarter End		Average Balance Outstanding For the Quarter Ended
March 31, 2019	$	4,252,893	$	3,931,335	$	4,266,684	$	727,212	$	722,264
December 31, 2018	3,267,984		2,992,513		3,269,307		882,230		814,478
September 30, 2018	2,690,858		2,564,863		2,701,797		780,865		982,665
June 30, 2018	2,514,984		2,716,097		2,844,225		782,408		722,005
March 31, 2018	2,613,892		2,645,714		2,716,729		844,941		863,615

(1) Balance outstanding as of quarter end and average balance outstanding for the quarter ended includes TBA dollar roll positions as reported at cost (as if settled). Does not include short TBA positions used to hedge interest rate risk exposure from fixed-rate Agency RMBS in applicable periods.

Depending on our liquidity levels, investment opportunities, the condition of the credit markets, and other factors, we may from time to time consider the issuance of debt, equity, or other securities. We have generally had access to the debt and equity capital markets on reasonable terms. In times of market stress, we may need to sell investments in order to provide additional liquidity for our business. While we will attempt to avoid dilutive or otherwise costly issuances, depending on market conditions and in order to manage our liquidity, we could be forced to issue equity or debt securities which may be dilutive to our capital base or our profitability.

Repurchase Agreements

 Our repurchase agreement borrowings are principally uncommitted and have short-term maturities. As such, we attempt to maintain unused capacity under our existing repurchase agreement credit lines with multiple counterparties which helps protect us in the event of a counterparty's failure to renew existing repurchase agreements. As of March 31, 2019, we had repurchase agreement borrowings outstanding with 19 of our 36 available repurchase agreement counterparties at a weighted average borrowing rate of 2.78% compared to 2.69% as of December 31, 2018. Our repurchase agreement borrowings generally carry a rate of interest based on a spread to an index such as LIBOR.

For our repurchase agreement borrowings, we are required to post and maintain margin to the lender (i.e., collateral in excess of the repurchase agreement financing) in order to support the amount of the financing. This excess collateral is often referred to as a “haircut” (and which we also refer to as equity at risk) and is intended to provide the lender some protection against fluctuations in fair value of the collateral and/or the failure by us to repay the borrowing at maturity. The majority of the collateral pledged to our repurchase agreement counterparties is MBS, the fair value of which fluctuates depending on market conditions. If the fair value of the collateral falls below the haircut required by the lender, the lender has the right to demand additional margin, or collateral, to increase the haircut back to the initial amount. These demands are typically referred to as “margin calls”. Declines in the value of investments occur for any number of reasons including but not limited to changes in interest rates, changes in ratings on an investment, changes in actual or perceived liquidity of the investment, or changes in overall market risk perceptions. Additionally, Fannie Mae and Freddie Mac announce principal payments on Agency MBS in advance of their actual remittance of principal payments, and repurchase agreement lenders generally make margin calls for an amount equal to the product of their advance rate on the repurchase agreement and the announced principal payments on the Agency RMBS. A margin call made by a lender reduces our liquidity until we receive the principal payments from Fannie Mae and Freddie Mac. 

If we fail to meet any margin call, our lenders also have the right to terminate the repurchase agreement and sell any collateral pledged. Therefore, we attempt to maintain cash and other liquid securities in sufficient amounts to manage our exposure to margin calls by lenders. The lender also has the right to change the required haircut at maturity of the repurchase agreement (if the term is renewed) which would require us to post additional collateral to the lender. The following table presents the weighted average minimum haircut contractually required by our counterparties for MBS pledged as collateral for our repurchase agreement borrowings as of the dates indicated:

40

	March 31, 2019		December 31, 2018		September 30, 2018		June 30, 2018		March 31, 2018
Agency CMBS and RMBS	4.8	%	4.9	%	4.8	%	4.9	%	4.8	%
CMBS IO	13.4	%	13.4	%	13.3	%	13.3	%	13.7	%

The counterparties with whom we have the greatest amounts of equity at risk may vary significantly during any given period due to the short-term and generally uncommitted nature of the repurchase agreement borrowings. Equity at risk represents the potential loss to the Company if the counterparty is unable or unwilling to return collateral securing the repurchase agreement borrowing at its maturity. Please refer to Note 3 for information regarding counterparties with whom we have the greatest amount of equity at risk as of March 31, 2019.

The following table discloses our repurchase agreement amounts outstanding and the value of the related collateral pledged by geographic region of our counterparties as of the dates indicated:

	March 31, 2019				December 31, 2018
($ in thousands)	Amount Outstanding		Market Value of Collateral Pledged		Amount Outstanding		Market Value of Collateral Pledged
North America	$	2,868,545	$	3,073,938	$	2,190,361	$	2,365,132
Asia	729,714		773,829		594,435		633,078
Europe	654,634		689,840		483,188		513,394
	$	4,252,893	$	4,537,607	$	3,267,984	$	3,511,604

Certain of our repurchase agreement counterparties require us to comply with various operating and financial covenants. The financial covenants include, among other things, requirements that we maintain minimum shareholders' equity (usually a set minimum, or a percentage of the highest amount of shareholders' equity since the date of the agreement), limits on maximum decline in shareholders' equity (expressed as a percentage decline in any given period), and limits on maximum leverage (as a multiple of shareholders' equity). Operating requirements include, among other things, requirements to maintain our status as a REIT and to maintain our listing on the NYSE. Violations of one or more of these covenants could result in the lender declaring an event of default which would result in the termination of the repurchase agreement and immediate acceleration of amounts due thereunder. In addition, some of the agreements contain cross default features, whereby default with one lender simultaneously causes default under agreements with other lenders. Violations could also restrict us from paying dividends or engaging in other transactions that are necessary for us to maintain our REIT status.

We monitor and evaluate on an ongoing basis the impact these customary financial covenants may have on our operating and financing flexibility. Currently, we do not believe we are subject to any covenants that materially restrict our financing flexibility.

Derivative Instruments

We are party to certain types of financial instruments that are accounted for as derivative instruments including interest rate swaps, Eurodollar futures and long and short positions in TBA securities. Certain of these derivative instruments may require us to post initial margin at inception and daily variation margin based on subsequent changes in their fair value. The collateral posted as margin by us is typically in the form of cash or Agency MBS. In addition, counterparties may have to post variation margin to us. Generally, as interest rates decline, we will be required to post collateral with counterparties on our interest rate derivatives, and vice versa as interest rates increase. As of March 31, 2019, we had cash of $86.8 million posted as collateral under these agreements.

As of March 31, 2019, approximately $35 million of the Company’s interest rate swaps were entered into under bilateral agreements which contain cross-default provisions with other agreements between the parties. In addition, these bilateral agreements contain financial and operational covenants similar to those contained in our repurchase agreements, as described above. Currently, we do not believe we are subject to any covenants that materially restrict our hedging flexibility.

Our TBA contracts are subject to master securities forward transaction agreements published by the Securities Industry and Financial Markets Association as well as supplemental terms and conditions with each counterparty. Under the terms of these agreements, we may be required to pledge collateral to, or have the right to receive collateral from, our counterparties when initiated or in the event the fair value of our TBA contracts declines. Declines in the fair value of TBA contracts are generally related to such factors as rising interest rates, increases in expected prepayment speeds, or widening spreads. Our TBA contracts generally

41

provide that valuations for our TBA contracts and any pledged collateral are to be obtained from a generally recognized source agreed to by both parties. However, in certain circumstances, our counterparties have the sole discretion to determine the value of the TBA contract and any pledged collateral. In such instances, our counterparties are required to act in good faith in making determinations of value. In the event of a margin call, we must generally provide additional collateral on the same business day.

Dividends

As a REIT, we are required to distribute to our shareholders amounts equal to at least 90% of our REIT taxable income for each taxable year after consideration of our tax NOL carryforwards. We generally fund our dividend distributions through our cash flows from operations. If we make dividend distributions in excess of our operating cash flows during the period, whether for purposes of meeting our REIT distribution requirements or other strategic reasons, those distributions are generally funded either through our existing cash balances or through the return of principal from our investments (either through repayment or sale). 

We have a net operating tax loss ("NOL") carryforward that we could use to offset our REIT taxable income distribution requirement. This NOL carryforward had an estimated balance of $89.8 million as of March 31, 2019, which will begin to substantially expire in 2020. We also have deferred tax hedge losses on terminated derivative instruments, which will be recognized over the original periods being hedged by those terminated derivatives. These losses have already been recognized in our GAAP earnings but will reduce taxable income over the next ten years as noted in the following table:

($ in thousands)	Tax Hedge Loss Deduction
2019	$	17,148
2020	6,132
2021 - 2028	3,620
	$	26,900

If any of the deferred tax hedge losses for the years noted in the table above result in dividend distributions to our shareholders in excess of REIT taxable income, the excess dividends distributed will be considered a return of capital to the shareholder. Approximately 72% of our common stock dividends declared during the three months endedMarch 31, 2019 will represent a return of capital to shareholders and not a distribution of REIT taxable income, principally as a result of the amount of the tax hedge loss deduction.

Contractual Obligations

The following table summarizes our contractual obligations by payment due date as of March 31, 2019:

($ in thousands)	Payments due by period
Contractual Obligations:	Total		< 1 year		1-3 years		3-5 years		> 5 years
Repurchase agreements (1)	$	4,258,755	$	4,258,755	$	—	$	—	$	—
Non-recourse collateralized financing (2)	3,260		1,045		1,335		704		176
Operating lease obligations	218		218		—		—		—
Total	$	4,262,233	$	4,260,018	$	1,335	$	704	$	176

(1) Includes estimated interest payments calculated using interest rates in effect and weighted average days remaining until maturity as of March 31, 2019.

(2) Amounts shown are for principal only and exclude interest obligations as those amounts are not significant. Non-recourse collateralized financing represents securitization financing that is payable solely from loans and securities pledged as collateral. Payments due by period were estimated based on the principal repayments forecasted for the underlying loans and securities, substantially all of which is used to repay the associated financing outstanding.

42

Other Matters

As of March 31, 2019, we do not believe that any off-balance sheet arrangements exist that are reasonably likely to have a material effect on our current or future financial condition, results of operations, or liquidity other than as discussed above. In addition, we do not have any material commitments for capital expenditures and have not obtained any commitments for funds to fulfill any capital obligations.

RECENT ACCOUNTING PRONOUNCEMENTS

There were no accounting pronouncements issued during the three months endedMarch 31, 2019 that are expected to have a material impact on the Company’s financial condition or results of operations.

FORWARD-LOOKING STATEMENTS

Certain written statements in this Quarterly Report on Form 10-Q that are not historical facts constitute “forward-looking statements” within the meaning of Section 27A of the 1933 Act and Section 21E of the Exchange Act. Statements in this report addressing expectations, assumptions, beliefs, projections, future plans and strategies, future events, developments that we expect or anticipate will occur in the future, and future operating results, capital management, and dividend policy are forward-looking statements. Forward-looking statements are based upon management’s beliefs, assumptions, and expectations as of the date of this report regarding future events and operating performance, taking into account all information currently available to us, and are applicable only as of the date of this report. Forward-looking statements generally can be identified by use of words such as “believe”, “expect”, “anticipate”, “estimate”, “plan” “may”, “will”, “intend”, “should”, “could” or similar expressions. We caution readers not to place undue reliance on our forward-looking statements, which are not historical facts and may be based on projections, assumptions, expectations, and anticipated events that do not materialize. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statement whether as a result of new information, future events, or otherwise.

Forward-looking statements in this Quarterly Report on Form 10-Q may include, but are not limited to statements about:

• Our business and investment strategy including our ability to generate acceptable risk-adjusted returns and our target investment allocations, and our views on the future performance of MBS and other investments;

• Our views on conditions in the investment, credit, and derivatives markets;

• Our views on the effect of actual or proposed actions of the U.S. Federal Reserve, the FOMC, or other central banks with respect to monetary policy (including the targeted Federal Funds Rate), and the potential impact of these actions on interest rates, inflation or unemployment;

• The effect of regulatory initiatives of the Federal Reserve (including the FOMC), other financial regulators, and other central banks;

• Our financing strategy including our target leverage ratios, our use of TBA dollar roll transactions, and anticipated trends in financing costs, and our hedging strategy including changes to the derivative instruments to which we are a party, and changes to government regulation of hedging instruments and our use of these instruments;

• Our investment portfolio composition and target investments;

• Our investment portfolio performance, including the fair value, yields, and forecasted prepayment speeds of our investments;

• Our liquidity and ability to access financing, and the anticipated availability and cost of financing;

• Our capital stock activity including the impact of stock issuances and repurchases;

• The amount, timing, and funding of future dividends;

• Our use of and restrictions on using our tax NOL carryforward;

• The status of pending litigation;

• The competitive environment in the future, including competition for investments and the availability of financing;

• Estimates of future interest expenses, including related to the Company’s repurchase agreements and derivative instruments;

• The status and effect of legislative reforms and regulatory rule-making or review processes, and the status of reform efforts and other business developments in the repurchase agreement financing market;

• Market, industry and economic trends, and how these trends and related economic data may impact the behavior of market participants and financial regulators; and

43

• Market interest rates and market spreads.

Forward-looking statements are inherently subject to risks, uncertainties and other factors that could cause our actual results to differ materially from historical results or from any results expressed or implied by such forward-looking statements. Not all of these risks and other factors are known to us. New risks and uncertainties arise over time, and it is not possible to predict those events or how they may affect us. The projections, assumptions, expectations or beliefs upon which the forward-looking statements are based can also change as a result of these risks or other factors. If such a risk or other factor materializes in future periods, our business, financial condition, liquidity and results of operations may vary materially from those expressed or implied in our forward-looking statements.

While it is not possible to identify all factors that may cause actual results to differ from historical results or from any results expressed or implied by forward-looking statements, or that may cause our projections, assumptions, expectations or beliefs to change, some of those factors include the following:

• the risks and uncertainties referenced in this Quarterly Report on Form 10-Q, particularly those set forth under and incorporated by reference into Part II, Item 1A, “Risk Factors”;

• our ability to find suitable reinvestment opportunities;

• changes in domestic economic conditions;

• changes in interest rates and interest rate spreads, including the repricing of interest-earning assets and interest-bearing liabilities;

• our investment portfolio performance particularly as it relates to cash flow, prepayment rates and credit performance;

• the impact on markets and asset prices from the Federal Reserve’s balance sheet normalization process through the reduction in its holdings of Agency RMBS and U.S. Treasuries;

• actual or anticipated changes in Federal Reserve monetary policy or the monetary policy of other central banks;

• adverse reactions in U.S. financial markets related to actions of foreign central banks or the economic performance of foreign economies including in particular China, Japan, the European Union, and the United Kingdom;

• uncertainty concerning the long-term fiscal health and stability of the United States;

• the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;

• the cost and availability of new equity capital;

• changes in our use of leverage;

• changes to our investment strategy, operating policies, dividend policy or asset allocations;

• the quality of performance of third-party servicer providers of our loans and loans underlying our securities;

• the level of defaults by borrowers on loans we have securitized;

• changes in our industry;

• increased competition;

• changes in government regulations affecting our business;

• changes or volatility in the repurchase agreement financing markets and other credit markets;

• changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;

• uncertainty regarding continued government support of the U.S. financial system and U.S. housing and real estate markets; or to reform the U.S. housing finance system including the resolution of the conservatorship of Fannie Mae and Freddie Mac;

• the composition of the Board of Governors of the Federal Reserve System;

• ownership shifts under Section 382 that further limit the use of our tax NOL carryforward;

• systems failures or cybersecurity incidents; and

• exposure to current and future claims and litigation.

44

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk is the exposure to losses resulting from changes in market factors. Our business strategy exposes us to a variety of market risks, including interest rate, spread, prepayment, reinvestment, credit, and liquidity risks. These risks can and do cause fluctuations in our comprehensive income and book value as discussed below.

Interest Rate Risk

Investing in interest-rate sensitive investments such as MBS and TBA securities subjects us to interest rate risk. Interest rate risk results from investing in securities that have a fixed coupon or when the coupon may not immediately adjust for changes in interest rates. Interest rate risk also results from the mismatch between the duration of our assets versus the duration of our liabilities and hedges.

The measures of an instrument’s price sensitivity to interest rate fluctuations are its duration and convexity. Duration measures the percentage change in projected market value of our investments and derivative instruments given a change in interest rates. The duration of RMBS and TBA securities tend to increase when interest rates rise and decrease when interest rates fall, which is commonly referred to as negative convexity. This occurs because prepayments of the mortgage loans underlying the RMBS tend to decline when interest rates rise (which extends the life of the security) and increase when interest rates fall (which shortens the life of the security). The fair value of TBA securities react similarly to RMBS to changes in interest rates as they are based on an underlying non-specified pool of fixed-rate residential mortgage loans. CMBS and CMBS IO, however, generally have little convexity because the mortgage loans underlying the securities contain some form of prepayment protection provision (such as prepayment lock-outs) or prepayment compensation provisions (such as yield maintenance or prepayment penalties) which create an economic disincentive for the loans to prepay.

We attempt to manage our exposure to changes in interest rates that results from the duration mismatch between our assets and liabilities by entering into interest rate swaps and other derivative instruments to hedge this risk. We manage interest rate risk within tolerances set by our Board of Directors. Our portfolio duration changes based on the composition of our investment portfolio and our hedge positions as well as market factors. We calculate our portfolio duration based on modeled projected cash flows, and such calculated duration can be an imprecise measure of actual interest rate risk. In the case of Agency RMBS and TBA securities, the primary input to the calculated duration is the anticipated prepayment speed of the underlying mortgage loans, which is sensitive to future interest rates and borrowers’ behavior. Changes in the level of interest rates can affect the rate of mortgage prepayments and the market value of our assets. Our hedging techniques are highly complex and are partly based on assumed levels of prepayments of our assets. If prepayments are slower or faster than assumed, the maturity our investments will also differ from our expectations, which could reduce the effectiveness of our hedging strategies and may cause losses on such transactions and adversely affect our cash flow. Estimates of prepayment speeds can vary significantly by investor for the same security, and therefore estimates of security and portfolio duration can vary significantly.

During a period of rising interest rates (particularly short-term rates in a flattening yield curve environment), normally our borrowing costs will increase faster than our asset yields, negatively impacting our net interest income. The amount of the impact will depend on the composition of our portfolio, our hedging strategy, the effectiveness of our hedging instruments as well as the magnitude and the duration of the increase in interest rates.

Changes in types of our investments, the returns earned on these investments, future interest rates, credit spreads, the shape of the yield curve, the availability of financing, and/or the mix of our investments and financings including derivative instruments may cause actual results to differ significantly from the modeled results shown in the tables below. There can be no assurance that assumed events used to model the results shown below will occur, or that other events will not occur, that will affect the outcomes; therefore, the modeled results shown in the tables below and all related disclosures constitute forward-looking statements.

45

The table below shows the projected sensitivity of our net interest income and net periodic interest benefit/cost on our interest rate swaps as of the periods indicated:

	Projected Change in Net Interest Income and Net Periodic Interest Benefit/Cost Due To
	Decrease in Interest Rates of				Increase in Interest Rates of
	50 Basis Points		100 Basis Points		50 Basis Points		100 Basis Points
As of March 31, 2019	(17.8	)%	(55.1	)%	11.4	%	19.1	%
As of December 31, 2018	(8.0	)%	(21.1	)%	4.2	%	6.1	%

(1) Includes estimated changes in net interest income as well as net periodic interest benefit/cost on our interest rate swaps recorded in “gain (loss) on derivatives instruments, net” and does not include estimated changes to TBA drop income generated by TBA dollar roll transactions, which are accounted for as derivative instruments in accordance with GAAP.

The projected sensitivity to changes in interest rates on our net interest income and net periodic interest benefit/cost from interest rate swaps has increased as of March 31, 2019 relative to December 31, 2018 due to the increase in our fixed-rate Agency RMBS portfolio and our leverage ratio as well as changes in our hedging portfolio during the first quarter of 2019.

The table below shows the projected sensitivity of the market value of our financial instruments ⁽¹⁾ and the percentage change in shareholders’ equity based on an instantaneous parallel shift in market interest rates as of the dates indicated:

	As of March 31, 2019
	Decrease in Interest Rates of								Increase in Interest Rates of
	50 Basis Points				100 Basis Points				50 Basis Points				100 Basis Points
Type of Instrument (1)	% of Market Value		% of Total Equity		% of Market Value		% of Total Equity		% of Market Value		% of Total Equity		% of Market Value		% of Total Equity
RMBS	0.6	%	4.6	%	0.6	%	5.2	%	(1.0	)%	(8.1	)%	(2.4	)%	(18.9	)%
CMBS	1.2	%	9.6	%	2.5	%	19.7	%	(1.1	)%	(9.2	)%	(2.2	)%	(18.0	)%
CMBS IO	0.1	%	1.0	%	0.3	%	2.1	%	(0.1	)%	(1.0	)%	(0.3	)%	(2.0	)%
TBAs	0.1	%	1.0	%	0.1	%	1.0	%	(0.2	)%	(1.9	)%	(0.6	)%	(4.8	)%
Interest rate swaps	(2.5	)%	(20.5	)%	(5.2	)%	(41.9	)%	2.4	%	19.5	%	4.8	%	38.2	%
Total	(0.5	)%	(4.3	)%	(1.7	)%	(13.9	)%	—	%	(0.7	)%	(0.7	)%	(5.5	)%
	As of December 31, 2018
	Decrease in Interest Rates by								Increase in Interest Rates by
	50 Basis Points				100 Basis Points				50 Basis Points				100 Basis Points
Type of Instrument (1)	% of Market Value		% of Total Equity		% of Market Value		% of Total Equity		% of Market Value		% of Total Equity		% of Market Value		% of Total Equity
RMBS	1.0	%	7.0	%	1.6	%	11.2	%	(1.3	)%	(9.4	)%	(2.9	)%	(20.6	)%
CMBS	1.0	%	7.1	%	2.0	%	14.6	%	(1.0	)%	(6.8	)%	(1.9	)%	(13.4	)%
CMBS IO	0.3	%	1.8	%	0.4	%	3.1	%	(0.1	)%	(0.7	)%	(0.3	)%	(1.9	)%
TBAs	0.2	%	1.7	%	0.4	%	2.5	%	(0.4	)%	(2.9	)%	(0.9	)%	(6.7	)%
Interest rate swaps	(2.7	)%	(19.0	)%	(5.5	)%	(39.0	)%	2.5	%	18.1	%	4.9	%	35.3	%
Total	(0.2	)%	(1.4	)%	(1.1	)%	(7.6	)%	(0.3	)%	(1.7	)%	(1.1	)%	(7.3	)%

(1) Changes in market value of our financings are excluded because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.

46

The percentage change in market value for our RMBS and TBAs declined slightly as of March 31, 2019 compared to December 31, 2018 due to declining interest rates during the first quarter of 2019 as increased prepayment expectations shortened the expected life of cash flows for these securities. As mentioned above, CMBS generally have some form of prepayment protection, so their market value sensitivity was not similarly impacted by declining interest rates. The increase in the percentage change in market value for CMBS as of March 31, 2019 compared to December 31, 2018 is primarily due to our first quarter purchases which increased weighted average life remaining overall for that portion of our portfolio. Unlike our CMBS, the CMBS IO remaining in our portfolio are more seasoned with shorter expected cash flows and fewer prepayment protection provisions remaining, so their percentage change in market value declined as of March 31, 2019 compared to December 31, 2018.

Management also considers changes in the shape of the interest rate curves in assessing and managing portfolio interest rate risk. Often interest rates do not move in a parallel fashion from quarter to quarter. The table below shows the percentage change in projected market value of our financial instruments ⁽¹⁾ for instantaneous changes in the shape of the U.S. Treasury (“UST”) curve (with similar changes to the interest rate swap curves) as of the dates indicated:

		March 31, 2019				December 31, 2018
Basis Point Change in		Percentage Change in
2-year UST	10-year UST	Market Value of Investments (1)		Shareholders’ Equity		Market Value of Investments (1)		Shareholders’ Equity
+25	+50	—	%	(0.2	)%	(0.1	)%	(0.8	)%
+25	+0	—	%	(0.1	)%	—	%	(0.3	)%
+50	+25	—	%	—	%	(0.2	)%	(1.1	)%
+50	+100	(0.6	)%	(4.8	)%	(0.8	)%	(5.7	)%
-10	-50	(0.6	)%	(4.5	)%	(0.4	)%	(2.6	)%

(1) Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.

Spread Risk

Spread risk is the risk of loss from an increase in the market spread between the yield on an investment versus its benchmark index. Changes in market spreads represent the market's valuation of the perceived riskiness of an asset relative to risk-free rates, and widening spreads reduce the market value of our investments as market participants require additional yield to hold riskier assets. Market spreads could change based on macroeconomic or systemic factors as well as the factors specific to a particular security such as prepayment performance or credit performance. Other factors that could impact credit spreads include technical issues such as supply and demand for a particular type of security or FOMC monetary policy. Likewise, most of our investments are fixed-rate or reset in rate over a period of time, and as interest rates rise, we would expect the market value of these investments to decrease. While we use derivative instruments to mitigate interest rate risk on our financial instruments, we do not hedge spread risk given the complexity of hedging credit spreads and the lack of liquid instruments available to use as hedges.

Fluctuations in spreads typically vary based on the type of investment. Sensitivity to changes in market spreads is derived from models that are dependent on various assumptions, and actual changes in market value in response to changes in market spreads could differ materially from the projected sensitivity if actual conditions differ from these assumptions.

The table below shows the projected sensitivity of the market value of our investments ⁽¹⁾ given the indicated change in market spreads as of the dates indicated:

47

	March 31, 2019				December 31, 2018
	Percentage Change in
Basis Point Change in Market Spreads	Market Value of Investments (1)		Shareholders’ Equity		Market Value of Investments (1)		Shareholders’ Equity
+20/+50 (2)	(1.3	)%	(10.2	)%	(1.3	)%	(9.5	)%
+10	(0.6	)%	(4.8	)%	(0.6	)%	(4.5	)%
-10	0.6	%	5.0	%	0.7	%	5.0	%
-20/-50 (2)	1.3	%	10.6	%	1.5	%	11.0	%

(1) Includes changes in market value of our MBS investments, including TBA securities.

(2) Assumes a 20-basis point shift in Agency and non-Agency RMBS and CMBS and a 50-basis point shift in Agency and non-Agency CMBS IO.

Prepayment and Reinvestment Risk

Prepayment risk is the risk of an early, unscheduled return of principal on an investment. We are subject to prepayment risk from premiums paid on investments, which are amortized as a reduction in interest income using the effective yield method under GAAP. Principal prepayments on our investments are influenced by changes in market interest rates and a variety of economic, geographic, government policy, and other factors beyond our control.

Loans underlying our CMBS and CMBS IO securities typically have some form of prepayment protection provisions (such as prepayment lock-outs) or prepayment compensation provisions (such as yield maintenance or prepayment penalties). Yield maintenance and prepayment penalty requirements are intended to create an economic disincentive for the loans to prepay; however, the amount of the prepayment penalty required to be paid may decline over time, and as loans age, interest rates decline, or market values of collateral supporting the loans increase, prepayment penalties may lessen as an economic disincentive to the borrower. Generally, our experience has been that prepayment lock-out and yield maintenance provisions result in stable prepayment performance from period to period. There are no prepayment protections, however, if the loan defaults and is partially or wholly repaid earlier as a result of loss mitigation actions taken by the underlying loan servicer. Historically, we have experienced low default rates on loans underlying CMBS and CMBS IO.

Because CMBS IO consist of rights to interest on the underlying commercial mortgage loan pools and do not have rights to principal payments on the underlying loans, prepayment risk on these securities would be particularly acute without these prepayment protection provisions. CMBS IO prepayment protection and compensation provisions vary by issuer of the security (i.e. Freddie Mac, Fannie Mae, Ginnie Mae, or non-Agency). The majority of our Agency CMBS IO are issued by Freddie Mac and these securities generally have initial prepayment lock-outs followed by a defeasance period which on average extends to within six months of the stated maturities of the underlying loans. Non-Agency CMBS IO generally have prepayment protection in the form of prepayment lock-outs and defeasance provisions.

Prepayments on the loans underlying our RMBS generally accelerate in a declining interest rate environment, as the loans age, and, with respect to ARMS, as the loans near their respective interest rate reset dates, particularly the initial reset date, or if expectations are that interest rates will rise in the future. Our prepayment models anticipate an acceleration of prepayments in these events. To the extent the actual prepayments exceed our modeled prepayments, or, with respect to adjustable-rate RMBS, if we change our future prepayment expectations, we will record adjustments to our premium amortization which may negatively impact our net interest income. In addition, changes in market expectations of prepayments could impact the fair value of our RMBS.

We seek to manage our prepayment risk on our MBS by diversifying our investments, seeking investments which we believe will have superior prepayment performance, and investing in securities which have some sort of prepayment prohibition or yield maintenance (as is the case with CMBS and CMBS IO). With respect to RMBS, when we invest in RMBS at a premium to the security’s par value, we tend to favor securities in which we believe the underlying borrowers have some disincentive to refinance as a result of the size of each loan’s principal balance, credit characteristics of the borrower, or geographic location of the property, among other factors.

48

We are also subject to reinvestment risk as a result of the prepayment, repayment and sales of our investments. In order to maintain our investment portfolio size and our earnings, we need to reinvest capital received from these events into new interest-earning assets or TBA securities. If we are unable to find suitable reinvestment opportunities or if yields on assets in which we reinvest are lower than yields on existing assets, our results and cash flows could be negatively impacted. In addition, based on market conditions, our leverage, and our liquidity profile, we may decide to not reinvest the cash flows we receive from our investment portfolio even when attractive reinvestment opportunities are available, or we may decide to reinvest in assets with lower yield but greater liquidity. If we retain capital or pay dividends to return capital to shareholders rather than reinvest capital, or if we invest capital in lower yielding assets for liquidity reasons, the size of our investment portfolio and the amount of income generated by our investment portfolio will likely decline.

Credit Risk

Credit risk is the risk that we will not receive all contractual amounts due on investments that we own due to default by the borrower or due to a deficiency in proceeds from the liquidation of the collateral securing the obligation. Credit losses on loans could result in lower or negative yields on our investments.

Agency RMBS and Agency CMBS have credit risk to the extent that Fannie Mae or Freddie Mac fails to remit payments on the MBS for which they have issued a guaranty of payment. Given the improved financial performance and conservatorship of these entities and the continued support of the U.S. government, we believe this risk is low. Since Agency CMBS IO represent the right to excess interest and not principal on the underlying loans, these securities are exposed to the loss of investment basis in the event a loan collateralizing the security liquidates without paying yield maintenance or prepayment penalty, which typically occurs when an involuntarily liquidating loan repays all or a portion of its related principal balance.

We attempt to mitigate our credit risk on our non-Agency securities through asset selection and by purchasing higher quality securities. Our non-Agency MBS are typically investment grade rated securities which we believe will have good credit performance. The majority of our non-Agency securities are CMBS IO and the return we earn on these securities is dependent on the credit performance of the underlying commercial loans. In particular, since investments in CMBS IO pay interest from the underlying commercial mortgage loan pools, returns generally are more negatively impacted by liquidations of loans in the underlying loan pool.

Liquidity Risk

We have liquidity risk principally from the use of recourse repurchase agreements to finance our ownership of securities. Our repurchase agreements are renewable at the discretion of our lenders and do not contain guaranteed roll-over terms. If we fail to repay the lender at maturity, the lender has the right to immediately sell the collateral and pursue us for any shortfall if the sales proceeds are inadequate to cover the repurchase agreement financing. In addition, declines in the market value of our investments pledged as collateral for repurchase agreement borrowings may result in counterparties initiating margin calls for additional collateral.

Our use of TBA long positions as a means of investing in and financing Agency RMBS also exposes us to liquidity risk in the event that we are unable to roll or terminate our TBA contracts prior to their settlement date. If we are unable to roll or terminate our TBA long positions, we could be required to take physical delivery of the underlying securities and settle our obligations for cash, which could negatively impact our liquidity position or force us to sell assets under adverse conditions if financing is not available to us on acceptable terms.

For further information, including how we attempt to mitigate liquidity risk and monitor our liquidity position, please refer to “Liquidity and Capital Resources” in Part I, Item 2 of this Quarterly Report on Form 10-Q.

49

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our management evaluated, with the participation of our Principal Executive Officer and Principal Financial Officer, the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this report. Based on that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2019 to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the three months ended March 31, 2019 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

As previously disclosed in the Company’s 2018 Form 10-K, in January 2019, the U.S. District Court, Northern District of Texas (the “Northern District Court”) dismissed the amended complaint of Basic Capital Management, Inc., et al. (the “DCI Plaintiffs”) against the Company and DCI Commercial, Inc. (“DCI”), a former affiliate of the Company and formerly known as Dynex Commercial, Inc., regarding the activities of DCI while it was an operating subsidiary of an affiliate of the Company (the “DCI Litigation”). The Northern District Court granted the DCI Plaintiffs until March 8, 2019 to file an amended complaint. The DCI Plaintiffs filed an amended complaint in April 2019, to which the Company has filed a response.

Also as previously disclosed in the 2018 Form 10-K, one of the DCI Plaintiffs also filed a claim (the “Cost Sharing Litigation”) in May 2018 against the Company seeking payment of a judgment previously entered only against DCI (the “DCI Judgment”), with such payment allegedly required pursuant to the provisions of a litigation cost sharing agreement, as amended, entered into initially in December 2000 between the Company and DCI. In June 2018, the Company filed a motion to transfer the lawsuit to the U.S. District Court for the Eastern District of Virginia (the “Eastern District Court”). The Company also filed a declaratory judgment action with the Eastern District Court seeking a declaration that the Company is not obligated under the litigation cost sharing agreement to pay any portion of the DCI Judgment. In March 2019, the Eastern District Court declined to hear the Company’s motions and the Cost Sharing Litigation therefore remains pending before the 68^th District Court of Dallas County, Texas. The Company has moved to dismiss the case from the 68th District Court for lack of subject matter jurisdiction. There were no other developments during the first quarter of 2019.

The Company believes that the above matters against it are baseless and without merit and intends to continue to defend itself vigorously in these actions. The Company believes, based upon information currently available, that the above matters will be resolved without a material adverse effect on the Company’s consolidated financial statements as a whole. The outcome, however, of any legal proceeding, including the above matters, cannot be predicted with certainty. As such, no assurances can be given that the Company will be successful in its defense of these actions on the merits or otherwise. If the Company is not successful in its defense efforts, the resolution of these matters could have a material adverse effect on the Company’s consolidated financial statements in a given future reporting period.

Other than as described above, to the Company’s knowledge, there are no pending or threatened legal proceedings, the resolution of which, in management’s opinion, individually or in the aggregate, could have a material adverse effect on the Company’s results of operations or financial condition. The garnishment action related to DCI, discussed in the 2018 Form 10-K, is ongoing, but there have been no material developments during the three months ended March 31, 2019.

50

ITEM 1A.    RISK FACTORS

Risks and uncertainties identified in our forward-looking statements contained in this Quarterly Report on Form 10-Q together with those previously disclosed in the 2018 Form 10-K or those that are presently unforeseen could result in significant adverse effects on our financial condition, results of operations and cash flows.  See “Forward-Looking Statements” contained in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” within this Quarterly Report on Form 10-Q as well as Part I, Item 1A, “Risk Factors” in our 2018 Form 10-K.

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

The Company has been authorized by its Board of Directors to repurchase up to $40 million of its outstanding shares of common stock through December 31, 2020. Subject to applicable securities laws and the terms of the Series A Preferred Stock designation and the Series B Preferred Stock designation, both of which are contained in our Articles of Incorporation, future repurchases of common stock will be made at times and in amounts as the Company deems appropriate, provided that the repurchase price per share is less than the Company's estimate of the current net book value of a share of common stock. Repurchases may be suspended or discontinued at any time. During the three months ended March 31, 2019, the Company did not repurchase any shares of common stock under this repurchase authorization.

The following table summarizes repurchases of our common stock that occurred during the three months ended March 31, 2019:

	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
					(in thousands)
January 1, 2019 - January 31, 2019	—	$	—	—	$	40,000
February 1, 2019 - February 28, 2019	48,693	—		—	40,000
March 1, 2019 - March 31, 2019	—	—		—	40,000
Total	48,693	$	—	—

(1) These shares were withheld from certain employees to satisfy tax withholding obligations arising upon the vesting of restricted shares. Accordingly, these shares are not included in the calculation of approximate dollar value of shares that may yet be purchased under the $40 million repurchase plan authorized by the Company's Board of Directors.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

None.

ITEM 5.    OTHER INFORMATION

51

None.

ITEM 6.    EXHIBITS

Exhibit No.	Description
3.1	Restated Articles of Incorporation, effective June 2, 2014 (incorporated herein by reference to Exhibit 3.1 to Dynex's Registration Statement on Form S-8 filed September 17, 2014).
3.2	Amended and Restated Bylaws, effective as of January 1, 2019 (incorporated herein by reference to Exhibit 3.2 to Dynex’s Annual Report on Form 10-K for the year ended December 31, 2018).
10.28	Dynex Capital, Inc. Executive Incentive Plan (as amended January 1, 2019) (filed herewith).
10.37	Underwriting Agreement, dated January 28, 2019, between Dynex Capital, Inc. and J.P. Morgan Securities LLC, as underwriter (incorporated herein by reference to Exhibit 1.1 to Dynex’s Current Report on Form 8-K filed on January 30, 2019).
10.38	Form of Restricted Stock Agreement for Executive Officers (for awards on or after February 27, 2019) under the Dynex Capital, Inc. 2018 Stock and Incentive Plan (filed herewith).
31.1	Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.2	Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1	Certification of principal executive officer and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101	The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended March 31, 2019, formatted in iXBRL (Inline Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income (Loss), (iii) Consolidated Statements of Shareholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Consolidated Financial Statements.

52

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		DYNEX CAPITAL, INC.
Date:	May 3, 2019	/s/ Byron L. Boston
		Byron L. Boston
		Chief Executive Officer, President,
		Co-Chief Investment Officer, and Director
		(Principal Executive Officer)
Date:	May 3, 2019	/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Executive Vice President, Chief Financial Officer and Chief Operating Officer
		(Principal Financial Officer)

EX-10.28

Exhibit 10.28

DYNEX CAPITAL, INC.

EXECUTIVE INCENTIVE PLAN

(as amended January 1, 2019)

1.    Purpose. The purpose of the Dynex Capital, Inc. Executive Incentive Plan (the “Plan”) is to attract, retain and motivate key employees by providing annual and long-term incentive awards to designated employees of Dynex Capital, Inc. (the “Company”) and its subsidiaries. The Plan is designed to align key employee interests with the interests of the Company’s shareholders and to create value by providing appropriate annual and long-term incentives to key employees to achieve corporate and individual performance goals, while appropriately balancing risk with reward.

2.    Annual Plan. The Plan is an annual plan and shall remain in effect until terminated by the independent directors of the Board of Directors (the “Independent Directors”). A new plan year shall commence on each January 1 and shall end each December 31. A new incentive opportunity (consisting of an annual incentive component and a separate long-term incentive component) will be granted under the Plan each plan year only to individuals who are eligible Participants for such plan year (as determined pursuant to Section 4). The annual incentive component and the long-term incentive component represent separate awards and are calculated and paid independent of each other under the Plan.

3.    Administration. The Plan shall be administered by the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of the Company. The Committee will have the power and authority to interpret the Plan, establish (except to the extent fixed by the Plan) the corporate/individual objectives and respective weightings of the annual incentive component, the minimum, target and maximum targets and applicable weightings of the other annual and long-term performance goals, determine the achievement of performance goals and assess individual performance, determine individual bonus amounts, determine rules for the operation and administration of the Plan and make all other necessary or advisable determinations with respect to the Plan. Subject to the provisions of Section 12, any interpretation or determination by the Committee under the Plan shall be binding on all parties.

4.    Participation. Only those individuals who are serving as executive officers as of the first quarter Board meeting each year are eligible to participate in the Plan for that plan year (the “Participants”). In the case of a promotion, an individual must have been promoted to “executive officer” by such first quarter Board meeting in order to participate in the Plan for that plan year.

5.     Bonus Opportunity. Each plan year, the Participant will be granted an incentive opportunity equal to the following percentages of his/her base salary as of January 1 of that plan year:

1

Executive	Target Incentive Opportunity	Maximum Incentive Opportunity
CEO	200%	400%
EVP	150%	300%

Each plan year, the incentive opportunity will be allocated between the annual incentive award and the long-term incentive award as follows: 80% to the annual incentive component and 20% to the long-term incentive component. The annual incentive component will have a 1-year performance period from January 1 through December 31 of that plan year. The long-term incentive component will have a 3-year performance period from January 1 of that plan year through December 31 of the second year immediately following that plan year.

6.    Performance Goals. Bonuses under the Plan will be earned by the Participants based on the achievement of performance goals established by the Committee for the applicable performance period. Except to the extent fixed by the Plan, no later than February 28 each plan year, the Committee will establish performance goals, targets and weightings for the annual incentive component and the long-term incentive component for the Participants for each performance period beginning in that plan year.

(a)    Annual Incentive Component. The annual incentive component will consist of the following performance goals for the applicable performance period, weighted as follows:

Metric	Weighting (of incentive opportunity)
Return on Equity (ROE)	0% - 40%
Book value per common share	0% - 40%
Corporate/individual objectives	40	%

(i)    “Return on Equity” shall be computed as the Company’s core net operating income per basic common share (as defined by the Company for the fourth quarter earnings release for the performance period), divided by the Company’s book value per common share at December 31 of the year before the performance period. The Committee will establish the weighting of this goal, as well as minimum, target and maximum targets for this goal for each plan year.

(ii)     “Book value per common share” shall be computed in accordance with GAAP. The Committee will establish the weighting of this goal, as well as minimum, target and maximum targets for this goal, expressed as a percentage of the prior year end book value per common share and/or in actual dollar amounts, for each plan year. If the prior year end book value per common share amount is restated after the Committee establishes

2

the targets for the plan year, then the Committee shall approve a change to the current year targets to reflect the restated amount.

(iii)    Corporate/individual objectives. The Committee will establish corporate and individual goals and their respective weightings for each Participant for each plan year. The corporate and individual goals for each Participant will account for 40% of each Participant’s incentive opportunity for the plan year but may be different for each Participant. The corporate and individual goals may consist of quantitative or qualitative Company or individual goals, including but not limited to the following: annual and/or longer-term performance versus a benchmark and/or a select group of peers; general and administrative expense efficiency ratio; attainment of Company strategic objectives; and attainment of personal objectives. For each corporate and individual goal, the Committee will also establish the criteria for determining minimum, target and maximum performance with respect to such goal.

(b)    Long-Term Incentive Component. The long-term incentive component will consist of the following performance goal for the applicable performance period, weighted as follows:

Metric	Weighting (of incentive opportunity)
Total Economic Return (TER)	20	%

“Total Economic Return (TER)” shall be a percentage that is the sum of (A) the change in the Company’s GAAP book value per common share over the 3-year performance period and (B) the cumulative dividends declared by the Company during the performance period, divided by the Company’s GAAP book value per common share at the beginning of the performance period and further divided by 3 to compute an annualized return. The Committee will establish minimum, target and maximum targets for this goal for each applicable performance period.

7.     Determination of Performance. Following the end of the applicable performance period, and no later than its first quarter Committee meeting held on or before March 10, the Committee will determine and certify the level of performance achieved with respect to each of the annual and long-term incentive component performance goals for the performance periods just ended.

(a)    Management will calculate the Company’s performance against the previously-established quantitative objectives and targets and present preliminary calculations of the same to the Committee for its review.

(b)     Performance with respect to the ROE, Book value per common share and TER goals will be calculated as follows:

(i)    If performance is equal to or below the minimum target for the goal, the performance level achieved is 0%.

3

(ii)     If performance is equal to the target for the goal, the performance level achieved is 100%.

(iii)     If performance is equal to or above the maximum target for the goal, the performance level achieved is 200%.

(iv)    If performance is between the minimum target and target or between the target and maximum target, the performance level achieved will be determined by applying linear interpolation to the performance interval.

(c)    Performance (which can range from 0% - 200%) with respect to the corporate/individual objectives will be calculated by the Committee in its good faith discretion in accordance with the weightings and criteria previously established.

(d)    The Committee certification of performance will occur no later than March 10 immediately following the end of the performance period but not before the results for the Company have been finalized for the prior year.

8.     Determination of Bonus Amounts Payable Each Year. Following the end of the applicable performance period, and no later than its first quarter Committee meeting held on or before March 10, the Committee will determine the bonus amounts for each Participant for the annual incentive component and the long-term incentive component, in each case based on the Committee’s certification of the applicable performance level achieved during the applicable performance period.

(a)    Bonus for Annual Incentive Component. The bonus amount for the annual incentive component will be based on the performance level achieved for the relevant performance goal (from 0% - 200%) for the applicable performance period, multiplied by the relevant weighting (of incentive opportunity) for such goal established for the applicable performance period, multiplied by the target incentive opportunity percentage for the Participant in Section 5, multiplied by the Participant’s applicable base salary amount.

Example: Annual Incentive Bonus Amount = ([performance level % achieved for ROE] x [weighting] x [target incentive opportunity %] x [applicable base salary]) + ([performance level % achieved for Book value per share] x [weighting] x [target incentive opportunity %] x [applicable base salary]) + ([performance level % achieved for each corp/indiv. objective] x [weighting for each corp/indiv. objective] x [target incentive opportunity %] x [applicable base salary]).

(b)    Bonus for Long-term Incentive Component. The bonus amount for the long-term incentive component will be based on the performance level achieved for the relevant performance goal (from 0% - 200%) for the applicable performance period, multiplied by 20%, multiplied by the target incentive opportunity percentage for the Participant in Section 5, multiplied by the Participant’s applicable base salary amount.

Example: Long-term Incentive Bonus Amount = [performance level % achieved for TER] x 20% x [target incentive opportunity %] x [applicable base salary].

4

9.     Cash/Stock Allocation of the Bonus Amount(s).      The bonus amounts determined for the annual incentive component and the long-term incentive component for any performance period will each be paid in cash or shares of the Company’s common stock (“Stock”), according to the following allocation:

Executive	Cash/Stock Allocation
CEO	Cash: 50% Stock: 50%
EVP	Cash: 66.67% Stock: 33.33%

The allocation between cash and Stock for the EVP bonus and CEO bonus amounts is fixed as set forth above.

The stock portion of the bonus amount for the annual incentive component shall be paid in restricted shares of Stock, vesting in equal 1/3 installments on dates to be determined by the Committee and set forth in the applicable award agreement that are within each of the first, second and third calendar years immediately following the Designated Payment Period (as defined below), and shall be granted by the Committee under the Company’s 2018 Stock and Incentive Plan (or its successor). The number of shares granted shall be determined by dividing the stock portion of the bonus amount for the annual incentive component by the average of the closing price of the Stock for the 10 trading days ending on the day before the grant date (rounded down to the nearest whole share).

The stock portion of the bonus amount for the long-term incentive component shall be paid in restricted shares of Stock, to the extent permitted under the Company’s 2018 Stock and Incentive Plan (or its successor), vesting in full on the grant date and, to the extent not so permitted under the Company’s 2018 Stock and Incentive Plan (or its successor), vesting on a date to be determined by the Committee and set forth in the applicable award agreement that is within the calendar year following the Designated Payment Period, and shall be granted by the Committee under the Company’s 2018 Stock and Incentive Plan (or its successor). The number of shares granted shall be determined by dividing the stock portion of the bonus amount for the long-term incentive component by the average of the closing price of the Stock for the 10 trading days ending on the day before the grant date (rounded down to the nearest whole share).

10.     Payment of the Bonus Amount(s).

(a)    For any performance period that began on January 1, 2018: The bonus amount for each applicable performance period ending on December 31 of any plan year shall be paid to the Participant (each, a “Payment Date”) during the period that begins on January 1 and ends on March 15 of the calendar year immediately following the end of the applicable performance period (the

5

“Designated Payment Period”). The “grant date” for the stock portion of any such bonus amount shall be same as the Payment Date.

(b)     For any performance period that begins on or after January 1, 2019: The cash portion of the bonus amount for each applicable performance period ending on December 31 of any plan year shall be paid to the Participant (each, a “Cash Payment Date”) during the period that begins on January 1 and ends on March 15 of the calendar year immediately following the end of the applicable performance period (the “Designated Payment Period”) on such date or dates that are determined by the Committee at the same time the Committee determines the bonus amount for the applicable performance period. The stock portion of the bonus amount for each applicable performance period ending on December 31 of any plan year shall be granted to the Participant (each, a “Stock Grant Date,” and together with the Cash Payment Date, each a “Payment Date”) during the Designated Payment Period on the date the Committee determines the bonus amount for the applicable performance period and shall vest as provided in Section 9. The Cash Payment Date does not need to be the same as the Stock Grant Date provided that the entire bonus amount for an applicable performance period shall be paid or granted, as applicable, during the Designated Payment Period.

(c)    Any bonus amounts paid under this Plan shall be subject to all applicable federal, state or local taxes required by law to be withheld.

11.     Termination of Employment. Subject to Section 16 to the extent applicable, the following provisions shall apply in the event the Participant’s employment terminates prior to a Payment Date under the Plan:

(a)     Except as otherwise provided in Section 11(b), the bonus amounts under the Plan shall be paid upon a termination of a Participant's employment as follows:

(i)     In the event of termination of the Participant’s employment (A) by the Company other than for Cause or (B) by the Participant voluntarily or (C) due to the Participant's death, after the end of a performance period but prior to the Payment Date for such performance period, any bonus amounts for any such completed performance periods will be paid to the Participant in a lump sum cash payment on the earlier of: (1) 60 days following the termination of Participant's employment or (2) the applicable Payment Date.

(ii)     In the event of termination of the Participant’s employment (A) by the Company for any reason other than for Cause or (B) due to the Participant's death, before the end of a performance period (but only if the termination occurs no earlier than the last day of the first quarter of the performance period), a pro-rata bonus (based on the period of the performance period during which the Participant was employed) will be paid to the Participant in a lump sum cash payment for any not yet completed performance period based upon: (x) with respect to the ROE, Book value per common share and TER goals, actual performance through the calendar quarter ending on or immediately prior to the date of the Participant's termination and (y) with respect to the corporate/individual objectives of the annual incentive component, the applicable portion of the maximum incentive opportunity under the Plan for the applicable performance period. A pro-rata bonus will be determined separately for each annual incentive award and each long-term incentive award for each not

6

yet completed performance period and each such pro-rata bonus will be paid in a lump sum cash payment on the earlier of: (1) 60 days following the termination of Participant's employment or (2) the applicable Payment Date.

(iii) In the event of termination of the Participant's employment (A) by the Company before the last day of the first quarter of a performance period or (B) a voluntary termination by the Participant at any time during a performance period, no bonus amounts will be paid to the Participant for any not yet completed performance period.

(iv)    In the event of termination of the Participant's employment for Cause, all rights under the Plan shall be immediately forfeited and no bonus amounts will be paid to the Participant following such termination.

(b)     If the Participant has an employment agreement, or if the Participant does not have an employment agreement, a severance agreement (an “Employment Agreement”) in place at time of termination of employment, then the Participant's right to receive bonus amounts under the Plan (if any) shall be governed by the Employment Agreement and, in the event of a conflict between the Plan and the Participant’s Employment Agreement, the Participant’s Employment Agreement shall control; provided, however, that the time and form of payment of any bonus amount payable under the Plan shall not be changed by the Employment Agreement to the extent such change would either violate Code Section 409A (as defined in Section 16) or cause an otherwise exempt payment to be subject to Code Section 409A.

(c)    Cause. For purposes of the Plan, if not defined in the Participant’s Employment Agreement, “Cause” shall mean any of the following:

(i)    the willful and continued failure of the Participant to substantially perform the Participant’s duties with the Company (other than any such failure resulting from incapacity due to physical or mental illness), if, within 30 days of receiving a written demand for substantial performance from the Board or the CEO that specifically identifies the manner in which the Participant has not substantially performed his duties, the Participant shall have failed to cure such non-performance or to take measures to cure the non-performance;

(ii)    the willful engaging by the Participant in gross misconduct that is materially and demonstrably injurious to the Company or any subsidiary;

(iii)    the willful disclosure to an external party by the Participant without authorization of any confidential information of the Company or any subsidiary; or

(iv)    the arrest of the Participant of a felony.

For purposes of this definition, no act or failure to act, on the part of the Participant, shall be considered “willful” unless it is done, or omitted to be done, by the Participant in bad faith or without reasonable belief that the Participant’s action or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or a committee thereof, or based upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by the Participant in good faith and in

7

the best interests of the Company. The termination of employment of the Participant shall not be deemed to be for Cause unless and until there shall have been delivered to the Participant a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters (3/4) of the Board at a meeting of the Board called and held for such purpose (after reasonable notice is provided to the Participant and the Participant is given an opportunity, together with counsel, to be heard before the Board), finding that, in the good faith opinion of the Board, the Participant is guilty of conduct described in subparagraph (i), (ii) or (iii) above, and specifying the particulars thereof in detail.

12.    Review Procedure. Any Participant with an issue regarding bonus amounts or the administration of the Plan may file a claim in writing to the Committee within 90 days of the date on which the Participant first knows (or should have known) of the facts on which the claim is based. The Committee shall consider the claim and notify the Participant in writing of the determination and resolution of the issue. The determination of the Committee as to any complaint or dispute will be final and binding.

13.    Deferral. Bonus amounts under the Plan may be deferred by the Participant in accordance with any deferred compensation plan adopted by the Company that is available to executive officers, except to the extent such deferral would violate Code Section 409A.

14.    Nonassignability. Bonus amounts may not be transferred, alienated or assigned. To the extent any bonus amounts are payable under the terms of the Plan following a Participant’s death, such bonus amounts will be paid to the Participant’s estate.

15.    Nonexclusive Plan. The adoption of the Plan shall not be construed as creating any limitations on the power of the Company or any subsidiary to adopt such other incentive arrangements as it may deem desirable, and such arrangements may be either generally applicable or applicable only in specific cases.

16.      Code Section 409A Compliance.

(a)       The Plan is intended to comply with Section 409A of the Code and applicable guidance issued thereunder (“Code Section 409A”) or comply with an exemption from the application of Code Section 409A and, accordingly, all provisions of the Plan and any award agreements under which any amounts are paid under the Plan (for purposes of this Section 16, the Plan and any applicable award agreement are collectively referred to as the “Plan”) shall be construed in a manner consistent with the requirements for avoiding taxes or penalties under Code Section 409A. Any right or benefit which is provided pursuant to or in connection with the Plan which is considered to be nonqualified deferred compensation subject to Code Section 409A is hereinafter referred to as a “409A Benefit”.

(b)       A 409A Benefit shall be provided and paid in a manner, and at such time and in such form, as to comply with Code Section 409A. Notwithstanding any other provision of the Plan, a 409A Benefit shall be paid at the earliest to occur of the following (but in all events subject to any forfeiture provisions if such 409A Benefit is not vested at the time of the payment event): (i) a fixed payment date as set forth in Sections 9 and 10 (for an amount paid in stock, during each of the first, second and third calendar years, as applicable, that immediately follow the calendar year that immediately follows the last day of the applicable performance period), separation from service of

8

the Participant as defined under Code Section 409A (see Section 16(c) below), death of the Participant, disability of the Participant as defined under Code Section 409A, or a change with respect to the Participant in the ownership or effective control of the Company or in the ownership of a substantial portion of its assets of the Company as defined under Code Section 409A or, in the discretion of the Committee or its delegate. Neither a Participant nor the Company shall take any action to accelerate or delay a 409A Benefit in any matter that would not be in compliance with Code Section 409A.

(c)       A termination of employment shall not be deemed to have occurred for purposes of any provision of the Plan providing for the form or timing of payment of any 409A Benefit and that are paid upon or following a termination of employment unless such termination is also a “separation from service” (within the meaning of Code Section 409A) and, for purposes of any such provision of the Plan under which (and to the extent) a 409A Benefit is paid, references to a “termination” or “termination of employment” or “resign” or “resignation” or like references shall mean separation from service.  If the Participant is deemed on the date of separation from service with the Company and any subsidiary to be a “specified employee”, within the meaning of that term under Code Section 409A(a)(2)(B) and using the identification methodology selected by the Company from time to time, or if none, the default methodology, then with regard to any 409A Benefit that is required to be delayed in compliance with Code Section 409A(a)(2)(B), payment of any such amounts shall not be made or provided prior to the earlier of (i) the expiration of the six-month period measured from the date of Participant’s separation from service or (ii) the date of the Participant’s death. 

(d)        The bonus amount payable for the annual incentive component for any applicable performance period and the bonus amount payable for the long-term incentive component for any applicable performance period are separate awards and payments under the Plan, are determined and calculated without any offset or other interaction with each other and are included in one Plan document for convenience purposes. For purposes of determining the application of Code Section 409A and any exemptions from Code Section 409A, each bonus amount determined under each component for each applicable performance period shall be treated as a separate payment and, to the extent paid in installments, each installment shall be considered a separate payment.

(e)       When, if ever, a payment under the Plan specifies a payment period with reference to a number of days (e.g., “payment shall be made within 10 days following the date of termination”), the actual date of payment within the specified period shall be within the sole discretion of the Company or Committee. For any bonus amount exempt from the requirements of Code Section 409A, payment shall in all events be made by the 15^th day of the third month following the end of the first calendar year during which the bonus amount is no longer subject to a substantial risk of forfeiture, subject to the provisions of Treas. Reg. §1.409A-1(b)(4)(ii) (regarding certain allowed delayed payments). For the avoidance of any doubt, any cash bonus amount payable for the annual incentive component for any applicable performance period is intended to be exempt from Code Section 409A and shall be administered consistent with that intention.

(f)       Notwithstanding any of the provisions of the Plan, the Company shall not be liable to the Participant if any payment which is to be provided pursuant to the Plan and which is considered deferred compensation subject to Code Section 409A otherwise fails to comply with, or be exempt from, the requirements of Code Section 409A.

9

17.    Amendment and Termination. The Plan may only be amended or terminated by approval of the Independent Directors, based on the recommendation of the Committee. The Committee shall review the Plan periodically and recommend any amendments thereto which it deems appropriate or desirable, for approval by the Independent Directors. Upon recommendation of the Committee, the Independent Directors may amend or terminate this Plan at any time. Any amendment or termination of the Plan shall be implemented in a manner which complies with any applicable provisions under Code Section 409A (as defined in Section 16).

18.    Effectiveness of the Plan. The Plan was first effective on January 1, 2016. For any performance period that began before January 1, 2018, the terms of the Plan as in effect on January 1, 2016 shall continue to apply, except as provided in the penultimate sentence in this Section 18. The Plan was amended effective February 22, 2018. For any bonus amount with a Payment Date before January 1, 2019 but on or after January 1, 2018, the terms of the Plan in effect on February 22, 2018 shall continue to apply. Subject to Section 17, and except as otherwise provided in Section 10(a)-(b), for any bonus amounts with a Payment Date on or after January 1, 2019, the terms of the Plan as amended on January 1, 2019 shall apply. The Plan shall continue indefinitely, subject to the Independent Directors’ right to terminate the Plan.

19.     Plan Not a Contract. The Plan shall not be deemed to constitute a contract between the Company and any employee, and nothing contained in the Plan shall confer upon an employee any right to continued employment, nor interfere with the right of the Company or any subsidiary to terminate a Participant’s employment with the Company or subsidiary.

20.    Clawback. Any bonus amount (whether paid in cash or Stock) that a Participant receives under the Plan is subject to repayment to (i.e., clawback by) the Company or a related entity as determined in good faith by the Independent Directors or the Board in the event repayment is required by the terms of the Company’s recoupment, clawback or similar policy as may be in effect from time to time or by applicable federal or state law or regulation or stock exchange requirement, but in no event with a look-back period of more than three (3) years, unless in the opinion of counsel satisfactory to Participant required by applicable federal or state law or regulation or stock exchange requirement. Any recovery of any bonus amount subject to the requirements of Code Section 409A (as defined in Section 16) shall be implemented in a manner which complies with Code Section 409A.

21.    Governing Law. The Plan shall be construed and interpreted under the laws of the Commonwealth of Virginia.

As Amended by the Independent Directors of the Board of Directors on February 27, 2019.

10

EX-10.38

Exhibit 10.38

DYNEX CAPITAL, INC.

2018 STOCK AND INCENTIVE PLAN

FORM OF

RESTRICTED STOCK AGREEMENT

FOR EXECUTIVE OFFICERS

This Restricted Stock Agreement (“Agreement”), which includes the attached Terms and Conditions, confirms the grant of restricted stock (the “Award”) by DYNEX CAPITAL, INC. (the “Company”), to <<name>> (“Employee”), under the Dynex Capital, Inc. 2018 Stock and Incentive Plan (the “Plan”) pursuant to the Dynex Capital, Inc. Executive Incentive Plan (as amended and restated January 1, 2019) (the “EIP”) as follows:

Date of Grant:	<< grant date >> (“Award Date”)
Number of Shares:	<< number of shares >> shares (“Award Shares”)
Vesting Dates:	<<insert vesting schedule>>, subject to the Terms and Conditions.

The Award is subject to the terms and conditions of the Plan and this Agreement, which includes the attached Terms and Conditions.

By signing below, the Company and Employee agree to the terms and conditions of this Agreement.

DYNEX CAPITAL, INC.                    EMPLOYEE

<< name>>                            << name>>

<<title>>

Date:            Date:

1

TERMS AND CONDITIONS

The following terms and conditions apply to the Award of restricted stock granted to Employee by the Company as specified on the preceding page (the “Summary Page”), which is an integral part of this Agreement.

1.    Award of Shares. Under the terms of the Plan, the Committee has granted to Employee the Award of restricted stock, effective on the Award Date.

2.    Period of Restriction and Vesting in the Award Shares.

(a) Subject to earlier vesting or forfeiture as provided below, the period of restriction (the “Period of Restriction”) applicable to each portion of the Award Shares is the period from the Award Date through the vesting date provided on the Summary Page, provided Employee continues to provide services to the Company or any Subsidiary as contemplated in Paragraph 6 through such vesting date.

(b) Except as contemplated in Paragraph 2(c), the Award Shares, and the rights and privileges conferred hereby, may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, otherwise than by will or by the laws of descent and distribution or to a Beneficiary upon the death of the Employee, and shall not be subject to execution, attachment or similar process, during the Period of Restriction; provided, however, that the Committee may permit, in its sole discretion, transfers of Award Shares that are not vested pursuant to a domestic relations order. Except as otherwise provided pursuant to Paragraph 2(c), the Award Shares as determined pursuant to Paragraph 2(a) shall become freely transferable by Employee as of the last day of the relevant Period of Restriction.

(c) Subject to earlier forfeiture as provided in Paragraph 6 below:    

(i) in the event a Vesting Acceleration Event occurs while Employee is providing services to the Company or a Subsidiary as contemplated in Paragraph 6 and prior to the vesting date applicable to any portion of the Award Shares, immediate vesting shall occur and the Period of Restriction shall end for such portion of the Award Shares, and the Award Shares shall be free of restrictions and freely transferable on the date of such Vesting Acceleration Event; and

(ii) in the event of the termination of Employee’s service with the Company and any Subsidiary by the Company other than for Cause (as defined in the Employment Agreement by and between the Company and Employee in effect on the Award Date (the “Employment Agreement”)) or the termination of Employee’s service with the Company and any Subsidiary by Employee for Good Reason (as defined in and subject to the notice provisions of Section 7(b)(i) of the Employment Agreement) prior to the applicable vesting date, the Committee may, in its sole discretion and no later than the date of termination of Employee’s service, waive the automatic forfeiture of any or all unvested Award Shares otherwise provided in Paragraph 6 below and provide for such vesting as it deems appropriate subject to such new restrictions, if any, applicable to the Award Shares as it deems appropriate, which may, but need not, include, without limitation, a requirement for Employee to

2

provide a release of claims or enter into a non-competition agreement with the Company or any Subsidiary.

(d) “Vesting Acceleration Event” shall mean the occurrence of (A) a Change of Control (as defined in the Plan), (B) Employee’s separation from service due to becoming “disabled” (as defined in the Employment Agreement or, if none, for purposes of Section 22(e)(3) of the Internal Revenue Code), (C) Employee’s death or (D) Employee’s retirement, with the consent of the Committee or its delegate, at or after age sixty-five (65) where there is no Cause (as defined in the Employment Agreement) for the Company to terminate Employee’s service.

3.    Stock Certificates.

(a) The Company shall issue the Award Shares either: (i) in certificate form, or (ii) in book-entry form, registered in the name of Employee with notations as to any restrictions on transfer imposed under this Agreement.

(b) Any certificates representing any of the Award Shares shall be held by the Company until the Period of Restriction with respect to any of the Award Shares lapses or until the Award Shares are forfeited hereunder. During the Period of Restriction, any Award Shares issued in book-entry form shall be subject to the following legend and any certificates representing the Award Shares shall bear the following legend:

The sale or other transfer of the shares of stock represented by this certificate, whether voluntary, involuntary, or by operation of law, is subject to certain restrictions on transfer set forth in the Dynex Capital, Inc. 2018 Stock and Incentive Plan, in the rules and administrative procedures adopted pursuant to such Plan, and in a Restricted Stock Agreement dated << grant date >>. A copy of the Plan, such rules and procedures, and such Restricted Stock Agreement may be obtained from the Secretary of Dynex Capital, Inc.

(c) Promptly after the Period of Restriction lapses for any of the Award Shares, the Company shall either remove the relevant notations for such Award Shares issued in book-entry form or deliver to Employee a certificate(s) evidencing the number of Award Shares as to which the Period of Restriction has lapsed.

(d) By execution of this Agreement, Employee hereby appoints the Secretary of the Company, with full power of substitution, as Employee’s attorney in fact with power and authority in the name and on behalf of Employee to take any action and execute all documents and instruments, including without limitation stock powers, which may be necessary to cancel or transfer to the Company any forfeited Award Shares (or shares otherwise reacquired or withheld by the Company hereunder) as may be required pursuant to the Plan or this Agreement.

4.    Voting Rights. During the Period of Restriction, Employee may exercise full voting rights with respect to all of the Award Shares.

3

5.    Dividends and Other Distributions. During the Period of Restriction, all dividends and other distributions paid with respect to the Award Shares in the Company’s Common Stock or other securities of the Company shall be registered in the name of Employee and held by the Company until payable or forfeited pursuant hereto. Such stock dividends and other stock distributions shall be subject to the same restrictions on transferability, forfeiture, and vesting as the Award Shares with respect to which they were paid and shall, to the extent vested, be paid when and to the extent the underlying Award Shares are vested and freed of restrictions. Dividends paid in cash shall be paid to Employee at the same time as they are paid to other shareholders of the Company and shall not be subject to any restrictions under this Agreement.

6.    Forfeiture on Separation from Service. If Employee separates from service with the Company and any Subsidiaries for any reason prior to the applicable vesting date and Paragraph 2(c) does not apply or has not applied for any portion of the Award Shares, then any Award Shares subject to restrictions at the date of such separation from service shall be forfeited to the Company immediately upon such separation from service, subject to the exceptions described below. For purposes of this Agreement, transfer of employment among the Company and any Subsidiaries shall not be considered a separation from service. For purposes of this Agreement, an Employee shall not be considered to have a separation from service under this Agreement if such Employee continues to provide services to the Company or a Subsidiary as an independent contractor or as a non-employee member of the Company’s or a Subsidiary’s board of directors (a “Non-Employee Service Provider”), provided such services as a Non-Employee Service Provider begin on, before or immediately following Employee’s last day of employment as an employee. The Committee shall have absolute discretion, subject to applicable law, to determine whether a separation from service or authorized leave of absence or absence due to military or government service is to be considered a retirement for purposes of this Agreement and whether an authorized leave of absence or absence due to military or government service shall constitute a separation from service for purposes of this Agreement.

7.    Withholding Taxes. The Company, or any Subsidiary, shall have the right to retain and withhold the amount of taxes required by any government to be withheld or otherwise deducted and paid with respect to the Award Shares. The Company shall withhold only the minimum amount necessary to satisfy applicable statutory withholding requirements, provided that the Committee may permit Employee to elect to have an additional amount (up to the maximum allowed by law) withheld. The Committee may require Employee or any successor in interest to pay or reimburse the Company, or any Subsidiary, for any such taxes required to be withheld by the Company, or any Subsidiary, and to withhold any distribution in whole or in part until the Company, or any Subsidiary, is so paid or reimbursed. In lieu thereof, the Company, or any Subsidiary, shall have the right to withhold from any other cash amounts due or to become due from the Company, or any Subsidiary, to or with respect to Employee an amount equal to such taxes required to be withheld by the Company, or any Subsidiary, to pay or reimburse the Company, or any Subsidiary, for any such taxes. Alternatively, Employee or any successor in interest may elect to have the Company withhold a number of vested Award Shares having a Fair Market Value equal to the amount required to be withheld and cancel any Shares so withheld in order to pay or reimburse the Company, or any Subsidiary, for any such taxes. Employee or any successor in interest is also authorized to deliver Shares of the Company’s Common Stock having a Fair Market Value equal to the amount required to be withheld in satisfaction of required tax withholding obligations. The value of any Shares so withheld or delivered shall be based on the Fair Market Value of the Shares on the date that the amount of tax to be withheld is to be determined. All elections by Employee shall be irrevocable and be made in writing and in such manner as determined by the Committee (or its delegate) in advance of the applicable vesting date.

8.    Certain Tax Matters. Employee shall provide the Company with a copy of any election made pursuant to Section 83(b) of the Internal Revenue Code, and similar provision of state law (collectively, an “83(b) Election”). If Employee decides to make an 83(b) Election, he or she must do so within a limited period of

4

time. (For federal tax purposes, generally, an 83(b) Election must be filed within thirty (30) days of the Award Date.) Employee should contact his or her tax advisor to determine if an 83(b) Election is appropriate.

9.    Plan, EIP and Prospectus. This Award is granted pursuant to the Plan and is subject to the terms of the Plan, EIP and this Agreement. To the extent the terms of the Plan and this Agreement are inconsistent, the terms of the Plan shall govern the Award. To the extent that the terms of the Plan and/or Agreement are inconsistent with the EIP, the terms of the EIP shall govern the Award. A copy of the Plan, as well as a prospectus for the Plan, and EIP have been provided to Employee, and Employee acknowledges receipt thereof.

10.    Notices. Any notice to the Company required under or relating to this Agreement shall be in writing (which may be an electronic writing) and addressed to:

Dynex Capital, Inc.

4991 Lake Brook Drive, Suite 100

Glen Allen, VA 23060    

Attention: Secretary

Any notice to Employee required under or relating to this Agreement shall be in writing (which may be an electronic writing) and addressed to Employee at his or her address as it appears on the records of the Company.

11.    Construction and Capitalized Terms. This Agreement shall be administered, interpreted and construed in accordance with the applicable provisions of the Plan. Capitalized terms in this Agreement have the meaning assigned to them in the Plan, unless this Agreement provides, or the context requires, otherwise.

5

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Byron L. Boston, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Dynex Capital, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 3, 2019
		/s/ Byron L. Boston
		Byron L. Boston
		Principal Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Stephen J. Benedetti, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Dynex Capital, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	May 3, 2019
		/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Principal Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 906

In connection with the Quarterly Report on Form 10-Q of Dynex Capital, Inc. (the “Company”) for the three months endedMarch 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, as the Principal Executive Officer of the Company and the Principal Financial Officer of the Company, respectively, certify, pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	May 3, 2019	/s/ Byron L. Boston
		Byron L. Boston
		Principal Executive Officer
Date:	May 3, 2019	/s/ Stephen J. Benedetti
		Stephen J. Benedetti
		Principal Financial Officer

XML

Entity Information - $ / shares	3 Months Ended
	Mar. 31, 2019	Apr. 30, 2019	Dec. 31, 2018
Entity Information [Line Items]
Entity Registrant Name	DYNEX CAPITAL INC
Entity Central Index Key	0000826675
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Common Stock, Shares Outstanding		73,763,826
Entity Emerging Growth Company	false
Common stock, par value	$ 0.01		$ 0.01

XML

Document and Entity Information Document Information	3 Months Ended
	Mar. 31, 2019
Document Information [Line Items]
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Assets:
Mortgage-backed securities (including pledged of $3,511,604 and $2,640,884 respectively)	$ 4,842,447	$ 3,749,464
Mortgage loans held for investment, net	10,862	11,527
Cash and cash equivalents	55,902	34,598
Restricted cash	86,761	54,106
Derivative assets	6,030	6,563
Accrued interest receivable	26,075	21,019
Other assets, net	7,056	8,812
Total assets	5,035,133	3,886,089
Liabilities:
Repurchase agreements	4,252,893	3,267,984
Payable for unsettled securities	151,075	58,915
Non-recourse collateralized financing	3,219	3,458
Derivative liabilities	0	1,218
Accrued interest payable	12,939	10,308
Accrued dividends payable	6,927	13,810
Other liabilities	3,406	3,243
Total liabilities	4,430,459	3,358,936
Shareholders’ Equity:
Preferred stock, par value $.01 per share; 50,000,000 shares authorized; 5,954,594 and 5,888,680 shares issued and outstanding, respectively ($148,865 and $147,217 aggregate liquidation preference, respectively)	147,898	142,883
Common stock, par value $.01 per share, 200,000,000 shares authorized; 62,817,218 and 55,831,549 shares issued and outstanding, respectively	722	628
Additional paid-in capital	872,010	818,442
Accumulated other comprehensive loss	50,688	(35,779)
Accumulated deficit	(466,644)	(399,021)
Total shareholders’ equity	604,674	527,153
Total liabilities and shareholders’ equity	$ 5,035,133	$ 3,886,089

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Assets:
Pledged MBS	$ 4,547,769	$ 3,511,604
Pledged U.S. Treasuries	$ 0	$ 0
Shareholders’ Equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	6,168,062	5,954,594
Preferred stock, shares outstanding	6,168,062	5,954,594
Preferred stock, aggregate liquidation preference	$ 154,202	$ 148,865
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	72,248,126	62,817,218
Common stock, shares outstanding	72,248,126	62,817,218

XML

Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Interest income	$ 39,957	$ 25,190
Interest expense	26,276	11,595
Net interest income	13,681	13,595
(Loss) gain on derivative instruments, net	61,697	(38,354)
Loss on sale of investments, net	0	(3,775)
Fair value adjustments, net	13	(29)
Other operating (expense) income, net	(231)	(253)
General and administrative expenses:
Compensation and benefits	(1,898)	(1,962)
Other general and administrative	(2,056)	(1,681)
Net income	(52,214)	44,307
Preferred stock dividends	3,059	2,940
Net (loss) income to common shareholders	(55,273)	41,367
Other comprehensive income:
Unrealized (loss) gain on available-for-sale investments, net	86,632	(49,189)
Reclassification adjustment for loss on sale of investments, net	0	3,775
Reclassification adjustment for de-designated cash flow hedges	(165)	(48)
Total other comprehensive (loss) income	86,467	(45,462)
Comprehensive (loss) income to common shareholders	$ 31,194	$ (4,095)
Net (loss) income per common share-basic and diluted	$ (0.81)	$ 0.74
Weighted average common shares-basic and diluted	68,435	55,871

XML

Consolidated Statements of Shareholders' Equity Statement - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Preferred Stock Including Additional Paid in Capital	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance, Preferred shares outstanding at Dec. 31, 2017		5,888,680
Balance, Common shares outstanding at Dec. 31, 2017			55,831,549
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock Issued During Period, Shares, New Issues		20,319	45,401
Stock Issued During Period, Shares, Restricted Stock Award, Gross			176,233
Shares Paid for Tax Withholding for Share Based Compensation			57,135
Balance, Preferred shares outstanding at Mar. 31, 2018		5,908,999
Balance, Common shares outstanding at Mar. 31, 2018			55,996,048
Balance at Dec. 31, 2017	$ 557,058		$ 558	$ 141,294	$ 775,873	$ (8,697)	$ (351,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issuance	788		1	494	293
Restricted stock granted, net of amortization	335		2		333
Adjustments for tax withholding on share-based compensation	(364)		(1)		(363)
Stock issuance costs	(19)			0	(19)
Net income (loss)	44,307						44,307
Dividends on preferred stock	(2,940)						(2,940)
Dividends on common stock	(10,079)						(10,079)
Other comprehensive income (loss)	(45,462)					(45,462)
Balance at Mar. 31, 2018	$ 543,624		$ 560	141,788	776,117	(54,159)	(320,682)
Balance, Preferred shares outstanding at Dec. 31, 2018	5,954,594	5,954,594
Balance, Common shares outstanding at Dec. 31, 2018	62,817,218		62,817,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock Issued During Period, Shares, New Issues		213,468	9,327,139
Stock Issued During Period, Shares, Restricted Stock Award, Gross			152,462
Shares Paid for Tax Withholding for Share Based Compensation			48,693
Balance, Preferred shares outstanding at Mar. 31, 2019	6,168,062	6,168,062
Balance, Common shares outstanding at Mar. 31, 2019	72,248,126		72,248,126
Balance at Dec. 31, 2018	$ 527,153		$ 628	142,883	818,442	(35,779)	(399,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issuance	58,887		93	5,015	53,779
Restricted stock granted, net of amortization	298		2		296
Adjustments for tax withholding on share-based compensation	(296)		(1)		(295)
Stock issuance costs	(212)			0	(212)
Net income (loss)	(52,214)						(52,214)
Dividends on preferred stock	(3,059)						(3,059)
Dividends on common stock	(12,350)						(12,350)
Other comprehensive income (loss)	86,467					86,467
Balance at Mar. 31, 2019	$ 604,674		$ 722	$ 147,898	$ 872,010	$ 50,688	$ (466,644)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Operating activities:
Net income	$ (52,214)	$ 44,307
Adjustments to reconcile net income to cash provided by operating activities:
(Increase) decrease in accrued interest receivable	(5,056)	(3,094)
Increase (decrease) in accrued interest payable	2,631	1,389
Loss (gain) on derivative instruments, net	61,697	(38,354)
Loss on sale of investments, net	0	(3,775)
Fair value adjustments, net	13	(29)
Amortization of investment premiums, net	31,083	35,769
Other amortization and depreciation, net	222	312
Stock-based compensation expense	298	335
Change in other assets and liabilities, net	1,625	(2,514)
Net cash and cash equivalents provided by operating activities	40,299	41,896
Investing activities:
Purchase of investments	(1,019,100)	(321,348)
Principal payments received on investments	73,817	51,972
Proceeds from sales of investments	0	154,613
Principal payments received on mortgage loans held for investment, net	646	649
Net receipts on derivatives, including terminations	(62,382)	36,271
Other investing activities	(102)	(67)
Net cash and cash equivalents (used in) provided by investing activities	(1,007,121)	(77,910)
Financing activities:
Borrowings under repurchase agreements	32,608,826	27,508,732
Repayments of repurchase agreement borrowings	(31,623,917)	(27,460,742)
Principal payments on non-recourse collateralized financing	(242)	(234)
Proceeds from issuance of preferred stock	5,015	494
Proceeds from issuance of common stock	53,872	294
Cash paid for stock issuance costs	(185)	0
Payments related to tax withholding for stock-based compensation	(296)	(364)
Dividends paid	(22,292)	(12,982)
Net cash and cash equivalents provided by (used in) financing activities	1,020,781	35,198
Net increase (decrease) in cash, cash equivalents, and restricted cash	53,959	(816)
Cash, cash equivalents, and restricted cash at beginning of period	88,704	87,200
Cash, cash equivalents, and restricted cash at end of period	142,663	86,384
Supplemental Disclosure of Cash Activity:
Cash paid for interest	$ 23,807	$ 10,251

XML

Organization and Summary of Significant Accounting Policies (Notes)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Organization and Summary of Significant Accounting Policies

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization

Dynex Capital, Inc. (“Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in debt securities, the majority of which are specified pools of Agency and non-Agency mortgage-backed securities (“MBS”) consisting of residential MBS (“RMBS”), commercial MBS (“CMBS”) and CMBS interest-only (“IO”) securities that are issued or guaranteed by U.S. Government sponsored agencies (“Agency MBS”) and MBS issued by others (“non-Agency MBS”). The Company also invests in other types of mortgage-related securities, such as to-be-announced securities (“TBAs” or “TBA securities”).

Basis of Presentation

The accompanying unaudited consolidated financial statements of Dynex Capital, Inc. and its subsidiaries (together, “Dynex” or, as appropriate, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all significant adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the consolidated financial statements have been included. Operating results for the three months endedMarch 31, 2019 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2019. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Form 10-K”) filed with the SEC.

Consolidation and Variable Interest Entities

The consolidated financial statements include the accounts of the Company and the accounts of its majority owned subsidiaries and variable interest entities (“VIE”) for which it is the primary beneficiary. All intercompany accounts and transactions have been eliminated in consolidation.

The Company consolidates a VIE if the Company is determined to be the VIE’s primary beneficiary, which is defined as the party that has both: (i) the power to control the activities that most significantly impact the VIE’s financial performance and (ii) the right to receive benefits or absorb losses that could potentially be significant to the VIE. The Company reconsiders its evaluation of whether to consolidate a VIE on an ongoing basis, based on changes in the facts and circumstances pertaining to the VIE.

The Company consolidates a securitization trust, which has residential mortgage loans included in “mortgage loans held for investment, net” on its consolidated balance sheet, of which a portion is pledged as collateral for one remaining bond recorded as “non-recourse collateralized financing” on its consolidated balance sheet. The Company owns the subordinate class in the trust and has been deemed the primary beneficiary.

Though the Company invests in Agency and non-Agency MBS which are generally considered to be interests in VIEs, the Company does not consolidate these entities because it does not meet the criteria necessary to be deemed a primary beneficiary. Please refer to Note 2 for financial information regarding the Company’s investments in these debt securities.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, amortization of premiums and discounts, fair value measurements of its investments, and other-than-temporary impairments. These items are discussed further below within this note to the consolidated financial statements.

Income Taxes

The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986 and the corresponding provisions of state law. To qualify as a REIT, the Company must meet certain tests including investing in primarily real estate-related assets and the required distribution of at least 90% of its annual REIT taxable income to stockholders after consideration of its net operating loss (“NOL”) carryforward and not including taxable income retained in its taxable subsidiaries. As a REIT, the Company generally will not be subject to federal income tax on the amount of its income or capital gains that is distributed as dividends to shareholders.

The Company assesses its tax positions for all open tax years and determines whether the Company has any material unrecognized liabilities in accordance with Accounting Standards Codification (“ASC”) Topic 740. The Company records these liabilities, if any, to the extent they are deemed more likely than not to have been incurred.

Net Income (Loss) Per Common Share

The Company calculates basic net income per common share by dividing net income to common shareholders for the period by weighted-average shares of common stock outstanding for that period. The Company did not have any potentially dilutive securities outstanding during the three months ended March 31, 2019 or March 31, 2018.

Holders of unvested shares of the Company’s issued and outstanding restricted common stock are eligible to receive non-forfeitable dividends. As such, these unvested shares are considered participating securities as per ASC Topic 260-10 and therefore are included in the computation of basic net income per common share using the two-class method. Upon vesting, restrictions on transfer expire on each share of restricted stock, and each such share of restricted stock represents one unrestricted share of common stock.

Because the Company’s 8.50% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) and 7.625% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”) are redeemable at the Company’s option for cash only and may convert into shares of common stock only upon a change of control of the Company, the effect of those shares and their related dividends is excluded from the calculation of diluted net income per common share.

Cash and Cash Equivalents

Cash and cash equivalents include cash on hand and highly liquid investments with original maturities of three months or less.

Restricted Cash

Restricted cash consists of cash the Company has pledged to cover initial and variation margin with its financing and derivative counterparties.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported on the Company's consolidated balance sheet as of March 31, 2019 that sum to the total of the same such amounts shown on the Company’s consolidated statement of cash flows for the three months endedMarch 31, 2019:

	March 31, 2019
Cash and cash equivalents	$	55,902
Restricted cash	86,761
Total cash, cash equivalents, and restricted cash shown on consolidated statement of cash flows	$	142,663

Investments in Debt Securities

The Company’s investments in debt securities are designated as available-for-sale (“AFS”) and are recorded at fair value on the Company’s consolidated balance sheet. Changes in unrealized gain (loss) on the Company’s debt securities are reported in other comprehensive income (“OCI”) until the investment is sold, matures, or is determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income (“AOCI”) into net income as a realized “gain (loss) on sale of investments, net” using the specific identification method.

The fair value of the Company’s debt securities pledged as collateral against repurchase agreements and derivative instruments is disclosed parenthetically on the Company’s consolidated balance sheets.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on debt securities is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or “IO”, securities) and their contractual terms. Premiums or discounts associated with the purchase of Agency MBS as well as any non-Agency MBS rated ‘AA’ and higher are amortized or accreted into interest income over the expected life of such securities using the effective yield method, and adjustments to premium amortization and discount accretion are made for actual cash payments. The Company may also adjust premium amortization and discount accretion for changes in projected future cash payments. The Company’s projections of future cash payments are based on input and analysis received from external sources and internal models and include assumptions about the amount and timing of loan prepayment rates, fluctuations in interest rates, credit losses, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets. The Company does not estimate future prepayments on its fixed-rate Agency RMBS.

The Company holds certain non-Agency MBS that had credit ratings of less than ‘AA’ at the time of purchase or were not rated by any of the nationally recognized credit rating agencies. A portion of these non-Agency MBS were purchased at discounts to their par value, which management does not believe to be substantial. The discount is accreted into income over the security’s expected life based on management’s estimate of the security’s projected cash flows. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

Determination of MBS Fair Value.The Company estimates the fair value of the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company’s MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security’s coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. Refer to Note 5 for further discussion of MBS fair value measurements.

Other-than-Temporary Impairment. An MBS is considered impaired when its fair value is less than its amortized cost. The Company evaluates all of its impaired MBS for other-than-temporary impairments (“OTTI”) on at least a quarterly basis. An impairment is considered other-than-temporary if: (1) the Company intends to sell the MBS; (2) it is more likely than not that the Company will be required to sell the MBS before its fair value recovers; or (3) the Company does not expect to recover the full amortized cost basis of the MBS. If either of the first two conditions is met, the entire amount of the impairment is recognized in earnings. If the impairment is solely due to the inability to fully recover the amortized cost basis, the security is further analyzed to quantify any credit loss, which is the difference between the present value of cash flows expected to be collected on the MBS and its amortized cost. The credit loss, if any, is then recognized in earnings, while the balance of impairment related to other factors is recognized in other comprehensive income.

Following the recognition of an OTTI through earnings, a new cost basis is established for the security. Any subsequent recoveries in fair value may be accreted back into the amortized cost basis of the MBS on a prospective basis through interest income. Please see Note 2 for additional information related to the Company’s evaluation for OTTI.

Repurchase Agreements

The Company’s repurchase agreements, which are used to finance its purchases of debt securities, are accounted for as secured borrowings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

Derivative Instruments

The Company’s derivative instruments generally include interest rate swaps, futures, and forward contracts for the purchase or sale of non-specified Agency RMBS, commonly referred to as “TBA securities” or “TBA contracts”. Derivative instruments are accounted for at the fair value of their unit of account. Derivative instruments in a gain position are reported as derivative assets and derivative instruments in a loss position are reported as derivative liabilities on the Company’s consolidated balance sheet. All periodic interest benefits/costs and changes in fair value of derivative instruments, including gains and losses realized upon termination, maturity, or settlement are recorded in “gain (loss) on derivative instruments, net” on the Company’s consolidated statement of comprehensive income. Cash receipts and payments related to derivative instruments are classified in the investing activities section of the consolidated statements of cash flows in accordance with the underlying nature or purpose of the derivative transactions.

The Company’s interest rate swap agreements are privately negotiated in the over-the-counter (“OTC”) market and the majority of these agreements are centrally cleared through the Chicago Mercantile Exchange (“CME”) with the rest being subject to bilateral agreements between the Company and the swap counterparty. The Company’s CME cleared swaps require that the Company post initial margin as determined by the CME, and in addition, variation margin is exchanged, typically in cash, for changes in the fair value of the CME cleared swaps. The exchange of variation margin for CME cleared swaps is legally considered to be the settlement of the derivative itself as opposed to a pledge of collateral. Accordingly, the Company accounts for the daily exchange of variation margin associated with its CME cleared interest rate swaps as a direct increase or decrease to the carrying value of the related derivative asset or liability. The carrying value of derivative instruments on the Company’s consolidated balance sheets is the unsettled fair value of the instruments subject to bilateral agreements and not centrally cleared through the CME.

A TBA security is a forward contract (“TBA contract”) for the purchase (“long position”) or sale (“short position”) of a non-specified Agency MBS at a predetermined price with certain principal and interest terms and certain types of collateral, but the particular Agency securities to be delivered are not identified until shortly before the settlement date. The Company accounts for long and short positions in TBAs as derivative instruments because the Company cannot assert that it is probable at inception and throughout the term of an individual TBA transaction that its settlement will result in physical delivery of the underlying Agency RMBS, or the individual TBA transaction will not settle in the shortest time period possible.

Please refer to Note 4 for additional information regarding the Company’s derivative instruments as well as Note 5 for information on how the fair value of these instruments are calculated.

Share-Based Compensation

Pursuant to the Company’s 2018 Stock and Incentive Plan (“2018 Plan”), the Company may grant share-based compensation to eligible employees, non-employee directors or consultants or advisors to the Company, including restricted stock awards, stock options, stock appreciation rights, performance units, restricted stock units, and performance cash awards. The Company’s restricted stock currently issued and outstanding may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date and recognized as compensation cost over the requisite service period with a corresponding credit to shareholders’ equity. The requisite service period is the period during which a participant is required to provide service in exchange for an award, which is equivalent to the vesting period specified in the terms of the time-based restricted stock award. None of the Company’s restricted stock awards have performance-based conditions. The Company does not currently have any share-based compensation issued or outstanding other than restricted stock issued to its employees, officers, and directors.

Contingencies

In the normal course of business, there may be various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, the Company evaluates whether to establish provisions for estimated losses from those matters. The Company recognizes a liability for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, Financial Instruments - Credit Losses, which replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For assets measured at amortized cost, the amendments in this ASU eliminate the probable initial recognition threshold in current GAAP and broaden the information that an entity must consider in developing its expected credit loss estimate to include the use of forecasted information. For assets classified as available-for-sale with changes in fair value recorded in other comprehensive income, measurement of credit losses will be similar to current GAAP. However, the amendments in this ASU require that credit losses be presented as an allowance rather than as a write-down, which is referred to in current GAAP as an other-than-temporary impairment. An entity will be able to record reversals of credit losses, if credit loss estimates decline, in net income for the current period. The amendments in this ASU will not permit an entity to use the length of time a debt security has been in an unrealized loss position to avoid recording a credit loss and removes the requirements to consider historical and implied volatility of the fair value of a security as well as recoveries or declines in fair value after the balance sheet date. The amendments in this ASU will affect an entity by varying degrees depending on a number of factors, including but not limited to, the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. These amendments will become effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. An entity will apply the amendments in this ASU through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Though the Company has not fully completed evaluating the impact this ASU will have on its financial condition and results of operations, the Company does not expect it will have a material impact given that the majority of its investments are Agency MBS.

XML

Investments in Debt Securities Investment in Debt Securities (Notes)

3 Months Ended

Mar. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Investments in Debt Securities

INVESTMENTS IN DEBT SECURITIES

The majority of the Company’s debt securities are pledged as collateral for the Company’s repurchase agreements. The following tables present the Company’s debt securities by investment type (including securities pending settlement) as of the dates indicated:

	March 31, 2019
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC (1)
RMBS:
Agency	$	2,683,276	$	77,584		$	2,760,860	$	31,813	$	(11,403	)	$	2,781,270	4.04	%
Non-Agency	803		—			803		27		(21		)	809		6.75	%
	2,684,079		77,584			2,761,663		31,840		(11,424		)	2,782,079
CMBS:
Agency	1,507,835		10,775			1,518,610		30,766		(9,864		)	1,539,512		3.23	%
Non-Agency	2,910		(1,927		)	983		677		—			1,660		6.27	%
	1,510,745		8,848			1,519,593		31,443		(9,864		)	1,541,172
CMBS IO (2):
Agency	—		282,636			282,636		5,982		(154		)	288,464		0.53	%
Non-Agency	—		227,868			227,868		3,249		(385		)	230,732		0.56	%
	—		510,504			510,504		9,231		(539		)	519,196
Total AFS securities:	$	4,194,824	$	596,936		$	4,791,760	$	72,514	$	(21,827	)	$	4,842,447

(1) The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).

(2) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $13,146,249 and $10,158,055 respectively, as of March 31, 2019.

	December 31, 2018
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC (1)
RMBS:
Agency	$	2,118,639	$	56,744		$	2,175,383	$	8,902	$	(26,264	)	$	2,158,021	3.95	%
Non-Agency	856		—			856		24		(22		)	858		6.75	%
	2,119,495		56,744			2,176,239		8,926		(26,286		)	2,158,879
CMBS:
Agency	1,071,906		8,518			1,080,424		6,141		(29,550		)	1,057,015		3.22	%
Non-Agency	3,040		(2,037		)	1,003		413		—			1,416		6.47	%
	1,074,946		6,481			1,081,427		6,554		(29,550		)	1,058,431
CMBS IO (2):
Agency	—		287,062			287,062		4,281		(239		)	291,104		0.55	%
Non-Agency	—		240,681			240,681		1,675		(1,306		)	241,050		0.57	%
	—		527,743			527,743		5,956		(1,545		)	532,154
Total AFS securities:	$	3,194,441	$	590,968		$	3,785,409	$	21,436	$	(57,381	)	$	3,749,464

(1) The WAC is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).

(2) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $13,048,666 and $10,275,494, respectively, as of December 31, 2018.

Actual maturities of MBS are affected by the contractual lives of the underlying mortgage collateral, periodic payments of principal, prepayments of principal, and the payment priority structure of the security; therefore, actual maturities are generally shorter than the securities' stated contractual maturities. The following table categorizes the Company’s debt securities according to their stated maturity as of the dates indicated:

	March 31, 2019				December 31, 2018
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Less than 1 year	$	119,121	$	121,882	$	39,868	$	39,808
>1 and <5 years	151,888		154,615		151,041		152,917
>5 and <10 years	911,278		910,315		828,543		806,015
> 10 years	3,609,473		3,655,635		2,765,957		2,750,724
	$	4,791,760	$	4,842,447	$	3,785,409	$	3,749,464

The following table presents information regarding the sales that generated the “loss on sale of investments, net” on the Company’s consolidated statements of comprehensive income (loss) for the periods indicated:

	Three Months Ended
	March 31,
	2019				2018
	Proceeds Received		Realized Gain (Loss)		Proceeds Received		Realized Gain (Loss)
Agency CMBS	—		—		$	108,758	$	(2,052	)
U.S. Treasuries	—		—		46,498		(1,723		)
	$	—	$	—	$	155,256	$	(3,775	)

The following table presents certain information for the AFS securities in an unrealized loss position as of the dates indicated:

	March 31, 2019						December 31, 2018
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	46,127	$	(174	)	9	$	581,440	$	(1,793	)	28
Non-Agency MBS	25,130		(177		)	7	70,876		(581		)	22
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	1,293,417	$	(21,248	)	61	$	1,543,892	$	(54,260	)	88
Non-Agency MBS	21,512		(228		)	13	46,154		(747		)	19

Because the principal related to Agency MBS is guaranteed by the government-sponsored entities Fannie Mae and Freddie Mac which have AAA ratings due to the Treasury’s commitment of capital under the Senior Preferred Stock Purchase Agreement, the Company does not consider any of the unrealized losses on its Agency MBS to be credit related. Although the unrealized losses are not credit related, the Company assesses its ability and intent to hold any Agency MBS with an unrealized loss until the recovery in its value in accordance with GAAP. This assessment is based on the amount of the unrealized loss and significance of the related investment as well as the Company’s leverage and liquidity position. Based on this analysis, the Company has determined that the unrealized losses on its Agency MBS as of March 31, 2019 and December 31, 2018 were temporary.

The Company reviews any non-Agency MBS in an unrealized loss position to evaluate whether any decline in fair value represents an OTTI. The evaluation includes a review of the credit ratings of the non-Agency MBS, the credit characteristics of the mortgage loans collateralizing these securities, and the estimated future cash flows including projected collateral losses. The Company also assesses its ability and intent to hold any non-Agency MBS with an unrealized loss until the recovery in its value in accordance with GAAP. The Company performed this evaluation for its non-Agency MBS in an unrealized loss position and has determined that there have not been any adverse changes in the timing or amount of estimated future cash flows that necessitate a recognition of OTTI amounts as of March 31, 2019 or December 31, 2018.

XML

Repurchase Agreements (Notes)

3 Months Ended

Mar. 31, 2019

Disclosure of Repurchase Agreements [Abstract]

Repurchase agreements

REPURCHASE AGREEMENTS

The Company’s repurchase agreements outstanding as of March 31, 2019 and December 31, 2018 are summarized in the following tables:

	March 31, 2019						December 31, 2018
Collateral Type	Balance		Weighted Average Rate		Fair Value of Collateral Pledged		Balance		Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,582,697	2.75	%	$	2,719,705	$	1,887,878	2.66	%	$	1,998,922
Agency CMBS	1,220,326		2.68	%	1,304,731		919,833		2.51	%	986,861
Agency CMBS IO	253,168		3.05	%	282,927		253,258		2.96	%	285,247
Non-Agency CMBS IO	196,702		3.39	%	230,244		207,015		3.38	%	240,574
Total repurchase agreements	$	4,252,893	2.78	%	$	4,537,607	$	3,267,984	2.69	%	$	3,511,604

The Company also had $151,075 and $58,915 payable to counterparties as of March 31, 2019 and December 31, 2018, respectively, which consisted of securities pending settlement as of those respective dates.

The following table provides information on the remaining term to maturity and original term to maturity for the Company’s repurchase agreements as of the dates indicated:

	March 31, 2019			December 31, 2018
Remaining Term to Maturity	Balance		WAVG Original Term to Maturity	Balance		WAVG Original Term to Maturity
Less than 30 days	$	3,459,566	52	$	2,319,911	56
30 to 90 days	793,327		82	948,073		89
Total	$	4,252,893	58	$	3,267,984	66

The following table lists the counterparties with whom the Company had approximately 10% or more of its shareholders’ equity at risk (defined as the excess of collateral pledged over the borrowings outstanding) as of the date indicated:

	March 31, 2019
Counterparty Name	Balance		Weighted Average Rate		Equity at Risk
Wells Fargo Bank, N. A. and affiliates	$	357,111	3.56	%	$	43,381

Of the amount outstanding with Wells Fargo Bank, N.A. and affiliates, $212,631 is under a committed repurchase facility which has an aggregate maximum borrowing capacity of $400,000 and is scheduled to mature on May 12, 2019, subject to early termination provisions contained in the master repurchase agreement. The facility is collateralized by CMBS IO, and its weighted average borrowing rate as of March 31, 2019 was 3.32%.

As of March 31, 2019, the Company had repurchase agreement amounts outstanding with 19 of its 36 available repurchase agreement counterparties. The Company’s counterparties, as set forth in the master repurchase agreement with the counterparty, require the Company to comply with various customary operating and financial covenants, including, but not limited to, minimum net worth and earnings, maximum declines in net worth in a given period, and maximum leverage requirements as well as maintaining the Company’s REIT status. In addition, some of the agreements contain cross default features, whereby default under an agreement with one lender simultaneously causes default under agreements with other lenders. To the extent that the Company fails to comply with the covenants contained in these financing agreements or is otherwise found to be in default under the terms of such agreements, the counterparty has the right to accelerate amounts due under the master repurchase agreement. The Company was in full compliance with all covenants as of March 31, 2019.

The Company's repurchase agreements are subject to underlying agreements with master netting or similar arrangements, which provide for the right of offset in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its repurchase agreements to these arrangements on a gross basis. The following tables present information regarding the Company's repurchase agreements as if the Company had presented them on a net basis as of March 31, 2019 and December 31, 2018:

	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet (1)					Net Amount
							Financial Instruments Posted as Collateral			Cash Posted as Collateral
March 31, 2019
Repurchase agreements	$	4,252,893	$	—	$	4,252,893	$	(4,252,893	)	$	—	$	—
December 31, 2018
Repurchase agreements	$	3,267,984	$	—	$	3,267,984	$	(3,267,984	)	$	—	$	—

(1) Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of debt securities up to and not exceeding the net amount of the repurchase agreement liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented.

Please see Note 4 for information related to the Company’s derivatives which are also subject to underlying agreements with master netting or similar arrangements.

XML

Derivatives (Notes)

3 Months Ended

Mar. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

DERIVATIVES

     The Company is a party to certain types of financial instruments that are accounted for as derivative instruments. Please refer to Note 1 for information related to the Company’s accounting policy for its derivative instruments.

Types and Uses of Derivatives Instruments

Interest Rate Derivatives. Changing interest rates impact the fair value of the Company’s investments as well as the interest rates on the Company’s repurchase agreement borrowings used to finance its investments. The Company primarily uses interest rate swaps as economic hedges to mitigate declines in book value and to protect some portion of the Company's earnings from rising interest rates. The Company may also periodically utilize other types of interest rate derivatives, such as Eurodollar and U.S. Treasury futures as economic hedges.

TBA Transactions. The Company also holds long positions in TBA securities by executing a series of transactions which effectively delay the settlement of a forward purchase of a non-specified Agency RMBS by entering into an offsetting TBA short position, net settling the paired-off positions in cash, and simultaneously entering into an identical TBA long position with a later settlement date. These long positions in TBA securities (“dollar roll positions”) are viewed by management as economically equivalent to investing in and financing non-specified fixed-rate Agency RMBS. TBA securities purchased for a forward settlement month are generally priced at a discount relative to TBA securities sold for settlement in the current month. This discount, often referred to as “drop income” represents the economic equivalent of net interest income (interest income less implied financing cost) on the underlying Agency security from trade date to settlement date.

Periodically, the Company may also hold short positions in TBA securities for the purpose of economically hedging a portion of the impact of changing interest rates on the fair value of the Company’s fixed-rate Agency RMBS. The Company did not hold any short positions in TBA securities as of March 31, 2019.

The table below summarizes information about the fair value by type of derivative instrument on the Company’s consolidated balance sheets as of the dates indicated:  

Type of Derivative Instrument	Balance Sheet Location	Purpose	March 31, 2019		December 31, 2018
Interest rate swaps	Derivative assets	Economic hedging	$	112	$	324
TBA securities	Derivative assets	Trading	5,918		6,239
			$	6,030	$	6,563
U.S. Treasury futures	Derivative liabilities	Economic hedging	$	—	$	(1,218	)

The table below provides detail of the Company’s “(loss) gain on derivative instruments, net” by type of derivative for the periods indicated:

	Three Months Ended
	March 31,
Type of Derivative Instrument	2019			2018
Receive-fixed interest rate swaps	$	—		$	(1,129	)
Pay-fixed interest rate swaps	(71,764		)	49,372
Eurodollar futures	—			1,905
TBA dollar roll positions	10,176			(12,087		)
TBA economic hedges	—			293
U.S. Treasury futures	(109		)	—
(Loss) gain on derivative instruments, net	$	(61,697	)	$	38,354

Interest Rate Swaps

The following tables present information about the Company’s interest rate swaps as of the dates indicated:

	March 31, 2019
			Weighted-Average:
Years to Maturity:	Notional Amount (1)		Pay Rate (2)		Life Remaining (in Years)	Fair Value (3)
< 3 years	$	1,435,000	2.01	%	1.3	$	112
>3 and < 6 years	1,930,000		2.27	%	5.7	—
>6 and < 10 years	1,530,000		2.85	%	9.0	—
>10 years	120,000		2.84	%	28.4	—
Total	$	5,015,000	2.38	%	6.0	$	112
	December 31, 2018
			Weighted-Average:
Years to Maturity:	Notional Amount (1)		Pay Rate (2)		Life Remaining (in Years)	Fair Value (3)
< 3 years	$	1,560,000	1.96	%	1.4	$	324
>3 and < 6 years	1,230,000		2.23	%	4.4	—
>6 and < 10 years	1,505,000		2.80	%	8.3	—
>10 years	220,000		2.81	%	21.9	—
Total	$	4,515,000	2.35	%	5.5	$	324

(1) The notional amounts include $0 and $775,000 of forward starting pay-fixed interest rate swaps as of March 31, 2019 and December 31, 2018, respectively.

(2) Excluding forward starting pay-fixed interest rate swaps, the weighted average pay rate was 2.38% and 2.29% as of March 31, 2019 and December 31, 2018, respectively.

(3) The majority of the Company’s interest rate swap agreements are centrally cleared through the CME. Please refer to Note 1 for information regarding the exchange of variation margin being legally considered as settlement of the derivative as opposed to a pledge of collateral.

A portion of the Company’s interest rate swaps were entered into under bilateral agreements which contain cross-default provisions with other agreements between the parties. In addition, these bilateral agreements contain financial and operational covenants similar to those contained in the repurchase agreements as described in Note 3. The Company was in compliance with all covenants with respect to bilateral agreements under which interest rate swaps were entered into as of March 31, 2019.

TBA Securities

The following table summarizes information about the Company's TBA securities as of the dates indicated:

	March 31, 2019		December 31, 2018
Implied market value (1)	$	733,130	$	888,469
Implied cost basis (2)	727,212		882,230
Net carrying value (3)	$	5,918	$	6,239

(1) Implied market value represents the estimated fair value of the underlying Agency MBS as if settled as of the date indicated.

(2) Implied cost basis represents the forward price to be paid for the underlying Agency MBS as if settled as of the date indicated.

(3) Net carrying value is the amount included on the consolidated balance sheets within “derivative assets (liabilities)” and represents the difference between the implied market value and the implied cost basis of the TBA security as of the date indicated.

Volume of Activity

The tables below summarize changes in the Company’s derivative instruments for the periods indicated:

Type of Derivative Instrument	Notional Amount as of December 31, 2018		Additions		Settlements, Terminations, or Pair-Offs			Notional Amount as of March 31, 2019
Interest rate swaps	$	4,515,000	$	1,500,000	$	(1,000,000	)	$	5,015,000
TBA dollar roll positions	860,000		2,720,000		(2,865,000		)	715,000
U.S. Treasury futures	50,000		—		(50,000		)	—

Offsetting

The Company's derivatives are subject to underlying agreements with master netting or similar arrangements, which provide for the right of offset in the event of default or in the event of bankruptcy of either party to the transactions. The Company reports its derivative assets and liabilities subject to these arrangements on a gross basis. The following tables present information regarding those derivative assets and liabilities subject to such arrangements as if the Company had presented them on a net basis as of March 31, 2019 and December 31, 2018:

	Offsetting of Assets
	Gross Amount of Recognized Assets		Gross Amount Offset in the Balance Sheet		Net Amount of Assets Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet (1)					Net Amount
							Financial Instruments Received as Collateral		Cash Received as Collateral
March 31, 2019
Interest rate swaps	$	112	$	—	$	112	$	—	$	—		$	112
TBA securities	5,918		—		5,918		—		(1,699		)	4,219
Derivative assets	$	6,030	$	—	$	6,030	$	—	$	(1,699	)	$	4,331
December 31, 2018
Interest rate swaps	$	324	$	—	$	324	$	—	$	—		$	324
TBA securities	6,239		—		6,239		—		(1,719		)	4,520
Derivative assets	$	6,563	$	—	$	6,563	$	—	$	(1,719	)	$	4,844

	Offsetting of Liabilities
	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet (1)					Net Amount
							Financial Instruments Posted as Collateral		Cash Posted as Collateral
March 31, 2019
U.S. Treasury futures	—		—		—		—		—			—
Derivative liabilities	$	—	$	—	$	—	$	—	$	—		$	—
December 31, 2018
U.S. Treasury futures	1,218		—		1,218		—		(1,218		)	—
Derivative liabilities	$	1,218	$	—	$	1,218	$	—	$	(1,218	)	$	—

(1) Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the derivative asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented. Please refer to the consolidated balance sheets for the total cash posted as collateral, which is recorded as "restricted cash", and the total fair value of financial instruments pledged as collateral for derivatives and repurchase agreements, which is shown parenthetically.

Please see Note 3 for information related to the Company’s repurchase agreements which are also subject to underlying agreements with master netting or similar arrangements.

XML

Fair Value of Financial Instruments (Notes)

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

FAIR VALUE OF FINANCIAL INSTRUMENTS

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 clarifies that fair value should be based on the assumptions market participants would use when pricing an asset or liability and also requires an entity to consider all aspects of nonperformance risk, including the entity’s own credit standing, when measuring fair value of a liability. ASC Topic 820 established a valuation hierarchy of three levels as follows:

• Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.

• Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.  

• Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.  

The following table presents the Company’s financial instruments that are measured at fair value on a recurring basis by their valuation hierarchy levels as of the dates indicated:

	March 31, 2019								December 31, 2018
	Fair Value		Level 1		Level 2		Level 3		Fair Value		Level 1		Level 2		Level 3
Assets carried at fair value:
MBS	$	4,842,447	$	—	$	4,839,977	$	2,470	$	3,749,464	$	—	$	3,747,190	$	2,274
Derivative assets:
Interest rate swaps	112		—		112		—		324		—		324		—
TBA securities	5,918		—		5,918		—		6,239		—		6,239		—
Total assets carried at fair value	$	4,848,477	$	—	$	4,846,007	$	2,470	$	3,756,027	$	—	$	3,753,753	$	2,274
Liabilities carried at fair value:
U.S. Treasury futures	$	—	$	—	$	—	$	—	$	1,218	$	1,218	$	—	$	—
Total liabilities carried at fair value	$	—	$	—	$	—	$	—	$	1,218	$	1,218	$	—	$	—

The fair value of interest rate swaps is measured using the income approach with the primary input being the forward interest rate swap curve, which is considered an observable input, and thus their fair values are considered Level 2 measurements. U.S. Treasury futures are valued based on closing exchange prices on these contracts and are classified accordingly as Level 1 measurements. The fair value of TBA securities is estimated using methods similar those used to fair value the Company’s Level 2 MBS.

The fair value measurements for a majority of the Company's MBS are considered Level 2 because these securities are substantially similar to securities that either are actively traded or have been recently traded in their respective markets. The Company determines the fair value of its Level 2 securities based on prices received from the Company's primary pricing service as well as other pricing services and brokers. The Company evaluates the third-party prices it receives to assess their reasonableness. Although the Company does not adjust third-party prices, they may be excluded from use in the determination of a security's fair value if they are significantly different from other observable market data. In valuing a security, the primary pricing service uses either a market approach, which uses observable prices and other relevant information that is generated by market transactions of identical or similar securities, or an income approach, which uses valuation techniques to convert future amounts to a single, discounted present value amount. The Company also reviews the assumptions and inputs utilized in the valuation techniques of its primary pricing service. Examples of these observable inputs and assumptions include market interest rates, credit spreads, and projected prepayment speeds, among other things.

The Company owns certain non-Agency MBS for which there are not sufficiently recent trades of substantially similar securities, and their fair value measurements are thus considered Level 3. The Company determines the fair value of its Level 3 securities by discounting the estimated future cash flows derived from cash flow models using significant inputs which are determined by the Company when market observable inputs are not available. Information utilized in those pricing models include the security’s credit rating, coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected credit losses, and credit enhancement as well as certain other relevant information. Significant changes in any of these inputs in isolation may result in a significantly different fair value measurement. Level 3 assets are generally most sensitive to the default rate and severity assumptions.

The activity of the Company’s non-Agency MBS measured at fair value on a recurring basis using Level 3 inputs is presented in the following table for the periods indicated:

	Three Months Ended
	March 31,
	2019			2018
Balance as of beginning of period	$	2,274		$	7,243
Unrealized gain included in OCI	268			(310		)
Principal payments	(183		)	(361		)
Accretion	111			311
Balance as of end of period	$	2,470		$	6,883

The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future if a change in type of inputs occurs.

The following table presents a summary of the carrying value and estimated fair values of the Company’s financial instruments as of the dates indicated:

	March 31, 2019				December 31, 2018
	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets:
Mortgage-backed securities	$	4,842,447	$	4,842,447	$	3,749,464	$	3,749,464
Mortgage loans held for investment, net (1)	10,862		7,458		11,527		8,566
Derivative assets	6,030		6,030		6,563		6,563
Liabilities:
Repurchase agreements (2)	$	4,252,893	$	4,252,893	$	3,267,984	$	3,267,984
Non-recourse collateralized financing (1)	3,219		3,073		3,458		3,475
Derivative liabilities	—		—		1,218		1,218

(1) The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.

(2) The carrying value of repurchase agreements generally approximates fair value due to their short-term maturities.

XML

(Notes)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Shareholders' Equity and Share-based Compensation

SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION

Preferred Stock. The Company's articles of incorporation authorize the issuance of up to 50,000,000 shares of preferred stock, par value $0.01 per share, of which the Company’s Board of Directors has designated 8,000,000 shares of 8.50% Series A Preferred Stock and 7,000,000 shares of 7.625% Series B Preferred Stock, (the Series A Preferred Stock and the Series B Preferred Stock collectively, the “Preferred Stock”). The Company had 2,300,000 shares of its Series A Preferred Stock and 3,868,062 shares of its Series B Preferred Stock issued and outstanding as of March 31, 2019 compared to 2,300,000 shares of Series A Preferred Stock and 3,654,594 shares of Series B Preferred Stock as of December 31, 2018.

The Preferred Stock has no maturity and will remain outstanding indefinitely unless redeemed or otherwise repurchased or converted into common stock pursuant to the terms of the Preferred Stock. The Company's Preferred Stock may be redeemed in whole, or in part, at any time and from time to time at the Company's option at a cash redemption price of $25.00 per share plus any accumulated and unpaid dividends. Because the Preferred Stock is redeemable only at the option of the issuer, it is classified as equity on the Company’s consolidated balance sheet. The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year. The Company paid its regular quarterly dividends of $0.053125 and $0.4765625on its Series A and Series B Preferred Stock, respectively, for the first quarter on April 15, 2019 to shareholders of record as of April 1, 2019.

Common Stock. The following table summarizes information regarding monthly dividend declarations on the Company’s common stock for the first quarter of 2019:

	Three Months Ended
	March 31, 2018
Declaration Date	Amount Declared		Record Date	Payment Date
January 7, 2019	$	0.06	January 18, 2019	January 31, 2019
January 28, 2019	0.06		February 14, 2019	February 28, 2019
March 12, 2019	0.06		March 22, 2019	April 1, 2019

Stock and Incentive Plans. The Company’s 2018 Stock and Incentive Plan, which replaced the Company’s 2009 Stock and Incentive Plan (the “2009 Plan”), reserves for issuance up to 3,000,000 shares of common stock for eligible employees, non-employee directors, consultants, and advisors to the Company to be granted in the form of stock options, restricted stock awards, restricted stock units, stock appreciation rights, performance units, and performance cash awards. Total stock-based compensation expense recognized by the Company for the three months endedMarch 31, 2019 was $298 compared to $335 for the three months endedMarch 31, 2018, respectively. The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended
	March 31,
	2019				2018
	Shares		Weighted Average Grant Date Fair Value Per Share		Shares		Weighted Average Grant Date Fair Value Per Share
Restricted stock outstanding as of beginning of period (1)	341,713		$	6.37	353,103		$	7.01
Restricted stock granted	152,462		6.10		176,233		6.28
Restricted stock vested (1)	(151,139	)	6.37		(194,827	)	7.37
Restricted stock outstanding as of end of period (1)	343,036		$	6.25	334,509		$	6.42

(1) Amounts include awards previously granted under the 2009 Plan which will remain outstanding in accordance with their terms. The Company is no longer granting new equity awards under the 2009 Plan.

As of March 31, 2019, the grant date fair value of the Company’s remaining nonvested restricted stock is $1,865 which will be amortized into compensation expense over a weighted average period of 2.3 years.

XML

Subsequent Events (Notes)

3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

Subsequent Events

SUBSEQUENT EVENTS

Management has evaluated events and circumstances occurring as of and through the date this Quarterly Report on Form 10-Q was filed with the SEC and has determined that there have been no significant events or circumstances that qualify as a "recognized" or "nonrecognized" subsequent event as defined by ASC Topic 855.

XML

Organization and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Organization [Text Block]

Organization

Dynex Capital, Inc. (“Company”) was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in debt securities, the majority of which are specified pools of Agency and non-Agency mortgage-backed securities (“MBS”) consisting of residential MBS (“RMBS”), commercial MBS (“CMBS”) and CMBS interest-only (“IO”) securities that are issued or guaranteed by U.S. Government sponsored agencies (“Agency MBS”) and MBS issued by others (“non-Agency MBS”). The Company also invests in other types of mortgage-related securities, such as to-be-announced securities (“TBAs” or “TBA securities”).

Basis of Presentation [Policy Text Block]

Basis of Presentation

The accompanying unaudited consolidated financial statements of Dynex Capital, Inc. and its subsidiaries (together, “Dynex” or, as appropriate, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10, Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all significant adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the consolidated financial statements have been included. Operating results for the three months endedMarch 31, 2019 are not necessarily indicative of the results that may be expected for any other interim periods or for the entire year ending December 31, 2019. The unaudited consolidated financial statements included herein should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Form 10-K”) filed with the SEC.

Consolidation [Policy Text Block]

Consolidation and Variable Interest Entities

The consolidated financial statements include the accounts of the Company and the accounts of its majority owned subsidiaries and variable interest entities (“VIE”) for which it is the primary beneficiary. All intercompany accounts and transactions have been eliminated in consolidation.

The Company consolidates a VIE if the Company is determined to be the VIE’s primary beneficiary, which is defined as the party that has both: (i) the power to control the activities that most significantly impact the VIE’s financial performance and (ii) the right to receive benefits or absorb losses that could potentially be significant to the VIE. The Company reconsiders its evaluation of whether to consolidate a VIE on an ongoing basis, based on changes in the facts and circumstances pertaining to the VIE.

The Company consolidates a securitization trust, which has residential mortgage loans included in “mortgage loans held for investment, net” on its consolidated balance sheet, of which a portion is pledged as collateral for one remaining bond recorded as “non-recourse collateralized financing” on its consolidated balance sheet. The Company owns the subordinate class in the trust and has been deemed the primary beneficiary.

Though the Company invests in Agency and non-Agency MBS which are generally considered to be interests in VIEs, the Company does not consolidate these entities because it does not meet the criteria necessary to be deemed a primary beneficiary. Please refer to Note 2 for financial information regarding the Company’s investments in these debt securities.

Use of Estimates [Policy Text Block]

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, amortization of premiums and discounts, fair value measurements of its investments, and other-than-temporary impairments. These items are discussed further below within this note to the consolidated financial statements.

Income Taxes [Policy Text Block]

Income Taxes

The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986 and the corresponding provisions of state law. To qualify as a REIT, the Company must meet certain tests including investing in primarily real estate-related assets and the required distribution of at least 90% of its annual REIT taxable income to stockholders after consideration of its net operating loss (“NOL”) carryforward and not including taxable income retained in its taxable subsidiaries. As a REIT, the Company generally will not be subject to federal income tax on the amount of its income or capital gains that is distributed as dividends to shareholders.

The Company assesses its tax positions for all open tax years and determines whether the Company has any material unrecognized liabilities in accordance with Accounting Standards Codification (“ASC”) Topic 740. The Company records these liabilities, if any, to the extent they are deemed more likely than not to have been incurred.

Net Income (Loss) Per Common Share [Text Block]

Net Income (Loss) Per Common Share

The Company calculates basic net income per common share by dividing net income to common shareholders for the period by weighted-average shares of common stock outstanding for that period. The Company did not have any potentially dilutive securities outstanding during the three months ended March 31, 2019 or March 31, 2018.

Holders of unvested shares of the Company’s issued and outstanding restricted common stock are eligible to receive non-forfeitable dividends. As such, these unvested shares are considered participating securities as per ASC Topic 260-10 and therefore are included in the computation of basic net income per common share using the two-class method. Upon vesting, restrictions on transfer expire on each share of restricted stock, and each such share of restricted stock represents one unrestricted share of common stock.

Because the Company’s 8.50% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) and 7.625% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”) are redeemable at the Company’s option for cash only and may convert into shares of common stock only upon a change of control of the Company, the effect of those shares and their related dividends is excluded from the calculation of diluted net income per common share.

Cash and Cash Equivalents [Policy Text Block]

Cash and Cash Equivalents

Cash and cash equivalents include cash on hand and highly liquid investments with original maturities of three months or less.

Restricted Cash [Policy Text Block]

Restricted Cash

Restricted cash consists of cash the Company has pledged to cover initial and variation margin with its financing and derivative counterparties.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported on the Company's consolidated balance sheet as of March 31, 2019 that sum to the total of the same such amounts shown on the Company’s consolidated statement of cash flows for the three months endedMarch 31, 2019:

	March 31, 2019
Cash and cash equivalents	$	55,902
Restricted cash	86,761
Total cash, cash equivalents, and restricted cash shown on consolidated statement of cash flows	$	142,663

Investments in Debt Securities [Policy Text Block]

Investments in Debt Securities

The Company’s investments in debt securities are designated as available-for-sale (“AFS”) and are recorded at fair value on the Company’s consolidated balance sheet. Changes in unrealized gain (loss) on the Company’s debt securities are reported in other comprehensive income (“OCI”) until the investment is sold, matures, or is determined to be other than temporarily impaired. Although the Company generally intends to hold its AFS securities until maturity, it may sell any of these securities as part of the overall management of its business. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of accumulated other comprehensive income (“AOCI”) into net income as a realized “gain (loss) on sale of investments, net” using the specific identification method.

The fair value of the Company’s debt securities pledged as collateral against repurchase agreements and derivative instruments is disclosed parenthetically on the Company’s consolidated balance sheets.

Interest Income, Premium Amortization, and Discount Accretion.Interest income on debt securities is accrued based on the outstanding principal balance (or notional balance in the case of interest-only, or “IO”, securities) and their contractual terms. Premiums or discounts associated with the purchase of Agency MBS as well as any non-Agency MBS rated ‘AA’ and higher are amortized or accreted into interest income over the expected life of such securities using the effective yield method, and adjustments to premium amortization and discount accretion are made for actual cash payments. The Company may also adjust premium amortization and discount accretion for changes in projected future cash payments. The Company’s projections of future cash payments are based on input and analysis received from external sources and internal models and include assumptions about the amount and timing of loan prepayment rates, fluctuations in interest rates, credit losses, and other factors. On at least a quarterly basis, the Company reviews and makes any necessary adjustments to its cash flow projections and updates the yield recognized on these assets. The Company does not estimate future prepayments on its fixed-rate Agency RMBS.

The Company holds certain non-Agency MBS that had credit ratings of less than ‘AA’ at the time of purchase or were not rated by any of the nationally recognized credit rating agencies. A portion of these non-Agency MBS were purchased at discounts to their par value, which management does not believe to be substantial. The discount is accreted into income over the security’s expected life based on management’s estimate of the security’s projected cash flows. Future changes in the timing of projected cash flows or differences arising between projected cash flows and actual cash flows received may result in a prospective change in the effective yield on those securities.

Determination of MBS Fair Value.The Company estimates the fair value of the majority of its MBS based upon prices obtained from third-party pricing services and broker quotes. The remainder of the Company’s MBS are valued by discounting the estimated future cash flows derived from cash flow models that utilize information such as the security’s coupon rate, estimated prepayment speeds, expected weighted average life, collateral composition, estimated future interest rates, expected losses, and credit enhancements as well as certain other relevant information. Refer to Note 5 for further discussion of MBS fair value measurements.

Other-than-Temporary Impairment. An MBS is considered impaired when its fair value is less than its amortized cost. The Company evaluates all of its impaired MBS for other-than-temporary impairments (“OTTI”) on at least a quarterly basis. An impairment is considered other-than-temporary if: (1) the Company intends to sell the MBS; (2) it is more likely than not that the Company will be required to sell the MBS before its fair value recovers; or (3) the Company does not expect to recover the full amortized cost basis of the MBS. If either of the first two conditions is met, the entire amount of the impairment is recognized in earnings. If the impairment is solely due to the inability to fully recover the amortized cost basis, the security is further analyzed to quantify any credit loss, which is the difference between the present value of cash flows expected to be collected on the MBS and its amortized cost. The credit loss, if any, is then recognized in earnings, while the balance of impairment related to other factors is recognized in other comprehensive income.

Following the recognition of an OTTI through earnings, a new cost basis is established for the security. Any subsequent recoveries in fair value may be accreted back into the amortized cost basis of the MBS on a prospective basis through interest income. Please see Note 2 for additional information related to the Company’s evaluation for OTTI.

Repurchase Agreements [Policy Text Block]

Repurchase Agreements

The Company’s repurchase agreements, which are used to finance its purchases of debt securities, are accounted for as secured borrowings under which the Company pledges its securities as collateral to secure a loan, which is equal in value to a specified percentage of the estimated fair value of the pledged collateral. The Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase agreement, the Company is required to repay the loan and concurrently receives back its pledged collateral from the lender or, with the consent of the lender, the Company may renew the agreement at the then prevailing financing rate. A repurchase agreement lender may require the Company to pledge additional collateral in the event of a decline in the fair value of the collateral pledged. Repurchase agreement financing is recourse to the Company and the assets pledged. Most of the Company’s repurchase agreements are based on the September 1996 version of the Bond Market Association Master Repurchase Agreement, which generally provides that the lender, as buyer, is responsible for obtaining collateral valuations from a generally recognized source agreed to by both the Company and the lender, or, in an instance when such source is not available, the value determination is made by the lender.

Derivative Instruments [Policy Text Block]

Derivative Instruments

The Company’s derivative instruments generally include interest rate swaps, futures, and forward contracts for the purchase or sale of non-specified Agency RMBS, commonly referred to as “TBA securities” or “TBA contracts”. Derivative instruments are accounted for at the fair value of their unit of account. Derivative instruments in a gain position are reported as derivative assets and derivative instruments in a loss position are reported as derivative liabilities on the Company’s consolidated balance sheet. All periodic interest benefits/costs and changes in fair value of derivative instruments, including gains and losses realized upon termination, maturity, or settlement are recorded in “gain (loss) on derivative instruments, net” on the Company’s consolidated statement of comprehensive income. Cash receipts and payments related to derivative instruments are classified in the investing activities section of the consolidated statements of cash flows in accordance with the underlying nature or purpose of the derivative transactions.

The Company’s interest rate swap agreements are privately negotiated in the over-the-counter (“OTC”) market and the majority of these agreements are centrally cleared through the Chicago Mercantile Exchange (“CME”) with the rest being subject to bilateral agreements between the Company and the swap counterparty. The Company’s CME cleared swaps require that the Company post initial margin as determined by the CME, and in addition, variation margin is exchanged, typically in cash, for changes in the fair value of the CME cleared swaps. The exchange of variation margin for CME cleared swaps is legally considered to be the settlement of the derivative itself as opposed to a pledge of collateral. Accordingly, the Company accounts for the daily exchange of variation margin associated with its CME cleared interest rate swaps as a direct increase or decrease to the carrying value of the related derivative asset or liability. The carrying value of derivative instruments on the Company’s consolidated balance sheets is the unsettled fair value of the instruments subject to bilateral agreements and not centrally cleared through the CME.

A TBA security is a forward contract (“TBA contract”) for the purchase (“long position”) or sale (“short position”) of a non-specified Agency MBS at a predetermined price with certain principal and interest terms and certain types of collateral, but the particular Agency securities to be delivered are not identified until shortly before the settlement date. The Company accounts for long and short positions in TBAs as derivative instruments because the Company cannot assert that it is probable at inception and throughout the term of an individual TBA transaction that its settlement will result in physical delivery of the underlying Agency RMBS, or the individual TBA transaction will not settle in the shortest time period possible.

Please refer to Note 4 for additional information regarding the Company’s derivative instruments as well as Note 5 for information on how the fair value of these instruments are calculated.

Share-based Compensation [Policy Text Block]

Share-Based Compensation

Pursuant to the Company’s 2018 Stock and Incentive Plan (“2018 Plan”), the Company may grant share-based compensation to eligible employees, non-employee directors or consultants or advisors to the Company, including restricted stock awards, stock options, stock appreciation rights, performance units, restricted stock units, and performance cash awards. The Company’s restricted stock currently issued and outstanding may be settled only in shares of its common stock, and therefore are treated as equity awards with their fair value measured at the grant date and recognized as compensation cost over the requisite service period with a corresponding credit to shareholders’ equity. The requisite service period is the period during which a participant is required to provide service in exchange for an award, which is equivalent to the vesting period specified in the terms of the time-based restricted stock award. None of the Company’s restricted stock awards have performance-based conditions. The Company does not currently have any share-based compensation issued or outstanding other than restricted stock issued to its employees, officers, and directors.

Contingencies [Policy Text Block]

Contingencies

In the normal course of business, there may be various lawsuits, claims, and other contingencies pending against the Company. On a quarterly basis, the Company evaluates whether to establish provisions for estimated losses from those matters. The Company recognizes a liability for a contingent loss when: (a) the underlying causal event has occurred prior to the balance sheet date; (b) it is probable that a loss has been incurred; and (c) there is a reasonable basis for estimating that loss. A liability is not recognized for a contingent loss when it is only possible or remotely possible that a loss has been incurred, however, possible contingent losses shall be disclosed. If the contingent loss (or an additional loss in excess of any accrual) is at least a reasonable possibility and material, then the Company discloses a reasonable estimate of the possible loss or range of loss, if such reasonable estimate can be made. If the Company cannot make a reasonable estimate of the possible material loss, or range of loss, then that fact is disclosed.

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, Financial Instruments - Credit Losses, which replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For assets measured at amortized cost, the amendments in this ASU eliminate the probable initial recognition threshold in current GAAP and broaden the information that an entity must consider in developing its expected credit loss estimate to include the use of forecasted information. For assets classified as available-for-sale with changes in fair value recorded in other comprehensive income, measurement of credit losses will be similar to current GAAP. However, the amendments in this ASU require that credit losses be presented as an allowance rather than as a write-down, which is referred to in current GAAP as an other-than-temporary impairment. An entity will be able to record reversals of credit losses, if credit loss estimates decline, in net income for the current period. The amendments in this ASU will not permit an entity to use the length of time a debt security has been in an unrealized loss position to avoid recording a credit loss and removes the requirements to consider historical and implied volatility of the fair value of a security as well as recoveries or declines in fair value after the balance sheet date. The amendments in this ASU will affect an entity by varying degrees depending on a number of factors, including but not limited to, the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. These amendments will become effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. An entity will apply the amendments in this ASU through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Though the Company has not fully completed evaluating the impact this ASU will have on its financial condition and results of operations, the Company does not expect it will have a material impact given that the majority of its investments are Agency MBS.

XML

Investments in Debt Securities Investments in Debt Securities (Tables)

3 Months Ended

Mar. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Debt Securities, Available-for-sale [Table Text Block]

The following tables present the Company’s debt securities by investment type (including securities pending settlement) as of the dates indicated:

	March 31, 2019
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC (1)
RMBS:
Agency	$	2,683,276	$	77,584		$	2,760,860	$	31,813	$	(11,403	)	$	2,781,270	4.04	%
Non-Agency	803		—			803		27		(21		)	809		6.75	%
	2,684,079		77,584			2,761,663		31,840		(11,424		)	2,782,079
CMBS:
Agency	1,507,835		10,775			1,518,610		30,766		(9,864		)	1,539,512		3.23	%
Non-Agency	2,910		(1,927		)	983		677		—			1,660		6.27	%
	1,510,745		8,848			1,519,593		31,443		(9,864		)	1,541,172
CMBS IO (2):
Agency	—		282,636			282,636		5,982		(154		)	288,464		0.53	%
Non-Agency	—		227,868			227,868		3,249		(385		)	230,732		0.56	%
	—		510,504			510,504		9,231		(539		)	519,196
Total AFS securities:	$	4,194,824	$	596,936		$	4,791,760	$	72,514	$	(21,827	)	$	4,842,447

(1) The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).

(2) The notional balance for Agency CMBS IO and non-Agency CMBS IO was $13,146,249 and $10,158,055 respectively, as of March 31, 2019.

	December 31, 2018
	Par		Net Premium (Discount)			Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		WAC (1)
RMBS:
Agency	$	2,118,639	$	56,744		$	2,175,383	$	8,902	$	(26,264	)	$	2,158,021	3.95	%
Non-Agency	856		—			856		24		(22		)	858		6.75	%
	2,119,495		56,744			2,176,239		8,926		(26,286		)	2,158,879
CMBS:
Agency	1,071,906		8,518			1,080,424		6,141		(29,550		)	1,057,015		3.22	%
Non-Agency	3,040		(2,037		)	1,003		413		—			1,416		6.47	%
	1,074,946		6,481			1,081,427		6,554		(29,550		)	1,058,431
CMBS IO (2):
Agency	—		287,062			287,062		4,281		(239		)	291,104		0.55	%
Non-Agency	—		240,681			240,681		1,675		(1,306		)	241,050		0.57	%
	—		527,743			527,743		5,956		(1,545		)	532,154
Total AFS securities:	$	3,194,441	$	590,968		$	3,785,409	$	21,436	$	(57,381	)	$	3,749,464

(1) The WAC is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).

(2) The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $13,048,666 and $10,275,494, respectively, as of December 31, 2018.

Actual maturities of MBS are affected by the contractual lives of the underlying mortgage collateral, periodic payments of principal, prepayments of principal, and the payment priority structure of the security; therefore, actual maturities are generally shorter than the securities' stated contractual maturities. The following table categorizes the Company’s debt securities according to their stated maturity as of the dates indicated:

	March 31, 2019				December 31, 2018
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Less than 1 year	$	119,121	$	121,882	$	39,868	$	39,808
>1 and <5 years	151,888		154,615		151,041		152,917
>5 and <10 years	911,278		910,315		828,543		806,015
> 10 years	3,609,473		3,655,635		2,765,957		2,750,724
	$	4,791,760	$	4,842,447	$	3,785,409	$	3,749,464

Schedule of Realized Gain (Loss) [Table Text Block]

The following table presents information regarding the sales that generated the “loss on sale of investments, net” on the Company’s consolidated statements of comprehensive income (loss) for the periods indicated:

	Three Months Ended
	March 31,
	2019				2018
	Proceeds Received		Realized Gain (Loss)		Proceeds Received		Realized Gain (Loss)
Agency CMBS	—		—		$	108,758	$	(2,052	)
U.S. Treasuries	—		—		46,498		(1,723		)
	$	—	$	—	$	155,256	$	(3,775	)

Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]

The following table presents certain information for the AFS securities in an unrealized loss position as of the dates indicated:

	March 31, 2019						December 31, 2018
	Fair Value		Gross Unrealized Losses			# of Securities	Fair Value		Gross Unrealized Losses			# of Securities
Continuous unrealized loss position for less than 12 months:
Agency MBS	$	46,127	$	(174	)	9	$	581,440	$	(1,793	)	28
Non-Agency MBS	25,130		(177		)	7	70,876		(581		)	22
Continuous unrealized loss position for 12 months or longer:
Agency MBS	$	1,293,417	$	(21,248	)	61	$	1,543,892	$	(54,260	)	88
Non-Agency MBS	21,512		(228		)	13	46,154		(747		)	19

XML

Repurchase Agreements (Tables)

3 Months Ended

Mar. 31, 2019

Disclosure of Repurchase Agreements [Abstract]

Schedule of Underlying Assets of Repurchase Agreements when Amount of Repurchase Agreements Exceeds 10 Percent of Assets [Table Text Block]

The Company’s repurchase agreements outstanding as of March 31, 2019 and December 31, 2018 are summarized in the following tables:

	March 31, 2019						December 31, 2018
Collateral Type	Balance		Weighted Average Rate		Fair Value of Collateral Pledged		Balance		Weighted Average Rate		Fair Value of Collateral Pledged
Agency RMBS	$	2,582,697	2.75	%	$	2,719,705	$	1,887,878	2.66	%	$	1,998,922
Agency CMBS	1,220,326		2.68	%	1,304,731		919,833		2.51	%	986,861
Agency CMBS IO	253,168		3.05	%	282,927		253,258		2.96	%	285,247
Non-Agency CMBS IO	196,702		3.39	%	230,244		207,015		3.38	%	240,574
Total repurchase agreements	$	4,252,893	2.78	%	$	4,537,607	$	3,267,984	2.69	%	$	3,511,604

Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Table Text Block]

The following table provides information on the remaining term to maturity and original term to maturity for the Company’s repurchase agreements as of the dates indicated:

	March 31, 2019			December 31, 2018
Remaining Term to Maturity	Balance		WAVG Original Term to Maturity	Balance		WAVG Original Term to Maturity
Less than 30 days	$	3,459,566	52	$	2,319,911	56
30 to 90 days	793,327		82	948,073		89
Total	$	4,252,893	58	$	3,267,984	66

Schedule of Repurchase Agreement Counterparties with Whom Repurchase Agreements Exceed 10 Percent of Stockholders' Equity [Table Text Block]

The following table lists the counterparties with whom the Company had approximately 10% or more of its shareholders’ equity at risk (defined as the excess of collateral pledged over the borrowings outstanding) as of the date indicated:

	March 31, 2019
Counterparty Name	Balance		Weighted Average Rate		Equity at Risk
Wells Fargo Bank, N. A. and affiliates	$	357,111	3.56	%	$	43,381

XML

Derivatives (Tables)

3 Months Ended

Mar. 31, 2019

Derivative [Line Items]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The table below summarizes information about the fair value by type of derivative instrument on the Company’s consolidated balance sheets as of the dates indicated:  

Type of Derivative Instrument	Balance Sheet Location	Purpose	March 31, 2019		December 31, 2018
Interest rate swaps	Derivative assets	Economic hedging	$	112	$	324
TBA securities	Derivative assets	Trading	5,918		6,239
			$	6,030	$	6,563
U.S. Treasury futures	Derivative liabilities	Economic hedging	$	—	$	(1,218	)

Derivative Instruments, Gain (Loss)

The table below provides detail of the Company’s “(loss) gain on derivative instruments, net” by type of derivative for the periods indicated:

	Three Months Ended
	March 31,
Type of Derivative Instrument	2019			2018
Receive-fixed interest rate swaps	$	—		$	(1,129	)
Pay-fixed interest rate swaps	(71,764		)	49,372
Eurodollar futures	—			1,905
TBA dollar roll positions	10,176			(12,087		)
TBA economic hedges	—			293
U.S. Treasury futures	(109		)	—
(Loss) gain on derivative instruments, net	$	(61,697	)	$	38,354

Schedule of Derivative Instruments

The following tables present information about the Company’s interest rate swaps as of the dates indicated:

	March 31, 2019
			Weighted-Average:
Years to Maturity:	Notional Amount (1)		Pay Rate (2)		Life Remaining (in Years)	Fair Value (3)
< 3 years	$	1,435,000	2.01	%	1.3	$	112
>3 and < 6 years	1,930,000		2.27	%	5.7	—
>6 and < 10 years	1,530,000		2.85	%	9.0	—
>10 years	120,000		2.84	%	28.4	—
Total	$	5,015,000	2.38	%	6.0	$	112
	December 31, 2018
			Weighted-Average:
Years to Maturity:	Notional Amount (1)		Pay Rate (2)		Life Remaining (in Years)	Fair Value (3)
< 3 years	$	1,560,000	1.96	%	1.4	$	324
>3 and < 6 years	1,230,000		2.23	%	4.4	—
>6 and < 10 years	1,505,000		2.80	%	8.3	—
>10 years	220,000		2.81	%	21.9	—
Total	$	4,515,000	2.35	%	5.5	$	324

(1) The notional amounts include $0 and $775,000 of forward starting pay-fixed interest rate swaps as of March 31, 2019 and December 31, 2018, respectively.

(2) Excluding forward starting pay-fixed interest rate swaps, the weighted average pay rate was 2.38% and 2.29% as of March 31, 2019 and December 31, 2018, respectively.

(3) The majority of the Company’s interest rate swap agreements are centrally cleared through the CME. Please refer to Note 1 for information regarding the exchange of variation margin being legally considered as settlement of the derivative as opposed to a pledge of collateral.

A portion of the Company’s interest rate swaps were entered into under bilateral agreements which contain cross-default provisions with other agreements between the parties. In addition, these bilateral agreements contain financial and operational covenants similar to those contained in the repurchase agreements as described in Note 3. The Company was in compliance with all covenants with respect to bilateral agreements under which interest rate swaps were entered into as of March 31, 2019.

TBA Securities

The following table summarizes information about the Company's TBA securities as of the dates indicated:

	March 31, 2019		December 31, 2018
Implied market value (1)	$	733,130	$	888,469
Implied cost basis (2)	727,212		882,230
Net carrying value (3)	$	5,918	$	6,239

(1) Implied market value represents the estimated fair value of the underlying Agency MBS as if settled as of the date indicated.

(2) Implied cost basis represents the forward price to be paid for the underlying Agency MBS as if settled as of the date indicated.

(3) Net carrying value is the amount included on the consolidated balance sheets within “derivative assets (liabilities)” and represents the difference between the implied market value and the implied cost basis of the TBA security as of the date indicated.

Schedule of Notional Amounts of Outstanding Derivative Positions

The tables below summarize changes in the Company’s derivative instruments for the periods indicated:

Type of Derivative Instrument	Notional Amount as of December 31, 2018		Additions		Settlements, Terminations, or Pair-Offs			Notional Amount as of March 31, 2019
Interest rate swaps	$	4,515,000	$	1,500,000	$	(1,000,000	)	$	5,015,000
TBA dollar roll positions	860,000		2,720,000		(2,865,000		)	715,000
U.S. Treasury futures	50,000		—		(50,000		)	—

Offsetting Assets

	Offsetting of Assets
	Gross Amount of Recognized Assets		Gross Amount Offset in the Balance Sheet		Net Amount of Assets Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet (1)					Net Amount
							Financial Instruments Received as Collateral		Cash Received as Collateral
March 31, 2019
Interest rate swaps	$	112	$	—	$	112	$	—	$	—		$	112
TBA securities	5,918		—		5,918		—		(1,699		)	4,219
Derivative assets	$	6,030	$	—	$	6,030	$	—	$	(1,699	)	$	4,331
December 31, 2018
Interest rate swaps	$	324	$	—	$	324	$	—	$	—		$	324
TBA securities	6,239		—		6,239		—		(1,719		)	4,520
Derivative assets	$	6,563	$	—	$	6,563	$	—	$	(1,719	)	$	4,844

Offsetting Liabilities

	Offsetting of Liabilities
	Gross Amount of Recognized Liabilities		Gross Amount Offset in the Balance Sheet		Net Amount of Liabilities Presented in the Balance Sheet		Gross Amount Not Offset in the Balance Sheet (1)					Net Amount
							Financial Instruments Posted as Collateral		Cash Posted as Collateral
March 31, 2019
U.S. Treasury futures	—		—		—		—		—			—
Derivative liabilities	$	—	$	—	$	—	$	—	$	—		$	—
December 31, 2018
U.S. Treasury futures	1,218		—		1,218		—		(1,218		)	—
Derivative liabilities	$	1,218	$	—	$	1,218	$	—	$	(1,218	)	$	—

(1) Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the derivative asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented. Please refer to the consolidated balance sheets for the total cash posted as collateral, which is recorded as "restricted cash", and the total fair value of financial instruments pledged as collateral for derivatives and repurchase agreements, which is shown parenthetically.

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table presents the Company’s financial instruments that are measured at fair value on a recurring basis by their valuation hierarchy levels as of the dates indicated:

	March 31, 2019								December 31, 2018
	Fair Value		Level 1		Level 2		Level 3		Fair Value		Level 1		Level 2		Level 3
Assets carried at fair value:
MBS	$	4,842,447	$	—	$	4,839,977	$	2,470	$	3,749,464	$	—	$	3,747,190	$	2,274
Derivative assets:
Interest rate swaps	112		—		112		—		324		—		324		—
TBA securities	5,918		—		5,918		—		6,239		—		6,239		—
Total assets carried at fair value	$	4,848,477	$	—	$	4,846,007	$	2,470	$	3,756,027	$	—	$	3,753,753	$	2,274
Liabilities carried at fair value:
U.S. Treasury futures	$	—	$	—	$	—	$	—	$	1,218	$	1,218	$	—	$	—
Total liabilities carried at fair value	$	—	$	—	$	—	$	—	$	1,218	$	1,218	$	—	$	—

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

The activity of the Company’s non-Agency MBS measured at fair value on a recurring basis using Level 3 inputs is presented in the following table for the periods indicated:

	Three Months Ended
	March 31,
	2019			2018
Balance as of beginning of period	$	2,274		$	7,243
Unrealized gain included in OCI	268			(310		)
Principal payments	(183		)	(361		)
Accretion	111			311
Balance as of end of period	$	2,470		$	6,883

Fair Value, by Balance Sheet Grouping

The following table presents a summary of the carrying value and estimated fair values of the Company’s financial instruments as of the dates indicated:

	March 31, 2019				December 31, 2018
	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets:
Mortgage-backed securities	$	4,842,447	$	4,842,447	$	3,749,464	$	3,749,464
Mortgage loans held for investment, net (1)	10,862		7,458		11,527		8,566
Derivative assets	6,030		6,030		6,563		6,563
Liabilities:
Repurchase agreements (2)	$	4,252,893	$	4,252,893	$	3,267,984	$	3,267,984
Non-recourse collateralized financing (1)	3,219		3,073		3,458		3,475
Derivative liabilities	—		—		1,218		1,218

(1) The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.

(2) The carrying value of repurchase agreements generally approximates fair value due to their short-term maturities.

XML

(Tables)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Dividends Declared

Common Stock. The following table summarizes information regarding monthly dividend declarations on the Company’s common stock for the first quarter of 2019:

	Three Months Ended
	March 31, 2018
Declaration Date	Amount Declared		Record Date	Payment Date
January 7, 2019	$	0.06	January 18, 2019	January 31, 2019
January 28, 2019	0.06		February 14, 2019	February 28, 2019
March 12, 2019	0.06		March 22, 2019	April 1, 2019

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

The following table presents a rollforward of the restricted stock activity for the periods indicated:

	Three Months Ended
	March 31,
	2019				2018
	Shares		Weighted Average Grant Date Fair Value Per Share		Shares		Weighted Average Grant Date Fair Value Per Share
Restricted stock outstanding as of beginning of period (1)	341,713		$	6.37	353,103		$	7.01
Restricted stock granted	152,462		6.10		176,233		6.28
Restricted stock vested (1)	(151,139	)	6.37		(194,827	)	7.37
Restricted stock outstanding as of end of period (1)	343,036		$	6.25	334,509		$	6.42

XML

Organization and Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Cash and cash equivalents	$ 55,902	$ 34,598
Restricted cash	86,761	54,106
Total cash, cash equivalents, and restricted cash shown on consolidated statement of cash flows	$ 142,663	$ 88,704	$ 86,384	$ 87,200

XML

Investments in Debt Securities Investments in Debt Securities (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Investment [Line Items]
Par value of available for sale debt security		$ 4,194,824		$ 3,194,441
Investments, Unamortized Premium (Discount)		596,936		590,968
Debt Securities, Available-for-sale, Amortized Cost		4,791,760		3,785,409
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		72,514		21,436
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		21,827		57,381
Debt Securities, Available-for-sale		4,842,447		3,749,464
Proceeds from Sale of Available-for-sale Securities		0	$ 155,256
Debt Securities, Available-for-sale, Realized Gain (Loss)		0	(3,775)
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost		119,121		39,868
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value		121,882		39,808
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost		151,888		151,041
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value		154,615		152,917
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost		911,278		828,543
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value		910,315		806,015
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Amortized Cost		3,609,473		2,765,957
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Fair Value		3,655,635		2,750,724
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost		4,791,760		3,785,409
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value		4,842,447		3,749,464
Agency MBS
Investment [Line Items]
Notional balance for interest only securities		13,146,249		13,048,666
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value		46,127		581,440
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss		$ 174		$ 1,793
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year		9		28
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value		$ 1,293,417		$ 1,543,892
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		$ 21,248		$ 54,260
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year		61		88
Non-Agency MBS
Investment [Line Items]
Notional balance for interest only securities		$ 10,158,055		$ 10,275,494
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value		25,130		70,876
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss		$ 177		$ 581
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year		7		22
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value		$ 21,512		$ 46,154
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		$ 228		$ 747
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year		13		19
Residential Mortgage Backed Securities
Investment [Line Items]
Par value of available for sale debt security		$ 2,684,079		$ 2,119,495
Investments, Unamortized Premium (Discount)		77,584		56,744
Debt Securities, Available-for-sale, Amortized Cost		2,761,663		2,176,239
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		31,840		8,926
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		11,424		26,286
Debt Securities, Available-for-sale		2,782,079		2,158,879
Commercial Mortgage Backed Securities
Investment [Line Items]
Par value of available for sale debt security		1,510,745		1,074,946
Investments, Unamortized Premium (Discount)		8,848		6,481
Debt Securities, Available-for-sale, Amortized Cost		1,519,593		1,081,427
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		31,443		6,554
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		9,864		29,550
Debt Securities, Available-for-sale		1,541,172		1,058,431
Interest-Only-Strip
Investment [Line Items]
Investments, Unamortized Premium (Discount)		510,504		527,743
Debt Securities, Available-for-sale, Amortized Cost		510,504		527,743
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		9,231		5,956
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		539		1,545
Debt Securities, Available-for-sale		519,196		532,154
U.S. Treasuries
Investment [Line Items]
Proceeds from Sale of Available-for-sale Securities		0	46,498
Debt Securities, Available-for-sale, Realized Loss		0	(1,723)
Agency | Residential Mortgage Backed Securities
Investment [Line Items]
Par value of available for sale debt security		2,683,276		2,118,639
Investments, Unamortized Premium (Discount)		77,584		56,744
Debt Securities, Available-for-sale, Amortized Cost		2,760,860		2,175,383
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		31,813		8,902
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		11,403		26,264
Debt Securities, Available-for-sale		$ 2,781,270		$ 2,158,021
Investments, Weighted Average Coupon Rate	[1]	4.04%		3.95%
Agency | Commercial Mortgage Backed Securities
Investment [Line Items]
Par value of available for sale debt security		$ 1,507,835		$ 1,071,906
Investments, Unamortized Premium (Discount)		10,775		8,518
Debt Securities, Available-for-sale, Amortized Cost		1,518,610		1,080,424
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		30,766		6,141
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		9,864		29,550
Debt Securities, Available-for-sale		$ 1,539,512		$ 1,057,015
Investments, Weighted Average Coupon Rate	[1]	3.23%		3.22%
Proceeds from Sale of Available-for-sale Securities		$ 0	108,758
Debt Securities, Available-for-sale, Realized Loss		0	$ (2,052)
Agency | Interest-Only-Strip
Investment [Line Items]
Investments, Unamortized Premium (Discount)		282,636		$ 287,062
Debt Securities, Available-for-sale, Amortized Cost		282,636		287,062
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		5,982		4,281
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		154		239
Debt Securities, Available-for-sale		$ 288,464		$ 291,104
Investments, Weighted Average Coupon Rate	[1]	0.53%		0.55%
Non-Agency | Residential Mortgage Backed Securities
Investment [Line Items]
Par value of available for sale debt security		$ 803		$ 856
Investments, Unamortized Premium (Discount)		0		0
Debt Securities, Available-for-sale, Amortized Cost		803		856
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		27		24
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		21		22
Debt Securities, Available-for-sale		$ 809		$ 858
Investments, Weighted Average Coupon Rate	[1]	6.75%		6.75%
Non-Agency | Commercial Mortgage Backed Securities
Investment [Line Items]
Par value of available for sale debt security		$ 2,910		$ 3,040
Investments, Unamortized Premium (Discount)		(1,927)		(2,037)
Debt Securities, Available-for-sale, Amortized Cost		983		1,003
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		677		413
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		0		0
Debt Securities, Available-for-sale		$ 1,660		$ 1,416
Investments, Weighted Average Coupon Rate	[1]	6.27%		6.47%
Non-Agency | Interest-Only-Strip
Investment [Line Items]
Investments, Unamortized Premium (Discount)		$ 227,868		$ 240,681
Debt Securities, Available-for-sale, Amortized Cost		227,868		240,681
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax		3,249		1,675
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax		385		1,306
Debt Securities, Available-for-sale		$ 230,732		$ 241,050
Investments, Weighted Average Coupon Rate	[1]	0.56%		0.57%

[1] The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).

XML

Repurchase Agreements (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Balance	$ 4,252,893	$ 3,267,984
Weighted Average Rate	2.78%	2.69%
Fair Value of Collateral Pledged	$ 4,537,607	$ 3,511,604
Payable for unsettled securities	151,075	58,915
Agency | Commercial Mortgage Backed Securities
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Balance	$ 1,220,326	$ 919,833
Weighted Average Rate	2.68%	2.51%
Fair Value of Collateral Pledged	$ 1,304,731	$ 986,861
Agency | Residential Mortgage Backed Securities
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Balance	$ 2,582,697	$ 1,887,878
Weighted Average Rate	2.75%	2.66%
Fair Value of Collateral Pledged	$ 2,719,705	$ 1,998,922
Agency | Interest-Only-Strip
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Balance	$ 253,168	$ 253,258
Weighted Average Rate	3.05%	2.96%
Fair Value of Collateral Pledged	$ 282,927	$ 285,247
Non-Agency | Interest-Only-Strip
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Balance	$ 196,702	$ 207,015
Weighted Average Rate	3.39%	3.38%
Fair Value of Collateral Pledged	$ 230,244	$ 240,574

XML

Repurchase Agreements Remaining Term to Maturity (Details) $ in Thousands	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Balance	$ 4,252,893	$ 3,267,984
WAVG Original Term to Maturity	58	66
Less than 30 days
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Balance	$ 3,459,566	$ 2,319,911
WAVG Original Term to Maturity	52	56
30 to 90 days
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]
Balance	$ 793,327	$ 948,073
WAVG Original Term to Maturity	82	89

XML

Repurchase Agreements Counterparty Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($) Agreements
Repurchase Agreement Counterparty [Line Items]
Borrowings outstanding with counterparty	$ 357,111
Weighted Average Rate	3.56%
Equity at Risk	$ 43,381
Line of Credit Facility, Amount Outstanding	212,631
Line of Credit Facility, Maximum Borrowing Capacity	$ 400,000
Line of Credit Facility, Expiration Date	May 12, 2019
Line of Credit Facility, Interest Rate at Period End	3.32%
Number of Counterparties with Borrowings Outstanding | Agreements	19
Available Repurchase Agreement Counterparties | Agreements	36

XML

Repurchase Agreements Offsetting (Details) - USD ($) $ in Thousands		Mar. 31, 2019	Dec. 31, 2018
Offsetting Liabilities [Line Items]
Gross Amount of Recognized Liabilities		$ 4,252,893	$ 3,267,984
Gross Amount Offset in the Balance Sheet		0	0
Net Amount of Liabilities Presented in the Balance Sheet		4,252,893	3,267,984
Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Securities	[1]	(4,252,893)	(3,267,984)
Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Cash		0	0
Securities Sold under Agreements to Repurchase, Amount Offset Against Collateral		$ 0	$ 0

[1] Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of debt securities up to and not exceeding the net amount of the repurchase agreement liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented.

XML

(Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Derivative [Line Items]
Derivative assets, fair value		$ 6,030		$ 6,563
Gain (loss) on derivative instruments, net		$ (61,697)	$ 38,354
Derivative, Average Fixed Interest Rate, Current Effective		2.38%		2.29%
Forward starting interest rate swap
Derivative [Line Items]
Derivative, Notional Amount		$ 0		$ (775,000)
Eurodollar futures
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain		0	1,905
U.S. Treasury futures
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain			0
Derivative Instruments Not Designated as Hedging Instruments, Loss		(109)
Long [Member] | Interest rate swaps
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Loss		0	(1,129)
Long [Member] | TBA securities
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain		10,176
Derivative Instruments Not Designated as Hedging Instruments, Loss			(12,087)
Short [Member] | Interest rate swaps
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain			49,372
Derivative Instruments Not Designated as Hedging Instruments, Loss		(71,764)
Short [Member] | TBA securities
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain		0	$ 293
Not Designated as Hedging Instrument, Economic Hedge [Member] | Interest rate swaps
Derivative [Line Items]
Derivative assets, fair value		112		324
Derivative, Notional Amount	[1]	$ (5,015,000)		$ (4,515,000)
Derivative, Average Fixed Interest Rate	[2]	2.38%		2.35%
Derivative, Average Remaining Maturity		5 years 11 months 16 days	5 years 6 months 1 day
Derivative, Fair Value, Net	[3]	$ 112		$ 324
Not Designated as Hedging Instrument, Economic Hedge [Member] | U.S. Treasury futures
Derivative [Line Items]
Derivative, Notional Amount		0		(50,000)
Notional Amount of Derivative Instruments Added		0
Notional Amount of Derivative Instruments Maturing, Settled, Terminated, or Paired-Off		(50,000)
Not Designated as Hedging Instrument, Economic Hedge [Member] | Short [Member] | Interest rate swaps
Derivative [Line Items]
Derivative, Notional Amount		(5,015,000)		(4,515,000)
Notional Amount of Derivative Instruments Added		1,500,000
Notional Amount of Derivative Instruments Maturing, Settled, Terminated, or Paired-Off		(1,000,000)
Not Designated as Hedging Instrument, Trading | Long [Member] | TBA securities
Derivative [Line Items]
Derivative assets, fair value		5,918		6,239
Derivative, Notional Amount		(715,000)		(860,000)
Notional Amount of Derivative Instruments Added		2,720,000
Notional Amount of Derivative Instruments Maturing, Settled, Terminated, or Paired-Off		(2,865,000)
Not Designated as Hedging Instrument, Trading | Short [Member] | U.S. Treasury futures
Derivative [Line Items]
Derivative liabilities, fair value		0		(1,218)
Maturity in three years or less | Not Designated as Hedging Instrument, Economic Hedge [Member] | Interest rate swaps
Derivative [Line Items]
Derivative, Notional Amount	[1]	$ (1,435,000)		$ (1,560,000)
Derivative, Average Fixed Interest Rate		2.01%		1.96%
Derivative, Average Remaining Maturity		1 year 3 months	1 year 4 months 18 days
Derivative, Fair Value, Net	[3]	$ 112		$ 324
Maturity between 3 and 6 years | Not Designated as Hedging Instrument, Economic Hedge [Member] | Interest rate swaps
Derivative [Line Items]
Derivative, Notional Amount	[1]	$ (1,930,000)		$ (1,230,000)
Derivative, Average Fixed Interest Rate		2.27%		2.23%
Derivative, Average Remaining Maturity		5 years 8 months 1 day	4 years 4 months 17 days
Derivative, Fair Value, Net	[3]	$ 0		$ 0
Maturity between 6 and 10 years | Not Designated as Hedging Instrument, Economic Hedge [Member] | Interest rate swaps
Derivative [Line Items]
Derivative, Notional Amount	[1]	$ (1,530,000)		$ (1,505,000)
Derivative, Average Fixed Interest Rate		2.85%		2.80%
Derivative, Average Remaining Maturity		8 years 11 months 16 days	8 years 3 months 16 days
Derivative, Fair Value, Net	[3]	$ 0		$ 0
Maturity greater than 10 years [Member] | Not Designated as Hedging Instrument, Economic Hedge [Member] | Interest rate swaps
Derivative [Line Items]
Derivative, Notional Amount	[1]	$ (120,000)		$ (220,000)
Derivative, Average Fixed Interest Rate		2.84%		2.81%
Derivative, Average Remaining Maturity		28 years 5 months 1 day	21 years 10 months 29 days
Derivative, Fair Value, Net	[3]	$ 0		$ 0

[1] The notional amounts include $0 and $775,000 of forward starting pay-fixed interest rate swaps as of March 31, 2019 and December 31, 2018, respectively.

[2] Excluding forward starting pay-fixed interest rate swaps, the weighted average pay rate was 2.38% and 2.29% as of March 31, 2019 and December 31, 2018, respectively.

[3] The majority of the Company’s interest rate swap agreements are centrally cleared through the CME. Please refer to Note 1 for information regarding the exchange of variation margin being legally considered as settlement of the derivative as opposed to a pledge of collateral.

XML

Derivatives TBA securities (Details) - Long [Member] - Not Designated as Hedging Instrument, Trading - TBA securities - USD ($) $ in Thousands		Mar. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Derivative, Notional Amount		$ 715,000	$ 860,000
Cost Basis,TBA		727,212	882,230
Market value, TBA	[1]	733,130	888,469
Net carrying value, TBA	[2]	$ 5,918	$ 6,239

[1] (1)Implied market value represents the estimated fair value of the underlying Agency MBS as if settled as of the date indicated.

[2] Net carrying value is the amount included on the consolidated balance sheets within “derivative assets (liabilities)” and represents the difference between the implied market value and the implied cost basis of the TBA security as of the date indicated.

XML

Derivatives Volume of Activity (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Not Designated as Hedging Instrument, Economic Hedge [Member] | Interest rate swaps
Derivative [Line Items]
Beginning of Period Notional Amount	$ 4,515,000	[1]
End of Period Notional Amount	5,015,000	[1]
Not Designated as Hedging Instrument, Economic Hedge [Member] | Interest rate swaps | Short [Member]
Derivative [Line Items]
Beginning of Period Notional Amount	4,515,000
Notional Amount of Derivative Instruments Added	1,500,000
Notional Amount of Derivative Instruments Maturing, Settled, Terminated, or Paired-Off	(1,000,000)
End of Period Notional Amount	5,015,000
Not Designated as Hedging Instrument, Economic Hedge [Member] | U.S. Treasury futures
Derivative [Line Items]
Beginning of Period Notional Amount	50,000
Notional Amount of Derivative Instruments Added	0
Notional Amount of Derivative Instruments Maturing, Settled, Terminated, or Paired-Off	(50,000)
End of Period Notional Amount	0
Not Designated as Hedging Instrument, Trading | TBA securities | Long [Member]
Derivative [Line Items]
Beginning of Period Notional Amount	860,000
Notional Amount of Derivative Instruments Added	2,720,000
Notional Amount of Derivative Instruments Maturing, Settled, Terminated, or Paired-Off	(2,865,000)
End of Period Notional Amount	$ 715,000

[1] The notional amounts include $0 and $775,000 of forward starting pay-fixed interest rate swaps as of March 31, 2019 and December 31, 2018, respectively.

XML

Derivatives Offsetting Assets (Details) - USD ($) $ in Thousands		Mar. 31, 2019	Dec. 31, 2018
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset		$ 6,030	$ 6,563
Derivative Asset, Fair Value, Amount Not Offset Against Collateral		6,030	6,563
Derivative, Collateral, Obligation to Return Securities	[1]	0	0
Derivative, Collateral, Obligation to Return Cash		1,699	1,719
Derivative Asset, Fair Value, Amount Offset Against Collateral		4,331	4,844
Interest rate swaps
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset		112	324
Derivative Asset, Fair Value, Amount Not Offset Against Collateral		112	324
Derivative, Collateral, Obligation to Return Securities	[1]	0	0
Derivative, Collateral, Obligation to Return Cash		0	0
Derivative Asset, Fair Value, Amount Offset Against Collateral		112	324
TBA securities
Offsetting Assets [Line Items]
Derivative Asset, Fair Value, Gross Asset		5,918	6,239
Derivative Asset, Fair Value, Amount Not Offset Against Collateral		5,918	6,239
Derivative, Collateral, Obligation to Return Securities	[1]	0	0
Derivative, Collateral, Obligation to Return Cash		(1,699)	(1,719)
Derivative Asset, Fair Value, Amount Offset Against Collateral		$ 4,219	$ 4,520

[1] Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the derivative asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented. Please refer to the consolidated balance sheets for the total cash posted as collateral, which is recorded as "restricted cash", and the total fair value of financial instruments pledged as collateral for derivatives and repurchase agreements, which is shown parenthetically.

XML

Derivatives Offsetting Liabilities (Details) - USD ($) $ in Thousands		Mar. 31, 2019	Dec. 31, 2018
Offsetting Liabilities [Line Items]
Derivative Liability, Fair Value, Gross Liability		$ 0	$ 1,218
Derivative Liability, Fair Value, Amount Not Offset Against Collateral		0	1,218
Derivative, Collateral, Right to Reclaim Securities	[1]	0	0
Derivative, Collateral, Right to Reclaim Cash		0	(1,218)
Derivative Liability, Fair Value, Amount Offset Against Collateral		0	0
TBA securities
Offsetting Liabilities [Line Items]
Derivative Liability, Fair Value, Gross Liability		0	1,218
Derivative Liability, Fair Value, Amount Not Offset Against Collateral		0	1,218
Derivative, Collateral, Right to Reclaim Securities	[1]	0	0
Derivative, Collateral, Right to Reclaim Cash		0	(1,218)
Derivative Liability, Fair Value, Amount Offset Against Collateral		$ 0	$ 0

[1] Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the derivative asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented. Please refer to the consolidated balance sheets for the total cash posted as collateral, which is recorded as "restricted cash", and the total fair value of financial instruments pledged as collateral for derivatives and repurchase agreements, which is shown parenthetically.

XML

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	$ 6,030	$ 6,563
Derivative liabilities	0	1,218
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	4,842,447	3,749,464
Assets, Fair Value Disclosure	4,848,477	3,756,027
Financial Liabilities Fair Value Disclosure	0	1,218
Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	0	0
Assets, Fair Value Disclosure	0	0
Financial Liabilities Fair Value Disclosure	0	1,218
Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	4,839,977	3,747,190
Assets, Fair Value Disclosure	4,846,007	3,753,753
Financial Liabilities Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage-backed securities	2,470	2,274
Assets, Fair Value Disclosure	2,470	2,274
Financial Liabilities Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	112	324
Fair Value, Measurements, Recurring | Interest rate swaps | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	0	0
Fair Value, Measurements, Recurring | Interest rate swaps | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	112	324
Fair Value, Measurements, Recurring | Interest rate swaps | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	0	0
Fair Value, Measurements, Recurring | TBA securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	5,918	6,239
Fair Value, Measurements, Recurring | TBA securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	0	0
Fair Value, Measurements, Recurring | TBA securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	5,918	6,239
Fair Value, Measurements, Recurring | TBA securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	0	0
Fair Value, Measurements, Recurring | U.S. Treasury futures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	0	1,218
Fair Value, Measurements, Recurring | U.S. Treasury futures | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	0	1,218
Fair Value, Measurements, Recurring | U.S. Treasury futures | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	0	0
Fair Value, Measurements, Recurring | U.S. Treasury futures | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 0	$ 0

XML

Fair Value of Financial Instruments Level 3 (Details) - Non-Agency MBS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of the period	$ 2,274	$ 7,243
Unrealized loss included in OCI	268	(310)
Principal payments	(183)	(361)
Balance at the end of the period	2,470	6,883
Interest Income
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Accretion	$ 111	$ 311

XML

Fair Value of Financial Instruments Recorded basis and Fair Value (Details) - USD ($) $ in Thousands		Mar. 31, 2019		Dec. 31, 2018
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets		$ 6,030		$ 6,563
Derivative liabilities		0		1,218
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage-backed securities		4,842,447		3,749,464
Mortgage loans held for investment, net		10,862		11,527
Derivative assets		6,030		6,563
Repurchase agreements		4,252,893		3,267,984
Non-recourse collateralized financing		3,219		3,458
Derivative liabilities		0		1,218
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage-backed securities		4,842,447		3,749,464
Mortgage loans held for investment, net	[1]	7,458		8,566
Derivative assets		6,030		6,563
Repurchase agreements		4,252,893	[2]	3,267,984
Non-recourse collateralized financing, fair value	[1]	3,073		3,475
Derivative liabilities		$ 0		$ 1,218

[1] The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.

[2] The carrying value of repurchase agreements generally approximates fair value due to their short-term maturities.

XML

Shareholders' Equity (Details) - $ / shares	1 Months Ended			3 Months Ended
	Mar. 31, 2019	Feb. 28, 2019	Jan. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Class of Stock [Line Items]
Preferred stock, shares authorized	50,000,000			50,000,000	50,000,000
Preferred stock, par value	$ 0.01			$ 0.01	$ 0.01
Preferred stock, shares issued	6,168,062			6,168,062	5,954,594
Preferred Stock, Liquidation Preference Per Share	$ 25.00			$ 25.00
Preferred Stock, Dividend Payment Terms				The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year.
Dividends declared per common share	$ 0.06	$ 0.06	$ 0.06
Series A Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares authorized	8,000,000			8,000,000
Preferred stock, shares issued	2,300,000			2,300,000	2,300,000
Preferred Stock, Dividend Rate, Percentage				8.50%
Preferred Stock, Dividends Per Share, Declared				$ 0.053125
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares authorized	7,000,000			7,000,000
Preferred stock, shares issued	3,868,062			3,868,062	3,654,594
Preferred Stock, Dividend Rate, Percentage				7.625%
Preferred Stock, Dividends Per Share, Declared				$ 0.4765625
Preferred Stock
Class of Stock [Line Items]
Dividends Payable, Date to be Paid				Apr. 15, 2019
Dividends Payable, Date of Record				Apr. 01, 2019
Common Stock
Class of Stock [Line Items]
Dividends Payable, Date to be Paid	Apr. 01, 2019	Feb. 28, 2019	Jan. 31, 2019
Dividends Payable, Date of Record	Mar. 22, 2019	Feb. 14, 2019	Jan. 18, 2019

XML

Shareholders' Equity and Share-Based Compensation Share-based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based incentive plan, number of shares authorized for issuance	3,000,000
Stock-based compensation expense	$ 298	$ 335
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options	$ 1,865
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	2 years 3 months 11 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Rollforward]
Restricted stock outstanding as of beginning of period	341,713	353,103
Restricted stock granted	152,462	176,233
Restricted stock vested	(151,139)	(194,827)
Restricted stock outstanding as of end of period	343,036	334,509
Restricted stock as of beginning of period of period, nonvested, weighted average grant date fair value per share	$ 6.37	$ 7.01
Restricted stock granted, weighted average grant date fair value per share	6.10	6.28
Restricted stock vested, weighted average grant date fair value per share	6.37	7.37
Restricted stock as of end of period, nonvested, weighted average grant date fair value per share	$ 6.25	$ 6.42

XML

Subsequent Events Subsequent Events (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Subsequent Event [Line Items]
Stock issuance subsequent to period end	$ 58,887	$ 788